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Abstract
Iron is an essential trace metal with many biochemical roles in the body that require 
its ability to convert between two oxidation states (Fe^^ and Fe^^). It is this property that 
makes iron so useful, which also causes significant toxicity in iron-overload disorders 
such as haemochromatosis, while iron-deficiency anaemia is one of the most common 
dietary deficiencies worldwide. The level of iron within the body is controlled at the point 
of absorption by regulation of the iron transporters divalent metal transporter 1 (DMTl) at 
the apical membrane, and Iregl at the basolateral membrane of duodenal enterocytes. One 
isoform of DMTl contains an iron response element (IRE) in its mRNA in the 
3’untranslated region (UTR), while iregl has an IRE in its 5’UTR. The significance of 
these regulatory elements remains unclear.
The purpose of this study was to investigate how iron transport and transporter 
expression is regulated in the duodenum. Tissue was obtained from iron-deficient and 
iron-loaded rats, and Caco-2 cells were used as an in vitro model of intestinal enterocytes. 
Radioisotope transport studies were used to measure iron transport across Caco-2 
monolayers, and protein and mRNA expression of transporters were measured using 
Western blotting and RT-PCR.
Initial studies on rat tissue showed DMTl (nonIRE) and Iregl mRNA levels were 
increased in iron-deficient rats, but expression of these transporters was not altered in 
iron-loaded rats. DMTl (IRE) mRNA and protein were increased in iron-deficient rats but 
decreased in iron-loaded rats. The mechanism involved in these responses was 
investigated further using Caco-2 cells.
The response to iron challenge in Caco-2 cells had two phases. There was a rapid 
response, in which DMTl (IRE) was internalised within 4 h of iron treatment and 
subsequently recycled to the membrane within 8 h of the iron challenge being withdrawn. 
Following longer exposure to iron, there was a specific decrease in cellular expression 
levels of DMTl (IRE), with the inverse response observed in cells treated with the iron 
chelator desferrioxamine (DFO), indicating possible IRE regulation. In contrast to in vivo 
studies, Iregl expression was not changed in DFO treated cells indicating this transporter 
may be regulated by endogenous signals (e.g. fi*om iron storage tissues) not present in cell 
culture.
Divalent metals other than iron may also influence expression of iron transporters. 
Previous studies have shown that cadmium and copper may regulate DMTl (IRE) via a 
common mechanism, however zinc induces the opposite response. In this study cobalt 
was found to induce expression of DMTl (nonIRE) indicating yet another mechanism for 
the effects of divalent metals on iron transporters.
Recently a liver expressed peptide named hepcidin has been implicated in the 
central regulation of iron homeostasis. Previous studies using Caco-2 cells have shown 
that hepcidin can directly target DMTl (IRE). In this study IL6 stimulated hepatocytes to 
release a substance, presumably hepcidin, which when applied to Caco-2 cells decreased 
DMTl (IRE) expression. This may explain the mechanism that induces anaemia during 
chronic illness (ACD) where IL6 levels are elevated. A second cytokine implicated in 
ACD is TNFa, which increases expression of the iron storage protein ferritin but 
decreases DMTl (IRE). This effect of TNFa may also have implications for the local
11
regulation of DMTl as TNFa expression by intraepithélial lymphocytes is stimulated by 
iron exposure.
These findings highlight the complexity of iron homeostasis. Proteins involved in 
iron metabolism are controlled in response to a range of stimuli including dietary 
components such as iron levels and the presence of additional divalent metals as well as 
humoral factors during illness, iron overload or deficiency and hypoxia.
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Chapter 1
1.0 Introduction
1.1 Physiology and Disorders o f  Iron Metabolism
Iron is an essential trace metal with many biochemical roles in the body that require 
its ability to convert between ferric (Fe^^) and ferrous (Fe^^) forms. As such iron is 
involved in oxygen transport and storage as part of the oxygen-binding component of 
haemoglobin and myoglobin. Iron also forms part of the functional structure of many 
enzymes such as cytochromes, oxidases, and ribonucleotide reductases leading to roles in 
DNA and RNA synthesis, electron transport and cell proliferation (reviewed in Lieu et 
a l, 2001).
Since iron has such wide-ranging fiinctions any disruption in iron metabolism either 
due to incorrect dietary supply, or defects in the transport, storage or utilisation of iron 
can result in significant clinical disorders.
1.1.1 Iron Deficiency
Iron deficiency occurs when there is a negative balance between iron intake and 
iron loss from the body. Demand for iron is greatest during periods of rapid growth, e.g. 
early childhood, adolescence and in pregnancy, hence during these periods the highest 
rates of anaemia are seen. In the early stages of iron deficiency body iron stores 
(haemosiderin and ferritin) are gradually depleted with few clinical signs. In the later 
stages of anaemia there is increasing fatigue, poor exercise tolerance and decreased work 
performance, while immunity and cognitive development may also be impaired (reviewed 
in Andrews, 1999; Wessling-Resnick, 2000; Hoffbrand and Pettit, 1991).
The most common cause of anaemia is dietary iron deficiency, which may affect up 
to 2 billion people worldwide (Lieu et al., 2001). It has been estimated that 8% of women 
and 7% of children in the USA suffer from anaemia while in Afi-ica rates are much higher 
with 41% of women and 8% of children suffering from the disease (INACG, 2004). 
Dietary differences are responsible for the rate varying between countries. In developing 
countries the diet is commonly high in factors that inhibit iron absorption (such as 
phytate) and low in meat (hence low in haem iron) (Zimmerman et al., 2005).
Iron recycling within the body is normally highly efficient, hence anaemia is 
unlikely to develop solely due to iron deficiency, but generally occurs as a result of low 
dietary supply of iron combined with additional risk factors. Chronic blood loss either in 
the menstrual cycle, or due to parasitic infections such as hookworm may contribute to 
the development of anaemia (Hoffbrand and Pettit, 1991). Anaemia may also develop 
during chronic illness such as infection, inflammation or neoplasia. This anaemia of 
chronic disease is characterised by adequate iron stores, but low serum iron (Spivak, 
2000). The low iron levels may be beneficial in limiting growth of pathogens, but at the 
same time (because iron is a growth factor for lymphocytes) cell-mediated immunity may 
be compromised by iron deficiency. This type of anaemia is discussed in more detail in 
chapter 6.0. Another form of the disease is sideroblastic anaemia, which generally 
involves defects in haem synthesis such as congenital mutations in haem synthase 
(Hoffbrand and Pettit, 1991).
The most effective means of curing many types of anaemia is to treat the underlying 
cause, but iron supplements may also be taken and are generally given as an oral 
preparation of ferrous sulphate (Hoffbrand and Pettit, 1991).
1.1.2 Iron Overload
The ability of iron to switch between two valence states is not only essential to its 
fonction, but also makes it highly toxic. Ferrous iron (Fe^^) is capable of transferring one 
electron to dioxygen to generate superoxide radicals (O2 ). Superoxide is unstable, and 
rapidly reacts with H2O2 to form O2 and OH' and OH* (hydroxyl radical) through the 
Fenton reaction. Once formed, the hydroxyl radical can induce lipid peroxidation, 
resulting in destruction of membranes. Radicals may also cause damage through 
interactions with proteins and DNA.
The term haemochromatosis is applied to several iron overload disorders which 
have similar clinical symptoms but which are due to mutations in different genes. Patients 
with haemochromatosis typically absorb 2-3 fold more iron than normal causing 
progressive iron accumulation. The liver, pancreas, heart and skin are the primary sites of 
iron deposition where the excess iron may induce liver fibrosis and cirrhosis, damage to 
the heart and diabetes (Andrews, 2002) ultimately resulting in organ failure.
Type 1 haemochromatosis is an autosomal recessive disorder affecting mainly 
populations of European decent with a homozygous frequency for the mutated gene 
(HFE) of 1 in 200 - 400. Symptoms of the disease are only apparent by 40-50 years of age 
with increased transferrin saturation being the first clinical indicator (Andrews, 1999). 
Treatment by phlebotomy can allow patients to enjoy normal life expectancy and quality 
if started before permanent damage is sustained (Andrews, 1999; Lieu et al., 2001). The 
function of the HFE gene product is discussed further in section 1.8. In type 1 
haemochromatosis the mutation C282Y in HFE is responsible for the disorder and 
accounts for about 80% of cases of haemochromatosis.
Iron overload causes clinical symptoms at a much younger age in type 2 
haemochromatosis (juvenile haemochromatosis). Life expectancy with untreated juvenile 
haemochromatosis is reduced since symptoms develop by 20 - 30 years of age with iron 
accumulation in the heart, which may result in organ failure. Juvenile haemochromatosis 
may be caused by mutations in at least two different loci. Most patients with juvenile 
haemochromatosis have a mutation in a gene on chromosome Iq (Roetto et al., 1999). 
Recently a candidate gene, named hemojuvelin, which is mutated in juvenile 
haemochromatosis, has been mapped to this locus (Papanikolaou et ah, 2004). A rare 
subset of juvenile haemochromatosis patients has mutations in the gene for hepcidin 
(Roetto et al., 2004). Hepcidin is a recently identified antimicrobial peptide (Krause et al., 
2000), expression of which appears to negatively regulate iron metabolism. Lack of 
hepcidin expression in mouse models causes severe iron overload in the liver and 
pancreas, accompanied by increased serum iron and transferrin saturation (Nicolas et al., 
2001; Nicolas et al., 2002a). The potential role of hepcidin as a negative regulator of iron 
homeostasis is discussed further in sections 1.10.4 and 6.0.
Type 3 haemochromatosis is caused by a mutation in the transferrin receptor 2 
(TfR2) gene. The function of transferrin receptor 1 (TfRl) is described in section 1.7. 
Whereas the fiinction and regulation of TfRl has been extensively studied, the exact role 
of TfR2 is not yet fully understood. As described in section 1.10.1, TfRl is regulated at 
the translational level through a structure known as an iron response element in the 
untranslated region of the mRNA. TfR2 is not regulated by iron in this manner but may 
have a role in regulatory pathways for sensing iron status. This is consistent with 
observations in patients with type 3 haemochromatosis and in animal models of the
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disease which suffer iron overload with increased iron content in the liver (Fleming et al., 
2002).
The mechanism for iron overload in each form of haemochromatosis is not entirely 
clear but is thought to involve miss-regulation of the duodenal iron transporters so that 
expression is higher than appropriate for the iron stores within the body (Stuart et al., 
2003). Details of this are discussed further in section 1.8.
Several mutations have been identified in Iregl that result in haemochromatosis 
type 4 (Montosi et al., 2001; Roetto et al., 2002; Arden et al., 2003; Rivard et al., 2003). 
This mutation appears to reduce the activity of this transporter (Montosi et al., 2001) and 
the disease is distinct from other forms of haemochromatosis since there is greater 
deposition of iron in reticuloendothelial cells rather than in the liver. This may result in a 
lack of iron available for erythropoiesis, which may induce feedback signals to the 
intestine to increase dietary iron uptake (Montosi et al., 2001). The other forms of 
haemochromatosis appear to result from mis-regulation concerning body stores, therefore 
comparing the mechanisms of overload in type 4 haemochromatosis with the mechanism 
present in other forms of the disease may help explain areas of crossover in the regulation 
by utilisation and storage sites.
1,2 Dietary Requirements and Sources o f Iron
Adult men have 35-45 mg/kg body weight iron. This level is maintained by
continuous recycling of body iron so that on average only about 1-2 mg of iron is lost
from the body each day and must be replaced by dietary intake. The circulating level of
iron is also low with about 4 mg being bound by transferrin. The rest of the iron is either
stored in sites such as the liver as ferritin or haemosiderin, or is taken to the bone marrow
II
and used for haemoglobin synthesis, or is present in skeletal muscle as myoglobin (Figure 
1.1). Red blood cells die after about 120 days and are broken down by reticuloendothelial 
macrophages in the spleen and liver (Kupffer cells), after which the iron is released into 
the circulation, bound by transferrin and recycled either back to the bone marrow for 
incorporation into new red blood cells (RBC) as haemoglobin, or to the liver for storage.
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Figure 1.1: Distribution of iron within the body
Total body iron levels are determined by the amount of iron absorbed from the diet since 
excretion is via uncontrolled processes. Iron carried in the blood by transferrin 
constitutes only a minor amount of iron within the body. There is efficient recycling of 
iron from plasma transferrin to the bone marrow for red blood cell (RBC) production, 
and subsequent recovery in the monocyte-macrophage system as the RBC is destroyed. 
The remainder of body iron performs functions as part of enzymes, or is stored in sites 
such as the liver as ferritin to reduce the risk of toxicity (Andrews, 1999).
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The highest levels of iron are found in meat, fish and cereals. Iron is present in the 
diet in two forms, haem and non-haem (inorganic) iron, which are taken up from the diet 
by distinct pathways. Iron is most bioavailable when in the haem form, however in a 
Western diet this may only account for 5-10% of the daily intake and is likely to be even 
lower in developing countries. Non-haem iron forms a greater proportion of dietary iron, 
but is less readily absorbed than haem iron and its uptake is strongly influenced by other 
components of the diet such as calcium or meat content (Table 1.1).
Dietary Factors
Promoters Inhibitors
Ascorbic Acid Phytic Acid
Meat Polyphenols
Citric Acid Tannins
Calcium
Physiological Factors
Promoters Inhibitors
Iron deficiency Iron Overload
Hypoxia Chronic inflammatory disease
Low stomach acid secretion 
(achlorhydria)
Table 1.1: Promoters and inhibitors of non-haem iron absorption
The bioavailability of non-haem iron is partially determined by the relative amounts of 
promoters and inhibitors of non-haem iron uptake in the diet, but physiological factors 
may also have some influence over iron uptake (Sharp et a i, 2003; Benito and Miller, 
1998; Minihane and Fairweather-Trait, 1998; Tapiero et al., 2001).
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Components of the diet that promote iron uptake, such as ascorbate, function by 
reducing iron to the Fe^  ^form (Han et al., 1995), whereas other dietary constituents such 
as phytate may inhibit iron uptake by chelating the iron and rendering it insoluble. The 
incidence of iron deficiency anaemia is especially high in developing countries because 
the diet contains little meat, while being rich in factors that inhibit iron uptake 
(Zimmerman et al., 2005).
1.3 Iron Absorption from the Intestine
There is no physiological mechanism for iron excretion, so its loss from the body is 
limited to non-specific processes such as desquamation of mature enterocytes, and blood 
loss. This means that the amount of iron in the body must be controlled through the 
amount absorbed from the intestine, primarily in the proximal duodenum. The structure of 
the intestine is optimised for nutrient uptake. To maximise the absorptive area the luminal 
surface of the small intestine is covered by projections called villi, which are lined by 
epithelial cells (enterocytes). Enterocytes are produced through the division of stem cells 
in the crypts of Lieberkühn and as the enterocytes migrate along the crypt-villus axis they 
differentiate to become absorptive cells (Figure 1.2).
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Serosa (connective tissue)
Muscularis Externa 
(circular and longitudinal muscle)
Submucosa (Connective tissue, nerves, blood vessels)
Muscularis Mucosae
ina Propria (connective tissue)
Villus Tip
Brush Border Membrane
Basolateral
Membrane
Crypts o f Lieberkühn
Figure 1.2: Structure of the proximal duodenum and the crypt-villus axis
The majority of dietary iron is absorbed in the proximal duodenum, where specialised 
absorptive epithelial cells line the folded layers of villi to maximise the area for nutrient 
uptake. Maturation of these epithelial enterocytes takes place over 2-3 days following 
division of stem cells in the crypts of Lieberkühn and migration up the crypt-villus axis. 
Material absorbed from the intestinal lumen is transferred across the epithelium to the 
lamina propria and subsequently the submucosa, which contain blood vessels to collect 
material absorbed from the lumen. The remainder of the structure consists of layers of 
connective tissue and muscle to aid the passage of material through the intestine.
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Enterocytes are polarised cells with distinct expression of proteins at the luminal 
and serosal membranes. The luminal side of an enterocyte develops a brush border, made 
up of microvilli to maximise the surface area for nutrient uptake.
Ferri tin
I r e g l
DMTl
Hephaest in
Haem
Porphyrin
ring
Figure 1.3: Iron transport across duodenal enterocytes
Inorganic iron is generally in the Fe^  ^ form and must be reduced by either dietary 
reducing agents, or the ferric reductase DcytB before the Fe^  ^ is taken up via DMTl. 
Haem iron is taken up via a separate pathway, which may involve a receptor-mediated 
mechanism. Once inside the cell iron is removed from the porphyrin ring by the action of 
haem oxygenase (HO). Iron from either source may be stored within the enterocyte as 
ferritin, or join a labile iron pool (LIP) that can be transported out of the enterocyte at the 
basolateral membrane through the action of Iregl and hephaestin (McKie et al., 2000;
2001 ; Lieu et ai, 2001 ).
Most dietary inorganic iron is in the Fe^  ^ form, which has poor bioavailability, so before 
transport Fe^  ^ is reduced to Fe^  ^by either dietary reducing agents such as ascorbate, or 
the membrane bound ferrireductase DcytB (McKie et a l, 2001). DMTl then mediates
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uptake of Fe^^ iron across the brush border membrane. Haem iron is absorbed via a 
distinct route that may involve a receptor-mediated mechanism. The haem-receptor 
complex is internalised, following which the haem is degraded by haem oxygenase to 
release inorganic iron (Lieu et al., 2001). Once inside the enterocyte the fate of the iron 
from either source depends on the iron status of the body. If iron levels are high then the 
newly absorbed iron may be re-oxidised to Fe^  ^and stored in ferritin. If the iron remains 
in this state it may be lost from the body when the mature enterocyte is shed into the 
lumen. Alternatively, if stores of iron are low it may be transported out of the cell via 
Iregl at the basolateral membrane. Hephaestin is a ferroxidase that is thought to work 
closely with Iregl to convert Fe^  ^ to Fe^^ in preparation for loading onto transferrin for 
transport in the plasma (Figure 1.3). Each of these steps is described in more detail in the 
following sections.
1.4 The Iron Storage Protein Ferritin
After crossing the apical membrane of the enterocyte iron may be reoxidised and 
stored in ferritin. Ferritin is made up of 24 subunits of either heavy (H) chain, or light (L) 
chain and can hold up to 4500 iron molecules. Ferritin is widely expressed, and its 
properties vary with the proportion of H and L sub-units. H chain is a ferroxidase that 
allows rapid incorporation of iron into ferritin. Ferritin rich in L-chain is found in tissues 
such as the liver, where longer storage of iron is needed. Ferritin may also store iron 
within enterocytes. As intestinal cells mature they migrate from the crypts up the villi. 
Once they reach the tip of the villi they are shed into the lumen and any iron stored as 
ferritin within the cells is lost from the body. Several in vitro studies have shown that 
labile iron pool (LIP) levels are inversely proportional to ferritin expression (Picard et al..
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1998; Cozzi et al., 2000). Storage of iron in ferritin has a protective role since cells over­
expressing ferritin have increased resistance to oxidative damage (Cozzi et al., 2000). 
Post-transcriptional regulation of ferritin by iron levels has been extensively studied and 
is described in section 1.10.1.
7.5  The Basolateral Transporter Iregl
Iron Regulated Transporter 1 (Iregl), also known as Metal Transporter Protein 1 
(MTPl) or Ferroportin 1 is a 62 kDa protein with 10 predicted transmembrane domains 
(McKie et al., 2000; Abboud and Haile, 2000; Donovan et al., 2000). In humans it is 
expressed in the placenta, liver, spleen, and kidney (Donovan et al., 2000). In contrast to 
DMTl, Iregl is expressed at the basolateral membrane of enterocytes, where it is 
responsible for the export of iron from the cell into the blood. Both Donovan et al. (2000) 
and McKie et al. (2000) have used Xenopus oocytes to demonstrate iron transport through 
Iregl. The activity of Iregl seems to be associated with the action of the two ferroxidases, 
hephaestin within the enterocyte or ceruloplasmin in serum (McKie et al., 2000), these 
ferroxidases are required to optimise iron release from the gut, or hepatocytes and 
macrophages respectively, so that it can be loaded onto transferrin for transport in the 
plasma.
1.6 Ceruloplasmin and Hephaestin
The links between the metabolism of different divalent metals is highlighted by the
anaemia that develops in copper-deficient swine, which can be corrected by copper, but
not by iron supplementation (Lee et al., 1968). Ceruloplasmin is a copper binding plasma
protein that is synthesised in the liver and enhances the rate of Fe^  ^ oxidation (Osaki et
al., 1966). Oxidation of Fe^  ^ is necessary for loading iron onto transferrin, hence
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ceruloplasmin has a role in iron export from hepatocytes and reticuloendothelial cells 
(Osaki and Johnson, 1969; Harris et a l, 1999).
In humans, a mutation in the ceruloplasmin gene leads to a condition known as 
aceruloplasminaemia, which causes iron deposition in many tissues. Patients with 
aceruloplasminaemia suffer neurodegeneration of the retina and basal ganglia due to iron 
accumulation within these tissues (Harris et al., 1998). A membrane bound form of 
ceruloplasmin, glycosylphosphatidylinositol-anchored ceruloplasmin, co-localises with 
Iregl in astrocytes to aid iron efflux from these cells (Jeong and David, 2003), however 
studies using Caco-2 cells as a model of intestinal enterocytes suggest that ceruloplasmin 
does not have a role in the transfer of iron out of these cells across the basolateral 
membrane (Zerounian and Linder, 2002).
Sex-linked anaemia (sla) mice have normal iron uptake into enterocytes, but release 
into the circulation is impaired (Chen et al., 2003). This defect was traced to a gene 
encoding a protein called hephaestin, which is very similar in structure to ceruloplasmin. 
Hephaestin expression is high in the small intestine and colon, with low amounts 
elsewhere (Vulpe et al., 1999). Within the intestine hephaestin is not expressed in the 
crypts but is present in the villi (Frazer et al., 2001) where its presence is consistent with a 
role in iron transport. Furthermore, in support of a role for hephaestin in iron efflux from 
enterocytes, copper-deficient rats have reduced serum iron and reduced iron absorption 
that is associated with significantly reduced hephaestin protein expression (Reeves et al., 
2005). Under normal circumstances hephaestin mRNA is up-regulated during iron 
deficiency to enhance iron transfer into the blood from enterocytes (Sakakibara and 
Aoyama, 2002).
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1.7 Transferrin and Transferrin Receptor
Large amounts of free iron in the blood are toxic due to the production of free 
radicals, therefore ferric iron is carried in the blood bound to transferrin (Tf). Tf is an 80 
kDa protein, which is synthesised in the liver and can bind up to two Fe^ .^ The majority 
of cells acquire iron by transferrin receptor (TfRl) mediated endocytosis (Figure 1.4). 
Diferric Tf binds to TfRl and the complex is taken into the cell where iron is released. Tf 
is only released from TfRl once the cycle is completed by exocytosis of the apoTf-TfRl 
complex.
Q
t i TfR
ApoTf
Diferric Tf
© Fe^ *
o DMTl
Figure 1.4: Delivery of iron to cells by TfRl mediated endocytosis
(1) TfRl on the surface of a cell binds diferric Tf and is internalised by transferrin 
receptor mediated endocytosis. (2) The iron is released from Tf following acidification of 
the endosome and is transported into the cytoplasm by DMTl. (3) Apotransferrin (iron- 
free Tf) is only released from the TfRl when it reaches neutral pH at the cell surface 
(Dautry-Versat et a/., 1983).
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In the duodenum TfRl is present only on the basolateral side of the enterocytes and 
expression of the protein decreases as the cells mature. TfRl expression is strictly 
regulated by iron. Iron deficiency anaemia patients have elevated TfRl mRNA in the 
duodenum compared to iron-replete subjects (Pietrangelo et aL, 1992). The mechanism 
behind this iron-mediated regulation is described in section 1.10.1. There is a second form 
of this receptor; TfR2 but the role of this form is not well understood. TfR2 does not have 
the same regulatory elements as TfRl and so is not regulated by iron levels (Kawabata et 
a l, 2000).
1.8 HFE and Hereditary Haemochromatosis
The term haemochromatosis covers a range of iron overload disorders that develop 
similar clinical symptoms but are caused by a number of mutations in different genes 
(described in section 1.1.2). The majority of cases of haemochromatosis are type 1. 
Patients with type 1 haemochromatosis have abnormally high iron uptake in the 
duodenum for a given level of iron stores. Iron levels build up to the extent that iron is 
deposited in the liver and the serum iron concentration is increased. This increases the 
risk of oxidative damage such that untreated haemochromatosis may lead to organ failure 
or cancer (Lieu et a l, 2001).
Type 1 haemochromatosis is caused by a mutation in a gene referred to as HFE. The 
HFE gene is a member of the major histocompatibility complex (MHC) class 1 gene 
family. MHC class 1 gene products are the human leukocyte antigens that are involved in 
antigen recognition by T-cells. MHC class 1 molecules (including HFE) form 
heterodimers with P2-Microglobulin (P2M) for transport to the cell surface for expression 
(Eales, 1997). HFE is a widely expressed protein that is present in high levels on the
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basolateral membrane of enterocytes in the crypts of the duodenum (Parkilla et al., 1997). 
In addition to interacting with P2M, HFE interacts with TfRl potentially inhibiting the 
uptake of transferrin bound iron (Feder et al., 1998; Waheed et al., 1999; Salter-Cid et al.,
1999). However, there are two theories about how this inhibition may be achieved. One 
theory is that HFE lowers the affinity of TfRl for Tf, resulting in decreased iron delivery 
to the cell (Feder et al., 1998; Gross et al., 1998). In contrast, studies by Salter-Cid et al. 
(1999) suggest that HFE does not alter the affinity of TfRl for Tf but instead HFE 
reduces the number of binding sites available for Tf and inhibits internalisation of TfRl 
hence reducing iron uptake.
More recent studies have concluded that HFE does not inhibit Tf-TfRl interactions, 
but instead enhances the Tf-TfRl cycle (Harrison and Bacon, 2003; Brissot et al., 2004). 
This hypothesis is more consistent with the observation that the C282Y mutation in HFE 
inhibits the interaction with P2M, limiting expression at the cell surface and preventing 
association with TfRl (Feder et al., 1998; Griffiths et al., 1999). Hence in patients with 
haemochromatosis the interaction of TfRl-HFE-Tf would be inhibited and this would 
reduce the delivery of diferric Tf to the enterocyte resulting in the iron-deficient state 
observed in enterocytes of haemochromatosis patients (Pietrangelo et al., 1992).
Although the exact role of HFE is still unclear, the molecular effects of 
haemochromatosis have been examined in humans and animal models of the disease 
(Adams et ah, 2003; Muckenthaler et al., 2004). In contrast to the general iron overload 
found in haemochromatosis, enterocytes show an iron deficient phenotype, with sustained 
IRP activity, lower ferritin expression and higher TfRl expression than would be 
expected in iron overload (Pietrangelo et al., 1992; Pietrangelo et al., 1995). In
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enterocytes of mice with a mutation in HFE, DMTl levels are up-regulated (Fleming et 
a i, 1999), potentially due to a reduction in the amount of iron delivered to the enterocyte 
at the basolateral membrane. This may lead to the cell incorrectly sensing that body iron 
stores are low, resulting in the up-regulation of DMTl that causes the iron overload seen 
in haemochromatosis patients. In untreated C282Y haemochromatosis patients, DMTl 
and Iregl levels were significantly increased when compared with non-haemochromatosis 
subjects for a given level of serum ferritin (a measure of body iron stores) (Stuart et al.,
2003).
The study of haemochromatosis has helped in the investigation of iron regulatory 
pathways and has provided evidence that iron metabolism and the immune system are 
closely linked. These interactions are discussed further in sections 1.10.4 and 6.0.
1.9 Divalent Metal Transporter 1
1.9.1 Use of Caco-2 Cells to Study Regulation of DMTl
Caco-2 cells originate from a human colon carcinoma, however when maintained in 
culture they take on the phenotype of human small intestinal enterocytes. After reaching 
confluence the cells differentiate over 14 days to develop morphological and biochemical 
features of mature intestinal enterocytes. They polarise and develop an apical brush 
border, where enzymes associated with intestinal enterocytes such as sucrase isomaltase 
are expressed (Chantret et al., 1994). In terms of iron metabolism the transition from 
proliferative to differentiated cells is associated with a decrease in TfRl, and an increase 
in the expression of DMTl and Iregl that are required for iron transport across the small 
intestinal epithelium (Sharp et al., 2002).
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1.9.2 Structure and Localisation of DMTl
The divalent metal transporter (DMTl), also known as the divalent cation 
transporter (DCTl) or natural resistance associated macrophage protein (Nramp2), was 
first identified in 1995 (Gruenheid et al., 1995) as a homologue of Nrampl, which confers 
resistance to several pathogens. DMTl is part of a family of transporters that have 12 
transmembrane domains (Gunshin et a l, 1997). The gene is 36 Kb long over 17 exons 
(Figure 1.5).
Exons:
l a / b  2 3
f -F
4 5 6-8 9-11 12-15 16/16A
- f t -------------------H i l l  Mi l C
Hubert & Hentze (2002)
17
/
Lee e t al., (1998)
DMTl (+ IRE):
Exon 16 Exon 16A
6WQCLIAL6M5FLDC6HT 1 V5I5K6LLTEEATR6YVK
DMTl (non-IRE):
Exon 16 Exon 17
6WQCLIAL6M5FLDC6HT | CHieLTAQPELYLLNTMDADSLVSR
Figure 1.5: Organisation of the DM Tl gene
Alternative splicing of the DMTl gene at exon lA /lB  and 16/16A may lead to up to 4 
isoforms. The IRE and nonIRE forms differ at the c-terminal.
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Two isoforms of the protein can arise from an alternative splice site in exon 16 that 
differ at the 3’ end. The 3’UTR of one variant contains a single IRE (DMTl (IRE)), 
whereas DMTl (nonIRE) lacks this regulatory element (Lee et al., 1998). Recently two 
further isoforms of DMTl have been identified. These arise from a second initiation site 
upstream of that previously termed exon 1. Therefore in addition to the IRE and nonIRE 
forms, DMTl may have either exon 1A or IB forms (Hubert and Hentze, 2002) leading to 
four possible splice variants.
Initial studies found that DMTl was widely expressed in most tissue and cell types 
(Gruenheid et al., 1995), but expression was highest in the intestine and the kidney. 
Epithelial cell lines express more DMTl (IRE), while DMTl (nonIRE) is more abundant 
in leukocyte cell lines (Tabuchi et al., 2002). The IRE and nonIRE forms of DMTl may 
have different functions reflected by their different locations within the cell. As described 
earlier, enterocytes are polarised with DMTl concentrated at the brush border membrane, 
but not present at the basolateral membrane (Canonne-Hergaux et al., 1999; Tandy et al.,
2000). DMTl (nonIRE) has an alterative 25 amino acids at the C-terminal compared to 
DMTl (IRE). In non-polarised HEp-2 (human larynx carcinoma) cells a specific signal in 
the C-terminal is thought to target DMTl (nonIRE) to early endosomes where it is 
responsible for the release of iron following transferrin receptor-mediated endocytosis 
(section 1.7), while in contrast, DMTl (IRE) is localised to late endosomes and 
lysosomes in Hep-2 cells (Tabuchi et al., 2002). Expression of the lA  isoform is tissue 
specific, while IB expression is more widespread. Regulation of each isoform is 
summarised in Table 1.2. The overall sensitivity of each isoform to iron levels may be the 
result of the combination of A or B type and the presence or absence of IRE (Hubert and 
Hentze, 2002).
26
DMTl Isoform Expression Regulation of mRNA by iron levels
DMTl A (IRE) Duodenum, Kidney Expression increases with 
desferrioxamine-induced low ironDMTl A (nonIRE) Duodenum, Kidney
DMTIB (IRE) Widespread Regulated by iron
DMTIB (nonIRE) Widespread No iron regulation
Table 1.2: DM Tl isoforms, expression and regulation by iron
DMTl type A is subject to iron regulation regardless of the presence or absence of an 
IRE while DMTl type B mRNA is only responsive to iron when an IRE is present.
1.9.3 Metal Transport by DMTl
Two rodent models highlight the importance of DMTl in iron transport. The 
microcytic anaemia {mk) mouse and the Belgrade {b) rat both have hypochromic, 
microcytic anaemia caused by abnormal iron uptake in the intestine and abnormal release 
of iron from endosomes after transferrin receptor-mediated endocytosis. In 1997 it was 
found that the gene responsible for the mk phenotype was DMTl (Fleming et al., 1997). 
Further experiments showed that the same mutation, an arginine replacing glycine 185, 
causes the defect in b rats (Fleming et al., 1998). It is unclear how this mutation affects 
DMTl function but it may inhibit transport ability (Su et al., 1998) as well as alter the 
localisation of the protein (Canonne-Hergaux et al., 2000).
Transport of iron through DMTl is pH dependent with an optimum of 5.5-6.5 
(Tandy et al., 2000). By measuring the inward current in oocytes when treated with 
various metals Gunshin et al. (1997) concluded that DMTl transports a range of divalent 
cations including Fe^ "^ , Cd^ ,^ Co^ ,^ Cu^’*’, Mn^^, Pb^ ,^ and Zn^ .^ However,
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subsequent studies suggest that DMTl is primarily an iron transporter (Tandy et al., 2000; 
Yamaji et al., 2001; Wareing et al., 2000). By measuring the relative ability of metals to 
inhibit iron uptake in Caco-2 cells it has been demonstrated that only Cd^^ and Co^  ^
compete with iron to a significant degree by inhibiting iron uptake 75% and 50% 
respectively (Tandy et al., 2000). Zinc showed the lowest inhibition of iron uptake. 
Unlike iron, zinc uptake is not pH dependent and although addition of a neutralising 
antibody to DMTl reduces iron uptake it has no effect on zinc transport (Tandy et al., 
2000; Yamaji et al., 2001). Other competition studies to assess DMTl function in rat 
kidney also indicate that zinc is not a major substrate for DMTl (Wareing et al., 2000). In 
contrast, there is strong evidence that DMTl can mediate cadmium uptake. In iron-treated 
Caco-2 cells a reduction in DMTl mRNA was found to correspond to a 50% reduction in 
cadmium uptake after 3 and 7 days (Tallkvist et al., 2001). In Madin-Darby canine kidney 
(MDCK) cells cadmium transport is pH dependant, which is characteristic of uptake 
through DMTl. In addition, over-expression of DMTl in HEK-293 (Human Embryonic 
Kidney) cells resulted in an increase in cadmium uptake (Olivi et al., 2001). The reverse 
effect was seen in DMTl knockdown Caco-2 cells, where both iron and cadmium uptake 
was reduced compared to wildtype cells (Bannon et al., 2003). DMTl knockdown 
reduces iron transport 80%, while copper transport is only decreased by 47%. This 
indicates that while DMTl is the major iron transporter at the apical surface, it is not the 
sole transporter of copper (Arredondo et al., 2003). It is likely that the copper transporter 
Ctrl accounts for the remaining uptake activity (Bauerly et al., 2005).
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1.10 Iron Homeostasis
Iron homeostasis is maintained through the complex interaction of various factors. 
Mechanisms for regulating the amount of iron absorbed by enterocytes are sometimes 
separated into three groups. These are known as the dietary regulator (sensing iron 
available from the diet), the stores regulator (sensing the level of iron stores in sites such 
as the liver) and the erythropoietic regulator. The majority of iron in the body is used for 
erythropoiesis, therefore the erythropoietic regulator is thought to modulate iron uptake to 
match the rate of erythropoiesis. One candidate for the erythropoietic regulator is 
erythropoietin. Erythropoietin is a growth factor for red blood cells that has been shown 
to negatively regulate the iron regulatory peptide hepcidin (Nicolas et al., 2002c). When 
hepcidin levels are increased, intestinal absorption in mice is decreased (Lafrah et al., 
2004), hence iron absorption may be regulated via the interaction of erythropoietin and 
hepcidin, resulting in alterations in iron absorption. The role of hepcidin in iron 
metabolism is described further in sections 1.10.4 and 6.0.
As described earlier, levels of iron in the body are primarily controlled by the 
amount absorbed from the diet in the intestine. A likely target for signals regulating iron 
absorption is DMTl. Possible regulatory elements have been found in the 5’ end of the 
DMTl gene, including a possible IFNy responsive element, 5 putative sequences that 
resemble metal response elements and two sequences that may recognise H IFla, which 
may mediate regulation of the transporter by hypoxia (Lee et a l, 1998).
1.10.1 Post-Transcriptional Regulation via IRE and IRP Interactions
Protein expression can be altered via changes in the rate of transcription by signals 
acting through the promoter region of a gene. However many proteins involved in iron
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homeostasis have an additional level of control via post-transcriptional regulation. During 
post-transcriptional regulation the interaction of cytosolic iron regulatory proteins (IRP) 
with one or more iron responsive elements (IRE) in the untranslated region (UTR) of the 
mRNA following specific stimuli may alter expression of a protein. IRE's have been 
found in the mRNA of various proteins including ferritin, Iregl, DMTl and the 
transferrin receptor. IRE’s consist of 28 nucleotides arranged in a stem-loop structure, 
with a characteristic 6 nucleotide loop at the end of an RNA helix and may be found in 
the 5' or 3' UTR of some mRNA.
There are two types of iron regulatory proteins, IRPl and IRP2. IRPl is a 
bifiinctional protein that can either act as a cytoplasmic aconitase, or as a mRNA binding 
protein depending on the iron status of a cell. It was thought that when cellular iron levels 
are high IRPl recruits a 4Fe-4S cluster and acts as an aconitase, however when cellular 
iron levels drop this cluster is disrupted and IRPl assumes mRNA binding activity 
(Constable et al., 1992). While iron levels do not affect IRPl protein expression, IRP2 is 
rapidly degraded in the presence of iron (Guo et al., 1995). IRPl is widely expressed, and 
can be activated in vitro (Mullner et al., 1992) therefore was thought to play a more 
significant role in regulation of cellular iron metabolism than IRP2. However, when 
IRPl'" mice were studied they showed little pathology (Meyron-Holtz et al., 2004a), 
while IRP2' " mice develop neurodegenerative disease due to poor regulation of iron 
metabolism in the brain and intestine (LaVaute et al., 2001) suggesting IRP2 is the most 
important protein in vivo. At physiological conditions IRPl exists mainly as a cytosolic 
aconitase and under conditions of iron saturation that would activate IRP2 does not 
increase the iron binding activity of IRPl (Meyron-Holtz et al., 2004a). In vitro, low iron 
levels promote mRNA binding by both proteins with a similar affinity (Kim et al., 1995).
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The differences observed between in vitro and in vivo regulation of IRPl are likely 
caused by the difference in oxygen saturation. At physiological oxygen concentrations 
IRPl is no longer sensitive to changes in iron levels (Meyron-Holtz et a l, 2004b) hence 
IRP2 is the most important iron regulatory protein responding to iron levels in vivo. 
Another study has shown that haem can bind to IRP2 and may induce its degradation, 
therefore may provide an iron sensing mechanism linked to erythropoiesis (Jeong et al.,
2004).
Other stimuli that can modulate IRP binding include IFNy and hypoxia, which have 
specific effects on each IRP. IFNy increases IRPl binding to IRE, while binding of IRP2 
is decreased (Bouton et al., 1998) and hypoxia results in decreased IRPl binding while 
binding of IRP2 is increased (Hanson et al., 1999) hence IRPl may have a role in 
regulation of iron metabolism in response to factors other than iron.
Depending on the position of an IRE, IRP binding can either block translation (if 
the element is in the 5’ of the mRNA), or increase the stability of the mRNA (if in the 3’ 
end) and either mechanism may lead to changes in expression of the protein product. 
When an IRP binds to an IRE in the 5’UTR of mRNA translation is inhibited. When IRP 
binds to the 5’UTR the cap binding complex binds to the mRNA, but is unable to interact 
with the 43S pre-initiation complex (Gary and Hentze, 1994). In this way translation is 
inhibited, but mRNA levels are unchanged (Figure 1.6).
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Figure 1.6: Regulation through a 5 IRE.
When IRP is stimulated (e.g. under low iron conditions) translation is inhibited resulting 
in decreased protein synthesis. When the IRE is not bound by IRP translation resumes 
and protein levels increase.
Ferritin and Iregl both have IRE’s in the 5’UTR of their mRNA (Aziz and Munro, 
1987; McKie et a l, 2000). The control of ferritin expression in response to iron status 
through IRE/IRP interactions is well characterised (Aziz and Munro, 1987). However, the 
functional role of the IRE in Iregl is unclear. Dietary iron levels may have a role in the 
regulation of Iregl in the duodenum (McKie et a l, 2000). Like ferritin, Iregl has an IRE 
in its 5’UTR, but it is unclear whether this IRE is functional. In iron-deficient mice the 
pattern of regulation is the opposite of that expected for a protein with an IRE in the 
5'UTR. Iregl protein expression in iron-deficient mice was high compared to iron-replete 
mice (Abboud and Haile, 2000). It has been suggested that the IRE may be too far from 
the transcription start site to be functional.
An IRE in the 3’UTR of mRNA leads to reciprocal control of translation compared 
to mRNA with a 5’IRE. Binding of IRP to a 3’IRE protects the mRNA from degradation 
by nucleases (Casey et a l, 1989) resulting in higher mRNA levels and increased protein
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expression. TfRl has five IRE’s in its 3’UTR, however regulation of TfRl by iron is 
dependent on IRP interacting with a 250 nucleotide region containing only three of the 
IRE’s (Casey et ah, 1989). When iron levels are low IRP binds to the IRE, stabilising the 
TfRl mRNA, increasing TfRl synthesis and ultimately increasing TfRl-mediated iron 
uptake (Figure 1.7).
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Figure 1.7: Regulation through 3 ’IRE
When cellular iron levels are low, either IRPl or IRP2 are active to bind IRE. If the IRE 
is in the 3’UTR, binding of the IRP stabilises the mRNA, resulting in higher protein 
expression. In contrast, when cellular iron levels are high IRPl is converted to the 
aconitase form, while IRP2 is degraded leaving IRE unbound and the mRNA with a 
3’IRE is rapidly degraded resulting in lower protein levels.
DMTl has four isoforms, two of which contain a single IRE in its 3’UTR, but so far 
the importance of this IRE in regulating the expression of DMTl in response to changing 
iron status is unclear. IRP has been shown to bind the IRE in vitro (Wardrop and 
Richardson, 1999), and DMTl mRNA responds to iron levels as expected in animal 
models (Gunshin et al., 1997). IRP binding to IRE in TfRl mRNA is associated with 
stabilisation of the mRNA (Casey et al., 1989) however, binding of IRP to the IRE in
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DMTl (IRE) does not alter the half-life of this mRNA in vitro (Tchemitchko et a i, 
2002), hence if this regulatory element in DMTl (IRE) is functionally significant it may 
work via different mechanism to that observed for TfR l.
1.10.2 Regulation of DMTl by Iron
Many studies have shown that the level of iron transport can be regulated in 
response to changing iron availability. In the intestine there may be two stages to this 
regulation each of which may involve distinct mechanisms to alter iron uptake. First there 
may be a rapid response to dietary iron within the mature enterocyte. In a response 
sometimes referred to as mucosal block or dietary regulation, the intestine becomes 
resistant to further iron absorption for a short time immediately after receiving dietary 
iron. A second, less rapid mechanism operating through the stores regulator, responds to 
total body iron levels. There is evidence from a number of studies that the mechanism for 
this iron dependent regulation may involve modulation of DMTl levels in the enterocyte 
(Figure 1.8).
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Figure 1.8: Model for regulation of iron in the duodenum
Changes in body iron stores may be sensed in the crypts of Lieberkühn. One model for 
the regulation of dietary iron absorption proposes that the capacity of an enterocyte to 
absorb iron is programmed in the immature cell, hence any changes in body iron stores 
would not result in altered absorption for 2-3 days. Dietary iron levels may be sensed at 
the tip of the villus leading to rapid modulation of iron uptake activity.
Frazer et a l (2003) investigated the immediate effects of a large dose of iron in the 
rat intestine. They found that uptake was rapidly reduced, and remained low for 12 h after 
iron exposure. This reduced uptake was matched by a 70% reduction in DMTl (IRE) 
mRNA after 3 h, and a reduction in protein levels by 6 h. DMTl (nonIRE), Iregl and 
hephaestin were unchanged indicating that the immediate response to iron is mediated 
through DMTl (IRE) in rat intestine.
Studies over longer time periods showed that in Caco-2 cells 24 h iron exposure 
leads to a reduction in iron uptake as a result of reduced DMTl at the plasma membrane. 
At 24 h there was no significant reduction in mRNA, but following prolonged iron
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exposure for 3-7 days the reduction in mRNA also became significant (Tandy et a l, 
2000; Yamaji et al., 2001; Sharp et al., 2002). A similar pattern of regulation has been 
seen in rat intestine. In iron-deficient rats DMTl mRNA was up-regulated and the protein 
levels were up to 100 fold higher than those in control animals (Gunshin et al., 1997; 
Canonne-Hergaux et al., 1999). In addition, the same response has been observed in iron- 
deficient human patients, where duodenal DMTl mRNA and protein were found to be 
higher than that in iron-replete patients (Zoller et a l, 2001).
At least part of this regulation by iron may be achieved through IRP interacting with 
an IRE in a manner similar to that seen with TfRl. As described in section 1.9.2, DMTl 
has at least two different splice forms, one of which has an IRE in its 3’ UTR (Gunshin et 
al., 1997; Lee e/ al., 1998). The expression pattern of each form varies between different 
tissues. In the intestine, where regulation of DMTl by iron appears to be strongest, there 
is a higher proportion of the IRE form compared to the nonIRE form (Lee et al., 1998), 
and in iron-deficient rats it is the IRE form that is up-regulated in the duodenum (Frazer 
et al., 2001). A suggested model for regulation proposes that an IRP binds to the 3' IRE in 
mRNA when iron availability is low. This stabilises the mRNA and more DMTl protein 
is produced. However, there is conflicting data on the regulation of DMTl indicating that 
the presence or absence of an IRE in DMTl is not sufficient to explain the iron-mediated 
regulation of the transporter. Although DMTl (IRE) in the intestine is regulated by iron, 
it is not regulated in the same way in other tissues. It is possible that these differences are 
caused by the tissue specific expression of the recently identified isoforms lA  and IB.
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The mechanisms involved in the response to acute iron treatment is investigated 
using Caco-2 cells in section 4.0 and more prolonged exposure to either high or low iron 
concentrations is investigated in section 5.0.
1.10.3 Regulation of DMTl by Divalent Metals
Other metals besides iron may influence DMTl expression and function. Cadmium 
has been shown to affect expression of DMTl in Caco-2 cells by reducing mRNA by 
30% after 3 days exposure (Tallkvist et a l, 2001). Investigations into the effects of 
copper on DMTl regulation have also shown a reduction in iron uptake following 24 h 
copper exposure (Tennant et ah, 2002). This reduction in uptake was accompanied by a 
decrease in DMTl protein and a specific reduction in DMTl (IRE), but not DMTl 
(nonIRE) mRNA suggesting that the 3’ region has a role in the response to metal 
treatment.
As described in section 1.9.3, there is evidence that zinc is unlikely to be 
transported by DMTl, however zinc can influence regulation of this transporter. In 
contrast to the effects of cadmium and copper, exposure to zinc induces DMTl mRNA 
and protein, leading to increased iron transport in Caco-2 cells (Yamaji et a l,  2001).
Together this suggests that several different mechanisms may be involved in 
regulation of iron metabolism in enterocytes by divalent metals and this regulation is 
investigated further in section 5.0.
1.10.4 Regulation by Hepcidin and Cytokines
Recently an antimicrobial peptide named hepcidin was isolated from human blood 
and urine (Krause et aL, 2000; Park et al., 2001). Hepcidin is synthesised in the liver as
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an 84 amino acid pro-peptide and is detected in the urine as 20, 22 and 25 amino acid 
metabolites, however the active form of hepcidin is not yet known. Since its discovery 
hepcidin has been shown to have a major regulatory role in controlling body iron status. 
The iron dependent expression of hepcidin has been demonstrated in iron-overloaded 
mice where hepcidin mRNA is up-regulated 2-4 fold (Pigeon et a l, 2001). The 
relationship between hepcidin and iron status is also demonstrated in mice over­
expressing hepcidin, as these mice are bom with severe iron deficiency anaemia (Nicolas 
et al., 2002a). A decrease in hepcidin expression with iron deficiency correlates with an 
increase in the expression of DMTl and Iregl in the intestine (Frazer et a l, 2002), 
suggesting that hepcidin may be the stores regulator that inhibits iron absorption from the 
diet when body stores are high.
As was discussed in section 1.8, the HFE gene is part of the major 
histocompatibility complex (MHC) class 1 gene family, which also includes the human 
leukocyte antigens. Mutations in HFE are responsible for the most common form of the 
iron overload disorder haemochromatosis. Further evidence that iron homeostasis is 
influenced by immune function is clear in patients with long-term inflammatory disease. 
Anaemia of chronic disease is a disorder that develops in patients with chronic activation 
of cellular immunity for example inflammation, infection or malignant disease (Reviewed 
in Means and Krantz, 1992). Individual components of the immune system that have been 
implicated in regulation of iron metabolism include the cytokines IL6, TNFa and IFNy 
which may regulate TfRl expression to reduce transferrin-iron uptake and increase 
expression of ferritin (Han et al., 1997; reviewed in Weiss, 1999). IL6 may be involved in 
a regulatory pathway to increase hepcidin expression, which is then associated with a
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decrease in serum iron and transferrin saturation in patients with anaemia of chronic 
disease (Nemeth et a l, 2003; Nemeth et al., 2004a).
Together current data suggests that hepcidin may function as a central regulator to 
co-ordinate the body’s response to signals from iron stores as well as from the immune 
system. These links between iron metabolism, the immune system, and hepcidin are 
investigated using Caco-2 and HuH7 cells (a hepatoma cell line) in section 6.0.
1.11 Aims
The research discussed in this thesis aims to improve the understanding of the 
mechanisms regulating iron uptake in the intestine. Studies have been performed using 
Caco-2 cells to investigate the effects of external and endogenous factors on the iron 
transporters DMTl and Iregl. In detail, specific aims for each section were as follows:
• Chapter 3.0. To study the effects of changes in body iron status on the level 
of expression and the localisation of iron transporters in intestinal cells. 
Studies used duodenal tissue obtained from rats fed diets with different iron 
content.
• Chapter 4.0. To determine the effects of rapid changes in apical iron on the 
cellular localisation of iron transporter proteins. Studies used the Caco-2 cell 
model of intestinal enterocytes to determine the underlying cellular 
mechanisms. Experiments focussed on the time course of changes in 
expression and localisation of the transporter protein.
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Chapter 5.0. To investigate the response of Caco-2 cells to prolonged 
exposure to high and low iron levels. The influence of cobalt and nickel on 
iron transport and transporter expression was also studied. This work led to 
investigation of a potential pathway for the regulation of iron absorption in 
response to hypoxia.
Chapter 6.0. To study the effects of endogenous factors on iron metabolism. 
In particular links between duodenal iron transporters and the immune 
system were investigated by looking at the effects of the cytokines TNFa 
and IL6.
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2.0 Materials and Methods
2.1 Materials
Cell culture materials were obtained from Invitrogen (Paisley, UK). All other 
materials were obtained from Sigma, (Poole, UK) or Fisher Scientific Ltd., 
(Loughborough, UK) unless otherwise stated.
2.2 Cell Culture
Stock cultures of Caco-2 TC7 cells were obtained from Drs Monique Rousset and 
Edith Brot-Laroche (INSERM U505, Paris, France) and frozen in Dulbecco’s Modified 
Eagles Medium (DMEM) supplemented with 10% glycerol and 30% heat-inactivated 
foetal bovine serum (FBS) and stored in liquid nitrogen until required. After thawing, 
cells were maintained in DMEM supplemented with 200 mM L-glutamine, 1% penicillin 
and streptomycin, 1% non-essential amino acids and 20% FBS, and cultures were kept in 
a 95% air 5% CO2 atmosphere at 37°C. Stock cells were passaged every seven days and 
seeded at a density of 1x10"^  cells per cm^ before use 21 days later. Generally for protein 
extraction, cells were grown in 75 cm^ flasks, for RNA extraction 6 well plates were used 
and transport studies were performed using cells grown on Transwell inserts (Costar UK, 
Buckinghamshire, UK).
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2.3 Isolation o f Whole Cell and Membrane Proteins
Cells grown in 75 cm^ flasks were washed in ice-cold homogenisation buffer (50 
mM mannitol, 10 mM N-2-hydroxyethylpiperazine-N’-2-ethanesulponic acid (HEPES) 
pH 7.2, 0.5 mM, phenylmethyl-sulfonyl fluoride (PMSF), 0.2 mM benzamidine, 0.02% 
sodium azide), and harvested into homogenisation buffer using a cell scraper. Samples 
were homogenised with two 30 sec bursts using an Ultra Turrax T8 homogeniser (Kika 
Labortechnik, Germany) on full power. For some experiments an aliquot of this whole 
cell protein sample was taken and stored at -80°C until required. The remaining 
homogenate was used to prepare a membrane protein sample. All centrifugation steps 
were performed using a Beckman J2-21 centrifuge with a JA-17 rotor. The homogenate 
samples were spun at l,500g for 15 min, and the resulting supernatant was re-centrifuged 
at 15,000g for 30 min. The pellets were resuspended in 200 |il resuspension buffer (300 
mM mannitol, 10 mM HEPES, 0.5 mM PMSF, 0.2 mM benzamidine, 0.02% sodium 
azide) and stored at -80°C until required. Protein levels in each sample were determined 
by the Coomasie blue dye binding method (Bradford, 1976) using Bio-Rad Protein Assay 
Dye Reagent (Bio-Rad Laboratories, Munich, Germany).
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2.4 Western Blotting
Protein expression was measured by Western blotting. Whole cell protein samples 
(40 tig) or membrane samples (20 p,g) in sample buffer (100 mM Dithiothreitol (DTT), 50 
mM Tris, 2% sodium dodecyl sulphate (SDS), 10% Glycerol, 0.1% Bromophenol Blue) 
were loaded onto a 10% polyacrylamide gel and run at 25 mA per gel. Samples were 
transferred from the gel onto nitrocellulose (Hybond ECL, Amersham, Buckinghamshire, 
UK) using a semi-dry blotter (HorizBlot AE-6677, ATTO Corporation, Japan) set at 2 
mA/cm^. The nitrocellulose was pre-soaked in transfer buffer (40 mM glycine, 48 mM 
Tris pH 8.3, 1.3 mM SDS, 20% Methanol). Following transfer the membrane was 
blocked in 5% PBS-T (5% fat-free milk, 0.1% Tween20 in PBS) for 30 min then 
incubated with the primary antibody (Table 2.1 and Table 3.2) for 1 h at room 
temperature. After three 15 min washes in 1% PBS-T (1% fat-free milk, 0.1% Tween20 
in PBS) the membrane was exposed to the appropriate secondary antibody (Table 2.1) for 
45 min. Following a further three 15 min washes in 1% PBS-T cross reactivity was 
visualised using enhanced chemiluminescence (ECL plus) and Hyperfilm ECL 
(Amersham, Buckinghamshire, UK). Band density was quantified by densitometric 
analysis using Scion Image software (Scion Corporation, Maryland, USA).
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Primary Antibodies
Antibody Supplier Dilution
Human DMTl (IRE), 
affinity pure
Alpha Diagnostic International, 
Texas, USA
2 pg/ml
Rat DMTl (nonIRE), 
antiserum
Alpha Diagnostic International, 
Texas, USA
1:500
Mouse Iregl, 
antiserum
Alpha Diagnostic International, 
Texas, USA
1:500
Villin Santa Cruz Biotechnology, Inc, 
California, USA
1:1000
Secondary Antibodies (Peroxidase conjugated)
Goat anti-rabbit DakoCytomation, Denmark 1:1000
Rabbit anti-goat DakoCytomation, Denmark 1:1000
Table 2.1: Antibody Specifications
Suppliers and dilutions of both primary and secondary antibodies used for Western 
blotting on Caco-2 cell samples. All antibodies were diluted in 1% PBS-T. Villin is an 
apical membrane associated structural protein (Baricault et al., 1993) used as a negative 
control in these experiments
2.5 Isolation o f  RNA
For RNA isolation, cells were grown on either 6 well plates, or Trans well 
membranes as appropriate for the experiment. To isolate total RNA the cells were lysed 
by incubation with 1 ml Trizol (Invitrogen, Paisley, UK) for 10 min. The sample was 
mixed with 200 pi chloroform, and incubated for 10 min before being centrifuged at 
12,000g for 15 min (Eppendorf Centrifuge 5415D). The aqueous phase was collected and 
incubated for 10 min with 500 pi propan-2-ol to precipitate the RNA. The sample was 
centrifuged again for 10 min at 12,000g and the pellet washed in 75% ethanol. The pellet
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was stored at -80 °C until required, and resuspended in DEPC-treated water before use. 
An aliquot of each sample was taken and the absorbance measured at 260 nm to 
determine the RNA concentration (One absorbance unit = 40 pg/ml RNA).
2.6 Reverse Transcription Polymerase Chain Reaction
Reverse transcription polymerase chain reaction (RT-PCR) was carried out using 
Ready-to-go RT-PCR Beads (Amersham, Buckinghamshire, UK). The primers were 
obtained from MWG-Biotech, Ebersberg, Germany using the following sequences:
P- Actin: Forward; 5’-CCAAGGCCAACCGCGAGAAGATGAC-3’
Reverse; 5’-AGCGTACATGGTGGTGCCGCCAGAC-3 ’
DMTl (IRE): Forward; 5’-AGTGGTTTATGTCCGGGACC-3’
Reverse; 5’-TTTAACGTAGCCACGGGTGG-3’
DMTl (nonIRE): Forward; 5’-TCCTAGATGACTGACAGCC-3 ’
Reverse; 5’-CCAAGACACAAGCCCATA-3’
Iregl: Forward; 5’-ATTGCTGCTAGAATCGGTCT-3’
Reverse; 5’-AGACTGAAATCAATACGAGC-3 
TfRl : Forward; 5 ’-CGATAACAGTCATGTGGA-3 ’
Reverse; 5’-AGTAACTGTTGCAGCCTTAC-3’
The first strand primer (0.5 pg) and appropriate forward and reverse primers (2 
pmoles) were added to the beads, with 1 pg total RNA, and the volume made up to 50 pi 
with DEPC-treated water. The cDNA transcript was produced by incubation at 42°C for 
30 min. The reaction was then heated to 95°C for 5 min to denature the DNA and 
inactivate the reverse transcriptase. PCR was performed by cycles of denaturing for 30 
sec, annealing for 30 sec and elongation for 1 min (Table 2.2).
46
Gene DenaturingTemperature
Annealing
Temperature
Elongation
Temperature
Number of 
Cycles
P-Actin 95°C 65°C 72°C 26
DMTl (IRE) 95''C 54°C 72°C 28
DMTl (nonIRE) 95''C 50°C 72°C 28
Iregl 95°C 50°C 72°C 28
TfRl 95''C 50°C 72°C 26
Table 2.2: RT-PCR conditions
RNA extracts were subjected to RT-PCR using specific primers for (3-Actin, DMTl 
(IRE), DMTl (nonIRE), Iregl, and TfRl. Amplification was achieved by cycles of 
denaturing, annealing, and elongation at gene specific temperatures.
In the last step of the PCR reaction, the samples were held at 72°C for 10 min for 
final elongation. PCR products were separated on a 2% agarose gel containing 20 pg 
ethidium bromide, in 100 ml TBE (IM Tris, IM Boric Acid, 0.02M EDTA) and 
visualised under UV light using a Fluor-S Multilmager (Bio-Rad Laboratories Ltd). Band 
intensity was analysed using Scion Image software (Scion Corporation, Maryland, USA).
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2 .7  Real Time PCR (QRT-PCR)
2.7.1 Ribogreen™ RNA Quantification
The Ribogreen^^ reagent is a nucleic acid stain used as part of the Ribogreen™ 
RNA quantitation kit (Molecular Probes, Oregon, USA). The assay was performed 
according to the manufactures instructions.
Briefly, RNA was isolated using Trizol as described in section 2.5. The test RNA 
samples from Caco-2 cells were diluted 1:40 in the Ix Tris:EDTA (TE) buffer provided 
with the kit. A standard curve using 0 ng, 20 ng, 100 ng, 500 ng and 1000 ng RNA was 
created by diluting the provided RNA standard in IX TE buffer. The Ribogreen™ reagent 
was diluted 200 fold in Ix TE buffer and applied to both test samples and standards. 
Samples were incubated at room temperature for 5 min, and then the fluorescence was 
read on a SpectraMax GeminiXS spectrophotometer (Molecular Devices Corporation, 
USA). Sample concentration was calculated using the standard curve and accounting for 
the dilution factor.
2.7.2 DNase Treatment
Contaminating DNA was removed from the samples using an RNase-Free DNase 
kit (Promega, Wisconsin, USA). A solution containing RNA (5 pg), lOx DNase buffer (2 
pi), and RNase-free DNase I (2 pi) was mixed and made up to a total volume of 20 pi 
with RNase-free water. The reactions were then incubated at 37°C for 30 min. DNase stop 
solution (2 pi) was added to each tube and the samples were incubated at 65°C for 10 
min.
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2.7.3 cDNA Synthesis
In the first step of cDNA synthesis, 1 pg DNase-treated RNA was mixed with step 
1 components (Table 2.3) and heated to 65°C for 10 min. The reactions were rapidly 
cooled on ice for at least 2 min. Step 2 components (Table 2.3) were mixed and 8 pi 
added to each reaction, which was then incubated at 25°C for 10 min, 42°C for 50 min 
and 70°C for 15 min. Finally 80 pi water was added to each reaction to give an equivalent 
of 10 ng/ml initial template RNA. For each RNA sample RT and non-RT samples were 
prepared. In the non-RT reactions the reverse transcriptase was replaced with the 
corresponding volume of water, hence no cDNA could be created in these negative 
controls.
Step Component Volume per RT Reaction
Volume per non- 
RT Reaction
1 10 mM dNTPs 1.5 pi 1.5 pi
1 150 ng/ml random hexamers 1.5 pi 1.5 pi
1 DEPC-treated water 5 pi 5 pi
2 5x RT Buffer 4 pi 4 pi
2 0.1 M DTT 2 pi 2 pi
2 RNase OUT 1 pi 1 pi
2 Water 0.75 pi I p l
2 Superscript II 0.25 pi Opl
Table 2.3: Reverse transcription reagents
For cDNA synthesis Step 1 and step 2 reagents made up in multiples as required. All 
materials were obtained from Invitrogen (Paisley, UK) except for dNTPs, which were 
supplied by Promega, Wisconsin, USA.
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2.7.4 TaqMan Real Time PCR
Human genomic DNA (Promega, Madison, Wisconsin) was used to generate a 
standard curve ranging from 10^  to 10  ^single stranded copies. Primer pairs and probes are 
described in Table 2.4.
Gene Primers and Probes
DMTl
(IRE)
Forward CTC TCA OCA GAA TCG TCA TGT TTT
Reverse TGA GAT TGC CTC GCA AGT CA
Probe CTG ATG CAC CGC TCT GCT TCA TGC
DMTl
(nonIRE)
Forward GAT CAG TTT TCC GTG CTG CAT
Reverse AAG CTA AAT GTT AGA AGT TTC CTC TTT TTT
Probe TCA GCT CAT TCT GGC ATT CAA GTT TTA GGC
Table 2.4: QRT-PCR primer and probe sequences
Primers and probes for DMTl (IRE) and DMTl (nonIRE) were designed by Dr Kelly 
Johnston using Primer Express software (Applied Biosystems, California, USA) and 
were synthesised by MWG Biotech (Ebersberg, Germany).
PCR reagent was prepared in bulk as described in Table 2.5 and 20 pi of this 
reagent was added to 5 pi sample or standard in wells of Thermo-Fast 96 detection plates 
(Applied Biosystems, California, USA). Plates were then sealed with an optical adhesive 
cover (Applied Biosystems, California, USA).
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Component
Amount
(stock concentration)
Supplier
Forward Primer 1 pi (10 pmol/pl) MWG Biotech (Ebersberg, Germany)
Reverse Primer 1 pi (10 pmol/pl) MWG Biotech (Ebersberg, Germany)
Probe 0.5 pi (5 pmol/pl) MWG Biotech (Ebersberg, Germany)
TaqMan Universal 
PCR MasterMix 12.5 pi (2x) Applied Biosystems, California, USA
DBPC-Treated
Water 5 pi
Table 2.5: PCR reagent
PCR reagent was made up in bulk as required using the appropriate primer/probe 
combination, 20 pi PCR reagent was added to each reaction.
Samples were analysed using ABI Prism 7000 sequence detection system (Applied 
Biosystems, California, USA) using the conditions specified in Table 2.6.
Step Temperature Duration Cycles
Step 1 50°C 2 min 1
Step 2 95°C 10 min 1
95°C 15 sec
Step 3
60°C 1 min
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Table 2.6: QRT-PCR conditions
QRT-PCR reactions were amplified and analysed using ABI Prism 7000 sequence 
detection system. Amplification was performed in three steps.
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2. s  Iron Transport Studies
For transport studies cells were grown in Trans wells to obtain a polarised 
monolayer. Following treatment, cells were washed in HEPES buffer (140 mM NaCl, 5 
mM KCl, 0.5 mM MgCb, 1 mM NaH2P0 4 , 10 mM HEPES, 1 mM CaCb, pH 7.5) and a 
transepithelial pH gradient was produced by placing HEPES buffer in the basolateral 
chamber and MES buffer (140 mM NaCl, 5 mM KCl, 0.5 mM MgC^, 1 mM NaH2P0 4 , 5 
mM glucose, 10 mM MES, 1 mM CaCb, pH 5.5) in the apical chamber. Uptake was 
initiated by adding 100 pM ascorbate, 10 pM FeCb and 37 KBq/ml ^^FeClg (Amersham, 
Buckinghamshire, UK) to the apical chamber.
To study uptake, cells were incubated at 37°C and transport was terminated after 15 
min by rinsing with HEPES buffer. The iron uptake curve has previously been shown to 
be linear at 15 min under these conditions (Tandy et ah, 2000). At the end of each 
experiment sodium hydroxide (200 mM) was applied to solubilise the cells on the 
Trans well insert. Radioactivity in the cell lysate was quantified by p-scintillation 
counting.
Alternatively, to measure transepithelial flux, transport was terminated after 1 hour 
once uptake had reached equilibrium (Tandy et al., 2000). The inserts were washed in 
HEPES buffer, and fresh HEPES and MES buffers were replaced in the basolateral and 
apical chambers respectively. The plates were incubated at 37°C for a further 2 h and then 
the inserts washed in ice-cold HEPES buffer. The basolateral fluid was kept to measure 
efflux from the cells. Radioactivity in the basolateral fluid was quantified by p- 
scintillation counting.
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2 .9 Statistical Analysis
Data are presented as means ± SEM. Statistical analysis was performed using SPSS 
statistics package using Student’s unpaired t-test or by one-way ANOVA followed by 
Scheffe’s or Tukey’s post hoc test where appropriate. Values of P  <0.05 were considered 
significant.
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3.0 Regulation of iron metabolism in rat duodenum
The majority of dietary iron absorption takes place in the proximal duodenum 
(Conrad et al., 1987), and since there is no specific mechanism for the excretion of excess 
iron from the body, regulation of iron uptake in this area is likely to have a large influence 
over whole body iron homeostasis. Iron uptake in the rat duodenum varies with the level 
of iron present in the diet; the amount absorbed is highest when the diet is deficient in 
iron and lowest when iron rich (Conrad et al., 1987). With the discovery of the iron 
transporters, DMTl and Iregl, and other proteins associated with the process of iron 
uptake and storage, the molecular mechanisms behind the regulation of iron homeostasis 
are becoming clearer.
3.1 Regulation at the Apical Membrane
The apical iron transporter protein DMTl, is not present in the crypts of 
Lieberkiihn, but is found in villus enterocytes at increasing levels towards the villus tip, 
where most absorption takes place (Canonne-Hergaux et a l, 1999; Trinder et al., 2000). 
Parallel to changes in iron uptake, iron availability strongly influences the expression of 
DMTl. An iron-deficient diet induces higher protein and mRNA expression, but an iron- 
loaded diet causes little change in DMTl expression levels compared to a control diet 
(Trinder et al., 2000). In addition to these alterations in the expression level of the 
transporter, the subcellular location of DMTl may be adjusted in response to changing 
iron status. When rats are iron replete, DMTl is found at intracellular locations, thus 
limiting the capacity to absorb further iron, however during iron deficiency the transporter 
is associated with the apical membrane (Trinder et al., 2000), promoting maximum iron 
absorption.
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Analysis of human duodenal tissue has correlated well with the data obtained from 
the animal work. Patients with iron deficiency had elevated DMTl mRNA and protein 
expression compared to control subjects (Zoller et a l, 2001) and as with animal studies, 
the IRE isoform of DMTl is the form that is up-regulated in iron-deficient patients (Rolfs 
et al., 2002).
3.2 Regulation at the Basolateral Membrane
Regulation of the basolateral transporter Iregl in response to changing iron levels is 
unclear. As described in section 1.10.1 Iregl has an IRE in its 5’UTR. If this were 
functional (based on the ferritin response to iron), then protein levels would be expected 
to decrease when iron availability is low. However, in mice administered an iron-deficient 
diet either short term (4 days), or chronically (4 weeks), Iregl mRNA levels increased in 
the duodenum (McKie et al., 2000) suggesting transcriptional rather that post- 
transcriptional regulation, and these changes were reflected at the protein level (Abboud 
and Haile, 2000). This effect is not species specific as results were similar in rats fed an 
iron-deficient diet for 6 weeks; Iregl mRNA was increased, while in rats fed an iron- 
loaded diet levels were slightly decreased (Frazer et al., 2001). In addition, both Iregl 
mRNA and protein expression were enhanced in duodenal tissue fi*om iron-deficient 
patients (Zoller et al., 2001).
In contrast to the pattern observed in the duodenum, when comparing Iregl protein 
in liver from iron-deficient and iron-replete mice, Iregl was found to be decreased in the 
deficient animals as would be expected for regulation through a 5’IRE (Abboud and 
Haile, 2000). So, together these results suggest that the regulation of Iregl is tissue 
specific, and in the duodenum local regulatory signals may override the regulation by the
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IRE system. This difference in regulation may be necessary so that in storage tissues such 
as the liver, iron can be conserved during iron deficiency (decreased Iregl), but in the 
duodenum iron can be more easily absorbed into the circulation from enterocytes 
(increased Iregl).
3.3 Aims
As a starting point for my studies we examined the effects of dietary iron levels on 
the expression of iron transport proteins in rats. The underlying cellular mechanisms were 
subsequently studied using the Caco-2 cell model (chapters 4-6). Duodenal samples were 
taken from rats administered control, iron-deficient and iron-loaded diets for two weeks 
and used to assess iron transporter protein and mRNA expression. In addition, 
immunohistochemistry was performed on tissue sections to visualise the location of the 
transporters.
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3.4 Methods
3.4.1 Animal Care and Treatment
All procedures were in accordance with Home Office Animals (Scientific 
Procedures) Act, 1986, and Dr Kelly Johnston performed the animal work. Male Wistar 
albino rats of approximately 250 g body weight were administered a control, iron- 
deficient or iron-loaded diet (Table 3.1) for 14 days.
Composition Control (g/kg) Deficient (g/kg) Loaded (g/kg)
Casein 200.00 200.00 200.00
DL-Methionine 3.00 3.00 3.00
Sucrose 549.94 549.94 549.94
Com Starch 150.00 150.00 150.00
Com Oil 50.00 50.00 50.00
Mineral Mix, Iron- 
deficient (TD 81062)
35.00 35.00 35.00
Vitamin Mix, AIN-76 A 10.00 10.00 10.00
Choline Bitartrate 2.00 2.00 2.00
Ethoxyquin
(antioxidant)
0.01 0.01 0.01
Carbonyl Iron 0.05 0.00 20.00
Table 3.1: Rat diet compositions
Control, iron-deficient and iron-loaded diets were produced by Harlan Teklad, (Bicester,
UK) and administered to groups of male Wistar albino rats for 14 days.
Treatment of the groups was staggered so that the control and deficient groups 
could be fed the same amount as the iron-loaded group limiting any effects caused by 
differences in food consumption. All animals were allowed free access to water 
throughout the experimental period.
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3.4.2 Measurement of Serum Iron
Blood samples were obtained by cardiac puncture from rats in each of the dietary 
groups. Total serum iron and unsaturated iron-binding capacity (UIBC) were measured 
using a Randox iron kit, number S I7967 (Randox Laboratories Ltd, Co Antrim, UK). 
This is a spectrophotometric method that measures the change in light absorbance caused 
by iron binding to the chromagen ferrozine.
3.4.3 Protein and RNA Analysis
Rats were killed by cervical dislocation and 5 cm sections of the duodenum were 
taken from each rat. Sections were opened along the anti-mesenteric border and the 
mucosal layer scraped away from the underlying musculature using microscope slides. 
Duodenal samples were subsequently used for both protein and RNA isolation.
Membrane protein was prepared as described in section 2.3 and subjected to 
Western blotting as described in section 2.4. Details of the antibodies used for the 
Western blotting are shown in Table 3.2.
RNA extraction was performed using Trizol as described in section 2.5 and 
analysed by RT-PCR using specific primers for DMTl (IRE), DMTl (nonIRE), Iregl, 
and p-actin as described in section 2.6.
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Primary Antibodies
Antibody Supplier Dilution
Human DMTl (IRE), 
antiserum
Alpha Diagnostic International, 
Texas, USA
1:250
Rat DMTl (nonIRE), 
antiserum
Alpha Diagnostic International, 
Texas, USA
1:250
Mouse Iregl, 
antiserum
Alpha Diagnostic International, 
Texas, USA
1:250
Secondary Antibody
Antibody Supplier Dilution
Peroxidase conjugated 
goat anti-rabbit
DakoCytomation, Denmark 1:1000
Table 3.2: Antibody specifications
Suppliers and dilutions of both primary and secondary antibodies used for Western 
blotting on rat duodenal samples. The primary antibodies were all raised in rabbits and 
all antibodies were diluted in 1% fat free milk, 0.1% Tween20 in PBS.
3.4.4 Confocal Microscopy
A further 1 cm section of duodenum was removed and rinsed free of its luminal 
contents. The lumen was filled with OCT (Merck, UK) and further OCT was used to 
surround the whole duodenal segment prior to snap freezing in liquid nitrogen. Frozen 
tissue samples were mounted in a cryostat and 10 pm frozen sections taken and placed 
onto poly-L+-lysine-coated slides.
Tissue sections were fixed by 15 min incubation in paraformaldehyde containing 
0.1% Triton X-100. Slides were then rinsed in PBS and incubated for 30 min with 10% 
goat serum in PBS to block non-specific binding of the antibody. Details of both the
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primary and secondary antibodies are shown in Table 3.3. Slides were incubated with the 
primary antibody for 1 hour then washed five times for 1 min with 1% goat serum in 
PBS. The appropriate secondary antibody (Table 3.3) was then applied for 1 hour and as 
this antibody is attached to a fluorescent probe slides were protected from the light for all 
subsequent steps. Before the coverslip was mounted onto the slide five 1 min washes 
were performed using 1% goat serum in PBS. Sections were analysed using an LSM 510 
confocal microscope (Carl Zeiss Inc. Germany).
Primary Antibodies
Antibody Supplier Dilution
Human DMTl (IRE), 
affinity pure
Alpha Diagnostic 
International, Texas, USA
10 pg/ml
Rat DMTl (nonIRE), 
affinity pure
Alpha Diagnostic 
International, Texas, USA
10 pg/ml
Mouse Iregl, affinity 
pure
Alpha Diagnostic 
International, Texas, USA
10 pg/ml
Secondary Antibody
TRITC-Conjugated 
Swine Anti-Rabbit
DakoCytomation,
Denmark
1:300
Table 3.3: Antibodies for confocal microscopy
Suppliers and dilutions of both primary and secondary antibodies used for confocal 
microscopy on rat duodenal samples. The primary antibodies were all raised in rabbits 
and all antibodies were diluted with 1% goat serum in PBS. (TRITC: 
T etramethylrhodamine).
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3.5 Results
3.5.1 Animal Weight Gain
Daily observations were made on the health of the animals and weight gain was 
recorded. Any significant changes in weight gain may induce changes in nutrient uptake 
independent of the level of iron in the diet, but although weight gain in the animals was 
highly variable there were no significant differences over the 14 days between the three 
dietary groups (Table 3.4).
Dietary Group Weight Gain (g)
Control 26.0 ±5.7
Deficient 26.8 ±9.8
Loaded 23.2 ± 12.9
Table 3.4: Animal weight gain
Weight gain in rats fed control, deficient or iron-loaded diets for 14 days. Data expressed 
as means of 8 animals per group ± SEM. No statistical differences were found using one­
way ANOVA.
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3.5.2 Serum Iron Levels
For any observed changes in iron transporter expression to be meaningful it needed 
to be confirmed that the different diets were capable of inducing changes in iron status. 
To do this serum iron levels and unsaturated iron binding capacity (UIBC) were measured 
in blood samples from animals in each of the dietary groups, and from these 
measurements the total iron binding capacity (TIBC) and transferrin saturation were 
derived (Table 3.5).
Diet Serum Iron 
i v m
UIBC (pM) TIBC (pM) Transferrin Saturation (%)
Control 45.7 ±5.6* 19.6 ±2.7* 68.4 ±4.5 66.4 ±6.2*
Deficient 12.2 ±4.8** 63.4 ±7.4** 75.6 ±3.6 lO.I ±3.0**
Loaded 56.7 ±2.2*** 5.9 ±1.9*** 63.5 ±4.2 91.4 ±2.6***
Table 3.5: Serum iron measurements
Blood was collected from animals in each dietary group. Randox iron kit number 817967 
was used to measure serum iron levels, unsaturated iron binding capacity (UIBC) and 
determine the total iron binding capacity (TIBC) and transferrin saturation. Analysis was 
performed by Dr Kelly Johnston. Data are expressed as means ± SEM of 8 experiments. 
Statistical analysis was performed using one-way ANOVA. * Significantly different from 
deficient and loaded, **significantly different from control and loaded, ***significantly 
different from control and deficient.
Serum iron was lowest in iron-deficient and highest in iron-loaded animals. UIBC is 
a measure of the level of transferrin in the blood that has no iron bound to it. TIBC can be 
derived from serum iron and UIBC measurements, and represents the maximum amount 
of iron that can be bound by transferrin (the transferrin concentration). Transferrin 
saturation (the proportion of transferrin that has iron bound to it) was lowest in deficient
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animals and highest in iron-loaded animals, while the TIBC was the same in all three 
dietary groups. This means that the changes in transferrin saturation reflect the level of 
iron in the body, rather than a change in the total transferrin concentration. Together this 
data show that iron status was modified in rats by two weeks exposure to the three 
different diets.
3.5.3 Transporter Expression and Localisation
As described previously there is no regulated mechanism for the loss of iron from 
the body, therefore the most effective mechanism for altering iron status would be to 
change the capacity of the duodenum to absorb more or less iron as appropriate. 
Transporter protein at the membrane of enterocytes gives an indication of the absorptive 
capacity of the cells, hence membrane protein samples were collected to examine the 
effects of iron-deficient and iron-loaded diets on the expression of DMT 1 (IRE), DMT I 
(nonIRE), and Iregl.
64
When measured using Western blotting, DMTl (IRE) expression was enhanced in 
iron-deficient rats compared to rats in both other dietary groups, however there was no 
difference in levels of the transporter when comparing rats on an iron-loaded diet to the 
control group (Figure 3.1).
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Figure 3.1: DM Tl (IRE) protein is increased in iron-deficient rats
Rats were maintained for 14 days on control, iron-deficient or iron-loaded diets. 
Membrane protein was collected from duodenal tissue and analysed by Western blotting. 
Band density was measured using Scion image software. Data are expressed as means ± 
SEM of 6 experiments. Statistical analysis was performed using one-way ANOVA 
followed by Tukey’s post hoc test. *Significantly different from control and loaded P 
<0.05.
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Measuring membrane protein alone gives very limited information on the location 
of transporter protein within the enterocytes, therefore confocal microscopy of duodenal 
sections was used to visualise expression of the DMTl (IRE) and to investigate any 
changes in localisation that may explain the increase in expression of this transporter in 
iron-deficient animals. Duodenal sections were first exposed to a primary antibody for 
DMTl (IRE), and then the sections were incubated with a secondary antibody conjugated 
to tetramethylrhodamine (TRITC) and finally examined at 20x objective on a Zeiss LSM 
510 confocal microscope. All sections for DMTl (IRE) and subsequent sections that were 
stained for DMTl (nonIRE) or Iregl showed intense staining in patches at the centre of 
the villi, which may be due to non-specific binding in immunological cells within the 
lamina propria.
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Figure 3.2 shows representative images of sections stained with DMTl (IRE) 
obtained from iron-deficient rats. Staining was consistently strongest at the brush border 
membrane and generally appeared higher towards the tip of the villi compared to the 
crypts.
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Figure 3.2: DM Tl (IRE) is localised to the brush border membrane in iron-deficient rats
Duodenal sections obtained from iron-deficient rats were stained using a specific 
antibody for DMTl (IRE) and a secondary antibody conjugated to TRITC. Sections were 
visualised using an LSM 510 microscope with 595 nm HeNel laser using the 20x 
objective.
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As Western blotting indicated that DMTl (IRE) levels at the membrane was 
dependent on iron status, a small number of sections from iron-loaded rats were analysed 
in an attempt to determine if DMTl (IRE) localisation, rather than absolute levels within 
enterocytes was altered. Staining of sections from iron-loaded animals generally more 
diffuse compared to deficient animals, and there was no enrichment at the brush border 
membrane. Some sections such as that shown in Figure 3.3 had distinct intracellular 
staining towards the basolateral side of the cell, which may represent transporter protein 
within intracellular vesicles such as endosomes.
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Figure 3.3: Intracellular staining of DM Tl (IRE) in iron-loaded rats
Duodenal sections obtained from iron-loaded rats were stained using a specific antibody 
for DMTl (IRE) and a secondary antibody conjugated to TRITC. Sections were 
visualised using an LSM 510 microscope with 595 nm HeNel laser using the 20x 
objective.
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DMTl (nonIRE) is not thought to have a role in iron transport at the outer 
membrane of cells, but instead is thought to be involved in the release of iron from 
endosomes following transferrin receptor mediated endocytosis (Fleming et aL, 1998; 
Tabuchi et a l, 2002). Comparing expression of both DMTl isoforms may provide 
information concerning the mechanism inducing changes in expression and help identify 
the role of the 3TRE in regulation of the IRE isoform. Although DMTl (nonIRE) 
appeared to be expressed at a higher level in iron-deficient animals compared to the other 
two dietary groups, large variation between samples meant there were no statistically 
significant differences between any of the groups (Figure 3.4).
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Figure 3.4: DM Tl (nonlRE) protein expression is unchanged by iron status
Rats were maintained for 14 days on control, iron-deficient or iron-loaded diets. 
Membrane protein was collected from duodenal tissue and analysed by Western blotting 
using a specific antibody for DMTl (nonIRE). Band density was measured using Scion 
image software. Data are expressed as means ± SEM of 6 experiments. No statistical 
differences were measured using one-way ANOVA.
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Figure 3.5 shows a representative image of a section stained for DMTl (nonIRE). 
As Western blotting showed no significant differences in expression of this transporter 
between the dietary groups sections were only taken from iron-deficient rats. . In contrast 
to DMTl (IRE), the nonIRE isoform did not concentrate at the brush border membrane 
and appears more diffuse within the enterocytes.
Figure 3.5: Duodenal tissue section stained for DM Tl (nonIRE)
Duodenal sections obtained from iron-deficient rats were stained using a specific 
antibody for DMTl (nonIRE) and a secondary antibody conjugated to TRITC. Sections 
were visualised using a LSM 510 microscope with 595 nm HeNel laser using the 20x 
objective.
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The expression of the basolateral iron transporter Iregl was also examined to see if 
the response to changing iron status is generalised across the cell or if it is limited the 
apical transport machinery. Using Western blotting no significant changes in Iregl 
protein expression were measured in response to any of the diets (Figure 3.6), though 
there was a general tendency for protein levels to be higher in the iron-deficient animals. 
Together these results suggest that the response of the duodenum to altered iron status 
targets the apical, rather than basolateral membrane of enterocytes.
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Figure 3.6: Iregl protein expression is unchanged by iron status in rat duodenum
Rats were maintained for 14 days on control, iron-deficient or iron-loaded diets. 
Membrane protein was collected from duodenal tissue and analysed by Western blotting 
using a specific antibody for Iregl. Data are expressed as means ± SEM of 6 
experiments. No significant differences were found using one-way ANOVA.
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As with DMTl (nonIRE) the staining seen for Iregl (Figure 3.7) was much more 
diffuse than that for DMTl (IRE). However, in some sections the staining towards the 
basolateral side of the enterocytes was more intense compared to either isoform of 
DMTl.
Staining towards 
basolateral side
Figure 3.7: Duodenal sections from iron-deficient rat stained for Iregl
Duodenal sections obtained from iron-deficient rats were stained using a specific 
antibody for Iregl and a secondary antibody conjugated to TRITC. Sections were 
visualised using a LSM 510 microscope with 595 nm HeNel laser using the 20x 
objective.
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There are several mechanisms that may lead to changes in protein expression 
including redistribution of existing protein within a cell or synthesis of new protein. 
Synthesis of new protein may be via an increase in transcription, or by an increase in the 
rate of translation of existing mRNA. Post-transcriptional regulation of TfRl and Ft via 
IRE/IRP interactions has been well characterised. DMTl (IRE) and Iregl also contain 
IRE’s in their mRNA but their regulatory role is less well understood. Therefore RNA 
samples from the duodenum of control, deficient and loaded rats were subjected to RT- 
PCR to investigate the potential role of these IRE.
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Consistent with an IRE/IRP mediated mechanism, DMTl (IRE) mRNA levels were 
high in rats maintained on the iron-deficient diet, but lowered in rats on the iron-loaded 
diet when compared to control animals (Figure 3.8).
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Figure 3.8; DM Tl (IRE) mRNA in control, deficient and loaded rats
Rats were maintained for 14 days on control, iron-deficient or iron-loaded diet, after 
which time the animals were sacrificed and mRNA was extracted from duodenal samples 
using Trizol. The mRNA was then subjected to RT-PCR using specific primers for 
DMTl (IRE). Values are expressed as mean ± SEM of 8 experiments. Statistical analysis 
was performed using one-way ANOVA. * Significant difference from control and loaded, 
**significant difference from control and deficient P <0.05.
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If the changes in DMTl (IRE) mRNA expression were dependent on the presenee 
of the IRE, then no change would be expected in the nonIRE isoform. However, although 
levels were comparable in eontrol and loaded animals, DMTl (nonIRE) mRNA 
expression was inereased in the duodenum of rats maintained on the deficient diet (Figure 
3.9).
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Figure 3.9: DM Tl (nonlRE) mRNA expression in rat duodenum
Rats were maintained for 14 days on control, iron-deficient or iron-loaded diet, after 
which time the animals were sacrificed and mRNA was extracted from duodenal samples 
using Trizol. The mRNA was then subjected to RT-PCR using specific primers for 
DMTl (nonlRE). Values are expressed as mean ± SEM of 8 experiments. Statistical 
analysis was performed using one-way ANOVA. *Significantly different from control 
and loaded P <0.05.
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In contrast to the protein data, Iregl mRNA was increased in the iron-deficient rats 
(Figure 3.10), but no differences were observed between levels in the control and iron- 
loaded animals.
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Figure 3.10: Iregl mRNA expression in rat duodenum
Rats were maintained for 14 days on control, iron-deficient or iron-loaded diet, after 
which time the animals were sacrificed and mRNA was extracted from duodenal samples 
using Trizol. The mRNA was then subjected to RT-PCR using specific primers for Iregl. 
Values are expressed as mean ± SEM of 8 experiments. Statistical analysis was 
performed using one-way ANOVA. *Significantly different from control and loaded P 
<0.05.
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3.6 Discussion
Iron homeostasis is maintained by balancing uptake and storage of iron to meet the 
body’s requirements, and to adjust for the loss of iron through non-specific processes 
such as blood loss and desquamation of cells. This chapter describes the molecular 
changes in the duodenum of rats administered diets containing different levels of iron for 
14 days.
3.6.1 Localisation of Duodenal Iron Transporters
In this study, the apical iron transporter DMTl (IRE) was detected by confocal 
microscopy of duodenal tissue sections. A distinct difference was observed in the pattern 
of staining when comparing sections obtained fi*om iron-deficient and iron-loaded 
animals. In all sections there was diffuse staining over the entire villus, but expression 
was generally stronger towards the tip of the villi compared with the crypts. In many 
sections fi*om iron-deficient animals expression was enriched at the brush border 
membrane. This expression pattern is consistent with DMTl (IRE) acting as the apical 
iron transporter, and correlates well with other studies (Canonne-Hergaux et al., 1999; 
Trinder et al., 2000). In contrast to the iron-deficient animals, none of the sections 
obtained from iron-loaded animals had DMTl (IRE) concentrated at the brush border 
membrane, instead some sections had distinct concentrations of DMTl (IRE) that may be 
at intracellular locations within the enterocytes. Again this expression pattern has been 
observed in previous studies (Trinder et al., 2000) and suggests that targeting of DMTl 
(IRE) is dependent on iron status. When iron levels are low DMTl (IRE) concentrates at 
the brush border membrane to maximise iron uptake. When iron status is high the 
transporter may be degraded or moved away fi*om the membrane to reduce absorption.
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The presence of strong intracellular staining in some of the sections from iron-loaded 
animals may represent DMTl (IRE) within intracellular compartments such as 
endosomes or lysosomes ready for degradation or recycling. The fate of DMTl once 
inside the cell is unclear and is examined in more detail in section 4.0.
Other sections from iron-deficient animals were stained for DMTl (nonIRE), and 
expression of this isoform was found to be diffuse within the enterocytes. DMTl 
(nonIRE) has been linked to a role in the exit of iron from acidified endosomes following 
TfRl-mediated endocytosis (Fleming et aL, 1998; Tabuchi et a l, 2002) hence the 
intracellular staining seen for the nonIRE isoform may represent protein within 
intracellular vesicles such as endosomes.
Consistent with a role in the efflux of iron from enterocytes, Iregl protein has been 
reported to be concentrated at the basolateral membrane of polarised cells (McKie et al., 
2000) and in the present work staining for Iregl was diffuse in the enterocytes with some 
enrichment at the basolateral side of the cells.
3.6.2 Iron Regulated Expression of Iron Transporters
As discussed in section 1.10.1, it is thought that iron response element and iron
regulatory protein (IRE/IRP) binding is important in the regulation of iron homeostasis.
Regulation by IRE/IRP binding has been best characterised in studies on ferritin and
transferrin receptor. Ferritin has a 5TRE in its mRNA, and the transferrin receptor (TfRl)
has five 3TREs in its mRNA. Levels of the iron storage protein ferritin vary directly with
the amount of iron in the diet of rats (Conrad et al., 1987), however characteristic of post-
transcriptional regulation mediated through a 5TRE there is no corresponding change in
mRNA levels with altered iron availability (McKie et al., 1996). The IREs in the 3’UTR
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of TfRl mediate stability of the mRNA, hence TfRl mRNA decreases in iron-loaded 
mice, and increases in deficient mice (McKie et ah, 1996). The expression pattern in 
human tissue matches that seen in the animal model; TfRl mRNA is increased in patients 
with iron-deficiency anaemia compared to controls (Pietrangelo et al., 1992). The pattern 
described above for ferritin and TfRl fits with the predicted responses for 5’ and 3TREs 
suggesting that post-transcriptional regulation is functional in duodenal enterocytes to 
achieve optimal iron absorption levels. Of the transporter isoforms, DMTl (IRE) is 
expressed at the higher level in the duodenum compared to the nonIRE isoform 
(Canonne-Hergaux et al., 1999), hence the increase in absorption that occurs during iron 
deficiency is likely to be brought about by increased expression of DMTl (IRE) (induced 
by IRP binding to the IRE) and therefore increased uptake of iron, or by increased activity 
of the IRE isoform.
In this study expression levels of DMTl (IRE), DMTl (nonIRE), and Iregl were 
measured by Western blotting using protein samples obtained from control, iron-deficient 
and iron-loaded rats. Correlating with published data (Trinder et al., 2000) we found np 
difference in DMTl (IRE) protein expression between control and iron-loaded rats. This 
suggests that high iron can reduce DMTl expression to a minimum level, after which 
increasing iron levels alone cannot depress DMTl (IRE) expression further. In contrast, 
DMTl (IRE) expression was significantly increased in deficient animals when compared 
to both other dietary groups. Consistent with IRE/IRP regulation, when RT-PCR was 
performed, levels of DMTl (IRE) mRNA were increased in iron-deficient rats but 
decreased in animals fed the iron-loaded diet when compared to the control group. The 
difference between the pattern of DMTl (IRE) protein and mRNA expression in the iron-
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loaded group may reflect a high efficiency of translation in the duodenum, though this 
possibility has not been examined here.
Previously it was assumed that the nonIRE isoform was unresponsive to iron status. 
However, when nonIRE mRNA levels were measured expression was significantly higher 
in the deficient group compared to both other groups, indicating that iron exerts some 
transcriptional control over this transporter variant. Despite many of the samples fi*om 
iron-deficient rats containing high levels of DMTl (nonIRE) protein this increase did not 
reach significance due to large variation between animals. Inter-individual variation in 
transporter expression such as this has been seen in other studies, for example Frazer et 
al. (2002), found that the timing of changes in transporter expression varied between 
individual animals following a change in dietary iron levels. The large variation is likely 
to be caused by other factors overriding the signal induced by low iron levels.
Despite the presence of a 5TRE in the mRNA of Iregl, analysis by PCR showed a 
significant increase in mRNA expression in iron-deficient animals compared to control 
and loaded animals. This reflects the pattern found in the mouse duodenum (McKie et al., 
2000), however in contrast to data published by Abboud and Haile (2000), protein 
expression was not significantly changed by iron status (though there was a trend for 
increased expression in the iron-deficient animals). As described earlier, when iron 
deficiency induces IRP binding to the 5TRE in ferritin, mRNA expression is unchanged 
while protein expression is decreased (Conrad et a l, 1987; McKie et a l, 1996), hence it 
is unclear if the IRE in Iregl is functional. Regulation of Iregl appears to be highly 
influenced by tissue specific factors that may be independent of IRE regulation. In the 
liver, Iregl protein expression varies as expected for 5TRE regulation (Abboud and
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Haile, 2000), however in the duodenum it is possible that tissue specific factors may 
override the IRE and transcriptional regulation may have a higher priority.
From this work it is unclear whether the IRE is an important mechanism of control 
in the duodenum. Although the IRE’s in DMTl (IRE) and Iregl have been demonstrated 
to bind IRP, the affinity of binding is 10 fold lower than that of ferritin (Zoller et a l, 
2002). Incubation with the iron chelator desferrioxamine (DFO) or with iron itself 
induced changes in the expression of DMTl (IRE) and Iregl in Caco-2 cells that were 
due to transcriptional events rather than post-transcriptional regulation via IRE/IRP 
binding (Zoller et al., 2002).
Potential regulators of iron transporter expression in the duodenum include 
endogenous factors such as the recently identified peptide hepcidin. A study by Lafiah et 
al. (2004) has demonstrated how hepcidin injections can reduce mucosal iron uptake and 
transfer in mice. In addition, rats switched from an iron-replete to iron-deficient diet have 
decreased hepcidin expression, which exactly correlates with changes in DMTl (IRE), 
(nonIRE) and Iregl expression (Frazer et al., 2002). The significance of endogenous 
factors on changes in transporter expression is investigated further in section 6.0.
The findings from these experiments using rat duodenal tissue are summarised in 
Figure 3.11. Whether the changes are induced directly through sensing the amount of iron 
in the local environment, or whether they occur as a result of systemic changes and a 
more complex signalling pathway cannot easily be distinguished in an in vivo system. 
Therefore, the studies described in subsequent chapters have used Caco-2 cells, a model 
for intestinal epithelial cells, to explore further some of the cellular and molecular 
mechanisms involved in the regulation of iron transport by dietary and humoral factors.
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Figure 3.11: Adaptation of rat duodenum to iron-deficient and loaded diet
An iron-deficient diet promotes expression of mRNA for DMTl (IRE), DMTl (nonlRE), 
and Iregl, while only DMTl (IRE) reflects these changes at the protein level. Of the 
three transporters, only DMTl (IRE) expression is influenced by an iron-loaded diet, 
which results in a decrease in mRNA and membrane protein expression. Confocal 
microscopy suggests that DMTl (IRE) may be internalised following iron exposure.
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Chapter 4
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4.0 Regulation of Intestinal Iron Transporter 
Expression by Dietary Iron
4.1 Chronic and Rapid Adaptation to Iron Exposure
The experiments described in chapter 3 demonstrated how iron metabolism in the 
duodenum responds to changing body iron status, however the signals initiating this 
response and the mechanisms for regulating transporter expression are not fully 
understood. When iron status is disrupted to produce an iron-deficient environment in 
rats, DMTl protein is up-regulated 50-100 fold in the duodenum compared to iron-replete 
animals (Canonne-Hergaux et al., 1999). In addition to this change in basic expression 
levels, localisation of the transporter may also be affected. Although DMTl is localised to 
the plasma membrane in the duodenum of iron-deficient rats it is mainly intracellular in 
iron-replete animals (Trinder et al., 2000).
Transferrin Receptor (TfRl) expression decreases as enterocytes mature along the 
crypt-villus axis, hence transferrin saturation is most effectively sensed by immature 
enterocytes. One model for regulation of iron homeostasis describes how chronic changes 
in intestinal iron metabolism may initiate pre-programming of immature enterocytes in 
the crypts of Lieberkühn to compensate for either iron deficiency or overload (Figure 
4.1). A delay between a change in iron status and changes in duodenal iron uptake may 
represent the time taken for an enterocyte to mature into an absorptive cell at the top of 
the villi (reviewed in Roy and Enns, 2000; Frazer and Anderson, 2003).
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Figure 4.1 : Pre programming of iron transporter machinery in duodenal crypt cells
Circulating transferrin binds to TfRl on duodenal crypt cells and iron is delivered to the 
enterocyte. Changes in the level of iron delivered to the immature enterocyte may be 
reflective of the body iron levels. This may be sensed by cellular proteins such as iron 
regulatory proteins, which may determine the expression of iron transport and storage 
machinery within the mature absorptive cell.
Although this mechanism cannot be ruled out, it seems likely that mature 
enterocytes are also capable of responding directly to regulatory signals. The most likely 
candidate for the stores regulator is the recently identified hepatic peptide hepcidin 
(Krause et a l, 2000, Park et al., 2001). The time course of changes in hepcidin expression 
and changes in intestinal transporter expression strongly suggests that mature enterocytes 
are directly targeted rather than crypt cells (Frazer et al., 2002).
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In addition to regulation of iron uptake in response to changing iron stores within 
the body, there is a more rapid adaptation induced by dietary iron, which is sometimes 
referred to as mucosal block or dietary regulator. In vivo it takes about 3 days for the 
enterocytes to mature and migrate up the villi. Hence, changes in duodenal iron 
transporter expression following more than 72 h disruption of iron status may be 
attributed to pre-programming of immature enterocytes in the crypts of Lieberkühn. 
However the inhibition of iron uptake during mucosal block is too rapid to be explained 
by pre-programming of crypt cells. Frazer et a l (2003) investigated the immediate effects 
of a large dose of iron in the rat intestine. They found that iron uptake was rapidly 
reduced, and remained low for 12 h after iron exposure. This reduced uptake was matched 
by a 70% reduction in DMTl (IRE) mRNA after 3 h, and a reduction in protein levels by 
6 h. DcytB showed a less pronounced response but with the same pattern as DMTl (IRE), 
while DMTl (nonlRE), Iregl and hephaestin were unchanged indicating that the 
immediate response to dietary iron is mediated through DMTl (IRE) in rat intestine. 
These changes are too rapid to be explained by pre-programming of immature cells 
suggesting that mature enterocytes are capable of sensing and reacting to acute changes in 
the local iron availability.
The Caco-2 cell line is a useful tool for investigating regulation of iron metabolism 
at distinct stages of maturation. Differentiation of Caco-2 cells is induced by contact 
inhibition and is associated with a decrease in expression of genes involved in 
proliferation, while genes associated with differentiated functions, such as xenobiotic 
detoxification, lipid metabolism and transport are increased, as the cells take on a 
phenotype more consistent with villus cells (Mariadason et a l, 2002). In terms of iron 
metabolism, this maturation process is characterised by a decrease in transferrin receptor
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(TfRl) expression, while there is an increase in DMTl expression and iron transport 
(Sharp et al., 2002).
In fully differentiated Caco-2 cells treated with iron for 24 h, although DMTl 
membrane expression decreases, with a corresponding decrease in iron uptake, there is no 
change in mRNA levels until after 72 h. In addition, iron treatment in a fibroblast cell 
line, LMTK’, did not induce any change in DMTl mRNA after 20 h iron treatment 
(Wardrop and Richardson, 1999). This is in contrast to chronic changes in iron status, 
where body iron stores are altered and changes in DMTl expression can be measured at 
the mRNA level (Gunshin et al., 1997). In addition, treatment of Caco-2 cells for 24 h 
with iron results in a specific decrease in DMTl protein at the membrane, without any 
significant differences in whole cell transporter expression (Sharp et al., 2002). This 
pattern of regulation may represent movement of protein, rather than a rapid change in 
expression. In support of this, staining of duodenal sections has demonstrated that DMTl 
(IRE) is located at the membrane as well as some intracellular locations within 
enterocytes and the localisation may be rapidly altered so that within two hours of iron 
intake, DMTl expression moves away from the membrane to be more pronounced in the 
apical side of the cytoplasm (results in chapter 3.0; Yeh et a l, 2000).
4.2 Aims
Experiments described in this chapter were performed to study the mechanism of 
rapid changes induced by dietary iron using the Caco-2 cell model of intestinal 
enterocytes. Experiments focussed on the time course of changes in expression and 
localisation of the transporter protein.
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4 3  Methods
4.3.1 Treatments
Fully differentiated Caco-2 cells were exposed to 100 pM FeClg for up to 24 h 
while control cells were maintained in serum free medium for the duration of each 
experiment. Protein and RNA were isolated as described in sections 2.3 and 2.5 then 
analysed using Western blotting and RT-PCR as described in sections 2.4 and 2.6.
4.3.2 Biotinylation
To label surface membrane protein, cells were washed twice in PBS and then 
exposed to 300 pg EZ-link Sulfo-NHS-SS-biotin (Pierce, Illinois, USA) per ml PBS for 
30 min at 4°C. Cells were washed with PBS before being exposed to 100 pM iron in 
serum free medium for 4 hours at 37°C while controls were maintained in serum free 
media. From this stage onwards the cells were kept at 4°C. After washing in PBS the cells 
were rinsed twice for 5 min with glutathione-strip buffer (50 mM glutathione, 75 mM 
NaCl, 55 mM NaOH, 10% FBS), then twice for 15 min with iodoacetamide (50 mM 
iodoacetamide, 1% BSA in PBS) to quench the excess biotin. Cells were lysed with Ripa 
lysis buffer (150 mM NaCl, 10 mM Tris (pH8), 1 mM EDTA, 1% NP40, 0.1% SDS, 0.5 
mM PMSF, 0.2 mM benzamidine, 0.02% sodium azide) then centrifuged (12,000g, 10 
min, Eppendorf Centrifuge 5415D). The supernatant was immunoprecipitated over 1 hour 
with DMTl (IRE) or DMTl (nonIRE) antibody and incubated for 1 h with 25 pl/ml 
Protein A-Sepharose (Amersham, Buckinghamshire, UK) and spun for 5 min at 12,000 g. 
The pellet was washed twice with wash buffer (150 mM NaCl, 10 mM Tris (pH8)) and 
once with PBS. 5 pi Sample buffer (100 mM Dithiothreitol (DTT), 50 mM Tris, 2%
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sodium dodecyl sulphate (SDS), 10% Glycerol, 0.1% Bromophenol Blue), and water (15 
pi) were added to the pellet and the sample run on a 10% polyacrylamide gel and 
transferred to a nitrocellulose membrane as described in section 2.4. The membrane was 
blocked for 30 min with 5% PBS-T (5% fat-free milk, 0.1% Tween20 in PBS) followed 
by incubation for 1 h with streptavidin-peroxidase polymer (Sigma) at 1:1000 dilution. 
After three 15 min washes in 1% PBS-T (1% fat-free milk, 0.1% Tween20 in PBS), 
cross-reactivity was visualised using ECL plus and Hyperfilm ECL (Amersham, 
Buckinghamshire, UK). The band density was quantified by densitometric analysis using 
Scion Image software (Scion Corporation, USA).
4.3.3 Immunoprécipitation for Lysosomal Associated Membrane 
Protein 1 (LAMPl) and Early Endosomal Antigen 1 (EEAl)
Cells exposed to 100 pM FeClg for 4 h were lysed using Ripa lysis buffer, followed 
by centrifugation (12,000 g, 10 min). Samples were incubated with either an antibody for 
lysosomal-associated membrane protein 1 (LAMPl) or early endosomal antigen 1 
(EEAl), (Santa Cruz Biotechnology, Inc, California, USA) at 1:200 dilution for 1 h at 
room temperature. Protein A-Sepharose was then added at 25 pl/ml to the lysate and 
incubated for a further hour at room temperature. Following centrifugation (12,000 g, 5 
min) the pellet was washed once with wash buffer (150 mM NaCl, 10 mM Tris, in PBS), 
and once with PBS. The pellet was then incubated for 5 min in sample buffer containing 
DTT. The sample was run on a 10% gel and transferred to nitrocellulose membrane. 
Membranes were then analysed to measure DMTl (IRE) and DMTl (nonIRE) expression 
as described in section 2.4.
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4.4 Results
To determine whether non-haem iron could alter DMTl expression within the time 
scale for digesting a meal, DMTl protein levels were measured in membrane samples 
from Caco-2 cells after 0 ,1 ,4 , 8, 16, and 24 h exposure to 100 pM FeClg. This study used 
a polyclonal antibody (a gift from Professor Kaila Srai, Department of Biochemistry and 
Molecular Biology, Royal Free and UCL Medical School) raised in rabbits against a 
synthetic peptide corresponding to amino acids 310-330 of the human DMTl sequence 
and detects both IRE and nonIRE isoforms.
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DMTl protein expression in the plasma membrane was found to significantly 
decrease after 1 to 4 h of iron exposure (Figure 4.2), and this low level was maintained 
throughout the rest of the experimental period. The intestinal-specific marker protein 
villin was unaffected by iron treatment and was used as a control for protein loading.
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Figure 4.2: Time course of iron-induced changes in membrane DM Tl
Caco-2 cells were treated with 100 pM iron for up to 24 h. Membrane proteins were 
isolated and subjected to Western blotting. Band density was analysed by densitometry 
using Scion image software. Data are expressed as means ± SEM of 4 experiments. 
Statistical analysis used one-way ANOVA followed by Scheffe’s post hoc test. 
*Significantly different than 0 and 1 h time points P <0.05.
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It has been shown previously that cellular DMTl protein does not change in Caco-2 
cells exposed to iron (Sharp et aL, 2002). Figure 4.3 shows that there are no transient 
changes in cellular DMTl up to 24 h.
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Figure 4.3: The effects of iron exposure on whole cell DM Tl protein expression
Caco-2 cells were treated with 100 pM iron for up to 24 h. Whole cell protein samples 
were taken and subjected to Western blotting. Band density was measured using Scion 
image software. No significant differences were found using one-way ANOVA. Data are 
expressed as means ± SEM of 4 experiments.
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As explained above, the analysis shown in Figure 4.2 and Figure 4.3 were 
performed using an antibody that does not distinguish between the 2 splice variants of 
DMTl. To clarify which isoform is responding to iron exposure, cells were treated with 
iron for 24 h and membrane protein subjected to Western blotting using specific 
antibodies for DMTl (IRE) and DMTl (nonIRE). Iregl levels were measured in the same 
samples to investigate the role of the basolateral membrane transport system. Figure 4.4 
shows that the decrease in DMTl was specific to the IRE variant while Figure 4.5 shows 
that Iregl is unchanged by 24 h iron exposure.
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Figure 4.4: DM Tl isoform expression following 24 h iron exposure in Caco-2 cells
Caco-2 cells were treated with 100 pM iron for 24 h, whole cell protein samples were 
taken and subjected to Western blotting. Band density was measured using Scion image 
software. Statistical analysis was performed using Student’s unpaired t-test. Data are 
expressed as means ± SEM of 6 experiments. *Significantly different from control P 
<0.05.
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Figure 4.5: 24 h iron exposure has no effect on Iregl membrane protein expression
Caco-2 cells were treated with 100 pM iron for 24 h, whole cell protein samples were 
taken and subjected to Western blotting. Band density was measured using Scion image 
software. Data are expressed as means ± SEM of 6 experiments. No significant 
differences were measured using Student’s unpaired t-test.
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To determine whether the decrease in membrane protein corresponded to changes in 
DMTl mRNA, levels were analysed by QRT-PCR following exposure of Caco-2 cells to 
iron for up to 4 h. No significant differences were found for expression of either splice 
variant over 4 h of iron exposure (Figures 4.6 and 4.7), but QRT-PCR did highlight the 
difference between expression levels of DMTl (IRE) and DMTl (nonIRE) in intestinal 
cells. The IRE isoform was expressed approximately five fold higher than the nonIRE 
form (2040 ±488 vs. 364 ±51 copies per ng). Canonne-Hergaux et a l (1999) showed that 
it is the IRE form that accounts for the majority of DMTl protein expression in the 
duodenum and Lee et a l (1998) have reported a ratio of 7:1, IRE: nonIRE clones in an 
intestinal cDNA library.
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Figure 4.6: DM Tl (IRE) mRNA expression is not altered by 4 h of iron exposure
Caco-2 cells were treated with 100 pM iron for up to 4 h and mRNA isolated, and 
amplified by QRT-PCR. Data are expressed as means ± SEM of 6 experiments. No 
significant differences were measured using one-way ANOVA.
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Figure 4.7: DM Tl (nonIRE) mRNA expression is not altered by 4 h iron exposure
Caco-2 cells were treated with 100 pM iron for up to 4 h and mRNA isolated, and 
amplified by QRT-PCR. Data are expressed as means ± SEM of 6 experiments. No 
significant differences were measured using one-way ANOVA.
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A decrease in membrane expression of DMTl without a change in whole cell 
protein is consistent with internalisation of the transporter protein. To examine whether 
this is the case in Caco-2 cells following iron exposure, cell surface proteins were labelled 
with a membrane impermeant form of biotin. Cells were exposed to iron for 4 h then 
lysed with RIPA lysis buffer. The cytosolic fractions were immunoprecipitated with 
antibodies to either DMTl (IRE) or DMTl (nonlRE) and biotinylated transporter levels 
were visualized using streptavidin-HRP. Biotinylated DMTl (IRE) was present in the cell 
lysates of all cells, but levels were higher in iron treated cells compared to the controls 
(Figure 4.8).
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Figure 4.8: Internalisation of DM Tl (IRE) following iron exposure
Caco-2 cells were treated with EZ-link NHS-Sulfo Biotin for 30 min to label surface 
membrane proteins. After washing with PBS cells were exposed to iron for 4 h. Excess 
biotin was quenched, the cells lysed then immunoprecipitated with DMTl (IRE) 
antibody. Bands were detected using streptavidin-HRP, and band density was measured 
by densitometry using Scion image software. Statistical analysis was performed using 
Student’s unpaired t-test. Data are means ± SEM of 4 experiments. *Significantly 
different from control P  <0.05.
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In contrast, when antibodies to the nonIRE isoform were used for 
immunoprécipitation, there was no difference in the intracellular levels of biotinylated 
DMTl (nonIRE) protein in iron-treated and control cells (Figure 4.9).
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Figure 4.9: Internalisation of DM Tl (nonIRE) is not induced by iron exposure
Caco-2 cells were treated with EZ-link NHS-Sulfo Biotin for 30 min to label surface 
membrane proteins. After washing with PBS cells were exposed to iron for 4 h. Excess 
biotin was quenched, the cells lysed then immunoprecipitated with DMTl (nonIRE) 
antibody. Bands were detected using streptavidin-HRP, and band density was measured 
by densitometry using Scion image software. No significant differences were found 
using Student’s unpaired t-test. Data are means ± SEM of 4 experiments.
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The precise intracellular location and fate of DMTl (IRE) following internalisation 
is unclear. The transporter may be recycled to the membrane once normal iron levels are 
restored, or the transporter may be degraded and replaced with freshly synthesised 
protein. Previous analysis of the cellular localisation of DMTl isoforms indicates that 
DMTl (IRE) is associated with late endosomes and lysosomes, while the nonIRE variant 
is associated with early endosomes (Tabuchi et aL, 2002). To investigate the iron-induced 
targeting of DMTl in the present study, Caco-2 cells were treated with iron for 4 h, then 
lysed and immunoprecipitated using antibodies against lysosomal associated membrane 
protein 1 (LAMPl) or against early endosomal antigen 1 (EEAl). The recovered protein 
was then subjected to Western blotting for DMTl (IRE) or DMTl (nonIRE).
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Levels of DMT 1 (IRE) were higher in the late endosomal/lysosomal fraction of iron 
treated cells compared to control cells (Figure 4.10).
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Figure 4.10: Iron induces DM Tl (IRE) protein in the lysosomal fraction of Caco-2 cells
Caco-2 cells were exposed to 100 pM iron for 4 h. Cell lysate was then 
immunoprecipitated using a specific antibody for LAMPl. The precipitated sample was 
subjected to Western blotting and the membrane probed for DMTl (IRE). Data are 
expressed as means ± SEM of 6 experiments. Statistical analysis was performed using 
Student’s unpaired t-test. *Significant difference from control P <0.05.
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The increased association of DMTl with LAMPl was specific to the IRE isoform. 
NonIRE levels were not altered in LAMPl immunoprecipitates prepared from iron- 
treated cells compared with the controls (Figure 4.11).
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Figure 4.11: DMTl (nonIRE) expression in the lysosomal fraction of Caco-2 cells is not altered 
by 4 h iron treatment
Caco-2 cells were exposed to 100 pM iron for 4 h. Cell lysate was then 
immunoprecipitated using a specific antibody for LAMPl. The precipitated sample was 
subjected to Western blotting and the membrane probed for DMTl (nonIRE). Data are 
expressed as means ± SEM of 5 experiments. No significant differences were found 
using Student’s unpaired t-test.
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In contrast to the association of DMTl (IRE) with LAMPl, when samples were 
immunoprecipitated with EEAl (an early endosomal marker) antibody, no difference was 
found in DMTl (IRE) levels in iron-treated compared to control cells (Figure 4.12). This 
implies that iron exposure induces a specific association between DMTl (IRE) and the 
late endosomal/lysosomal compartment.
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Figure 4.12: DMTl (IRE) expression in the early endosomal fraction of Caco-2 cells is not 
changed by 4 h iron treatment
Cells were exposed to 100 pM iron for 4 h. Cell lysate was then immunoprecipitated 
using a specific antibody for EEAl. The precipitated sample was subjected to Western 
blotting and the membrane probed for DMTl (IRE). Data are expressed as means ± SEM 
of 6 experiments. No significant differences were found using Student’s unpaired t-test.
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As cellular DMTl (IRE) levels do not change over 24 h of iron exposure, it seems 
unlikely that DMTl (IRE) is rapidly degraded in lysosomes following iron induced 
internalisation. It is possible that DMTl is targeted to late endosomes and lysosomes after 
internalisation, and from this location the transporter may be recycled to the membrane 
when iron levels return to normal. To investigate this possibility, Caco-2 cells were 
treated with iron-supplemented medium for 4 h (protein samples were isolated before 
(time -4 h) and after iron treatment (time 0 h). After the 4 h pre-incubation, iron- 
supplemented medium was replaced with iron-free medium and protein samples isolated 
at various times over the next 24 h. In agreement with data presented earlier (Figure 4.4), 
Western blotting revealed that DMTl (IRE) expression was significantly decreased by 4 h 
iron exposure (time 0 h), however by 8 h following the removal of iron, DMTl (IRE) had 
returned to control levels at the membrane (Figure 4.13).
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Figure 4.13: Recovery of DMTl (IRE) at the plasma membrane following iron exposure
Caco-2 cells were exposed to iron-supplemented medium for 4 h, after which time the 
medium was replaced by iron free medium (at t=0). Membrane samples were collected at 
time points up to 24 h and analysed by Western blotting. Band density was measured by 
densitometry using Scion image software. Data are expressed as means ± SEM of 6 
experiments. Statistical analysis was performed using one-way ANOVA followed by 
Tukey’s post hoc test. *P <0.05 compared with baseline value for DMTl (IRE) 
expression (i.e. at t=-4 h).
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The original time course following DMTl levels at the membrane with iron 
exposure used an antibody that was unable to distinguish between the two isoforms of 
DMTl (Figure 4.2). It was assumed that the reduction in DMTl at the membrane would 
be due to changes in the IRE isoform. Interestingly DMTl (nonIRE) levels also showed 
changes in the recovery time course but the time scale was different to the IRE isoform. 
NonIRE levels did not fall until 4 h after the iron was removed and did not recover to 
control levels until 24 h after normal iron levels were reintroduced (Figure 4.14).
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Figure 4.14: Recovery of DMTl (nonIRE) at the plasma membrane following iron exposure
Caco-2 cells were exposed to iron-supplemented medium for 4 h, after which time the 
medium was replaced by iron free medium. Membrane samples were collected at time 
points up to 24 h and analysed by Western blotting. Band density was measured by 
densitometry using Scion image software. Data are expressed as means ± SEM of 6 
experiments. Statistical analysis was performed using one-way ANOVA followed by 
Tukey’s post hoc test. *P <0.05 compared with baseline value for DMTl (IRE) 
expression (i.e. at t=-4 h).
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To determine whether changes in DMTl (IRE) mRNA expression could account for 
the time course of recovery following the removal of the iron challenge, RNA was 
isolated at various times and analysed by RT-PCR. No significant changes in DMTl 
(IRE) mRNA levels were observed over the recovery time course (Figure 4.15) 
suggesting that the changes were post-transcriptional.
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Figure 4.15: DMTl (IRE) levels do not change over the recovery time course
Caco-2 cells were pre-incubated with 100 (iM iron 4 h, after which time non-iron 
supplemented medium was applied to the cells. mRNA isolated over the time course, and 
amplified by RT-PCR. Data are expressed as means ± SEM of 6 experiments. No 
significant differences were measured using one-way ANOVA.
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To establish whether new protein synthesis was required for the recovery of DMTl 
(IRE) levels at the plasma membrane, cells were incubated in the presence or absence of 
the protein synthesis inhibitor cycloheximide (applied at the 0 h time point). Figure 4.16 
shows that cycloheximide had no effect on recovery of DMTl (IRE) protein at the 
membrane at the 8 h time point.
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Figure 4.16: Cycloheximide exposure has no effect on the recovery of DM Tl (IRE) protein at the 
membrane of Caco-2 cells
After 4 h iron treatment Caco-2 cells were placed in iron-free medium either with 
(+CHX) or without (control) cycloheximide. Membrane protein was isolated 8 h after the 
removal of iron and membrane protein subjected to Western blotting for DMTl (IRE). 
Data are expressed as means ± SEM of 4 experiments. No significant differences were 
observed using Student’s unpaired t-test.
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4.5 Discussion
4.5.1 Iron induced internalisation of DMTl (IRE)
In addition to chronic regulation of iron uptake by signals from body iron stores, 
there is a more rapid response to dietary iron (Yeh et aL, 2000; Sharp et aL, 2002). In a 
proeess known as mucosal block the intestine beeomes resistant to iron absorption 
immediately after a large dose of dietary iron (Han et aL, 1943). Enterocytes mature over 
approximately 72 h hence this immediate reduction in iron absorption is too rapid to 
involve programming of crypt cells, and is likely to be directly targeting the mature upper 
villus enterocytes. When the mechanism of mucosal block was investigated in rats, a 
reduetion in iron uptake within 3 h of iron exposure was found to be assoeiated with a 
decrease in DMTl (IRE) mRNA and protein (Yeh et aL, 2000; Frazer et aL, 2003). 
Previous work in our laboratory has shown that following iron treatment there is a 
dramatie down-regulation of DMTl transporter protein present in the plasma membrane, 
and iron uptake in Caco-2 cells (Sharp et aL, 2002).
To investigate the nature of this iron-mediated response, a time course study was 
performed to measure changes in DMTl protein levels following iron treatment. Plasma 
membrane DMTl protein (total protein was measured using an antibody that recognises 
all DMTl isoforms) deereased significantly following exposure to iron for 4 h, matching 
the response seen in rat duodenum. Furthermore, the deereased level of expression was 
sustained in the presence of the continuing iron challenge. Interestingly, despite the 
decrease in membrane expression of the transporter, whole cell DMTl levels were not 
signifieantly altered following iron treatment. To determine whether both the IRE and 
nonIRE variants were influenced by exposure to iron, cells were ineubated in iron-free
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(control) or iron-supplemented medium for 4 h prior to plasma membrane isolation and 
Western blotting. Membrane levels of DMTl (IRE) were signifieantly decreased in iron- 
treated cells compared with controls. In contrast, DMT I (nonIRE) levels were unaltered. 
Furthermore, the expression of the basolateral iron efflux transport protein IREGl and of 
villin, an apical membrane associated structural protein (Baricault et ah, 1993) used as a 
housekeeper protein in these studies, were not altered following acute (4 h) exposure to 
iron. This evidence suggests that the effects of iron were specific to the DMTl (IRE) 
protein.
Previous studies have demonstrated that DMTl (IRE) mRNA levels (but not the 
expression of the nonIRE splice variant) are down-regulated by 24 h exposure to iron in 
Caco-2 cells (Yamaji et ah, 2002). However in the present study, when DMTl mRNA 
levels were analysed over the first 4 h of exposure to iron (when the decrease in DMTl 
(IRE) protein expression was maximal) no significant changes were found in mRNA 
expression.
One explanation for the observed changes in DMTl expression is internalisation of 
transporter protein from the plasma membrane following iron exposure. Investigations in 
rat duodenum have shown that although DMTl is at the membrane in iron-deficient rats it 
is mainly intracellular in iron-replete animals (Trinder et al., 2000). Furthermore, rats 
administered a bolus dose of iron accumulate DMTl in intracellular vesicles (Yeh et al., 
2000). However it is not clear whether this intraeellular DMTl is exclusively formed 
from protein internalised from the plasma membrane or comprises newly synthesised 
transporter. To study the fate of DMTl in Caco-2 cells, surface proteins were 
biotinylated, and then the cells were exposed to iron and the amount of biotinylated
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DMTl in the cell lysate was taken as a measure of internalised transporter. Results 
showed that biotinylated protein levels increased within the cell after 4 h iron treatment 
indicating that the initial response to iron exposure is a rapid internalisation of DMTl that 
can occur within the time scale for processing a meal.
4.5.2 Localisation of internalised DMTl (IRE)
In animal studies and in Caco-2 cells internalisation of DMTl has been 
demonstrated within 1-2 h of iron treatment (Yeh et ah, 2000; Ma et a l, 2002). Several 
studies have investigated the subcellular localisation of DMTl. DMTl has been shown to 
co-localise with early endosomes in various cell lines including HEK293T cells (Kidney), 
RAW 264.7 cells (macrophage), and transfected CHO cells (Su et a l, 1998; Gruenheid et 
al., 1999), where it is thought to play a role in cellular acquisition of iron from transferrin. 
The IRE and nonIRE isoforms are localised differently within the cell and this may be a 
reflection of their distinct functions. DMTl (IRE) has been shown to be present in late 
endosomes and lysosomes of HEp-2 (human larynx carcinoma cells), HeLa (human 
cervical carcinoma) and COS-7 (transformed African green monkey kidney fibroblast) 
cells, while DMTl (nonIRE) is found to colocalise with markers for early endosomes in 
HEp-2 cells (Tabuchi et al., 2000; 2002). Using this previous data as a model, the precise 
location of internalised DMTl in Caco-2 cells was investigated by immunoprécipitation 
with antibodies specific to lysosomal associated membrane protein 1 (LAMPl) to isolate 
the late endosome and lysosomal compartment, or early endosomal antigen 1 (EEAl) to 
isolate the early endosomes. Prior to protein collection and immunoprécipitation cells 
were exposed to iron for 4 h. DMTl (IRE) levels were significantly elevated in the late 
endosomal/lysosomal compartment of iron treated compared to control cells.
114
Immunoprécipitation followed by Western blotting for DMTl (nonIRE) showed no 
change in levels of this isoform associated with LAMPl. Additional immunoprécipitation 
was performed to measure DMTl (IRE) association with the early endosomal 
compartment. An antibody specific for the marker early endosomal antigen 1 (EEAl) was 
used for the immunoprécipitation. In contrast to the association of this transporter with 
LAMPl, DMTl (IRE) levels were not altered in the endosomal compartment of cells 
treated with iron for 4 h. Together this suggests that on exposure to iron there is a rapid 
internalisation of DMTl (IRE) from the apical membrane and the transporter is 
specifically targeted to late endosomes and lysosomes. The precise physiological function 
of this mechanism is unclear.
4.5.3 Recovery of DMTl (IRE) membrane expression
To investigate the fate of internalised DMTl (IRE) a recovery time course was 
performed. Caco-2 cells were subjected to a 4 h pre-incubation with iron to initiate 
internalisation of DMTl (IRE), after which the iron was removed and expression of 
DMTl at the membrane was monitored for 24 h. This time course showed that DMTl 
(IRE) levels return to control levels 8 hours after iron has been withdrawn. Interestingly 
DMTl (nonIRE) levels were modulated over a different time seale compared to DMTl 
(IRE). Expression of the nonIRE variant did not decrease until 4 hours after the iron was 
removed from the cells. This suggests that DMTl (nonIRE) may not be regulated until 
iron levels within the cell reach a critical level and reinforces the argument that the two 
variants of DMTl have different roles in iron transport. DMTl (nonIRE) expression did 
not return to eontrol levels within the time scale of this study (24 h).
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The recovery of DMTl (IRE) expression may be due to new protein synthesis, or 
recycling of existing protein from the lysosomal compartment. To distinguish between 
these possibilities mRNA expression was measured over the recovery time course, 
however no significant changes were found using real-time PCR. To further rule out 
freshly synthesised protein as a mechanism for recovery of DMTl (IRE) some cells were 
treated with the protein synthesis inhibitor cycloheximide at the beginning of the iron-free 
stage of the recovery time course. Recovery of DMTl (IRE) was not altered by the 
addition of cycloheximide suggesting that levels of the transporter are restored using 
existing cellular protein. This hypothesis is supported by measurements of the synthesis 
and degradation rate of DMTl over 3 h that demonstrate no difference in the rate in iron 
treated and control cells (Ma et al., 2002). It is unclear at this stage whether the recycled 
DMTl (IRE) protein derives from the intracellular pool that is associated with the late 
endosomal/lysosomal compartment. Interestingly, a recent study has shown that proteins 
associated with the apical membrane in T84 intestinal epithelial cells when endocytosed 
can be targeted to a cellular compartment that is distinct from late or recycling endosomes 
(Ivanov et al., 2004). At present the possibility that a similar mechanism is involved in 
DMTl recycling in Caco-2 cells cannot be ruled out.
Figure 4.17 shows a proposed model for the rapid response of fully differentiated 
Caco-2 cells to iron exposure and the subsequent recovery of transporter levels once 
normal iron levels are restored.
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Figure 4.17: Rapid regulation of DMTl (IRE) by dietary iron
DMTl (IRE) is expressed on the apical membrane of Caco-2 cells. When cells are 
exposed to iron, DMTl is internalised within 4 h and is associated with LAMPl, a 
marker for the late endosome/lysosomal compartment. When iron levels return to normal 
the internalised DMTl (IRE) is recycled to the apical membrane within 8 h. Regulation 
of DMTl (nonlRE) follows a different time course and this variant of DMTl has been 
implicated in the exit of iron from early endosomes following TfRl mediated 
endoeytosis.
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Chapter 5
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5.0 Regulation of Iron Transport by Divalent Metals
5.1 Regulation by iron
As described in previous chapters, the expression of DMTl is strongly influenced 
by the level of iron present in the local environment. Chapter 4 described experiments 
following acute exposure to iron to give an insight into the response of enterocytes to 
dietary iron. Chronic iron deficiency in human patients also results in increased 
expression of the iron transport machinery in the duodenum. The body adapts to low iron 
availability at least in part through an up regulation of DMTl (IRE) and Iregl mRNA and 
protein expression in the intestine (Zoller et al., 2001; Rolfs et al., 2002). Using in vivo 
studies alone it is difficult to distinguish whether this response occurs as a direct result of 
the cell sensing low iron concentrations in the diet, or if the changes are induced by an 
intermediate endogenous factor that is released when iron stores are depleted.
Early investigations into the role of DMTl suggested that it was capable of 
transporting a variety of divalent metals including copper, zinc and cobalt (Gunshin et al., 
1997). More recently it has been shown that DMTl is primarily an iron transporter, but as 
described in section 1.9.3 exactly which other metals are substrates for DMTl is still 
unclear. Evidence seems to show that in addition to iron, the metals cadmium, copper and 
cobalt are likely to be taken up via DMTl whereas zinc is not (Olivi et al., 2001 ; Tandy et 
al., 2000; Yamaji et al., 2001).
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5.2 Regulation by Copper
Divalent metals other than iron can influence the regulation of iron metabolism. For 
example, alterations in copper availability may affect both iron uptake and efflux. One of 
the roles of copper in the body is as part of the structure of the ferrioxidases hephaestin 
and ceruloplasmin. Copper-deficient pigs develop anaemia due to the retention of iron in 
the duodenal mucosa and reticuloendothelial system (Lee et al., 1968). This suggests that 
at the basolateral membrane and systemically, low copper levels may impair iron efflux 
due to reduced ability of hephaestin and ceruloplasmin to oxidise the iron.
In addition, there is strong evidence that DMTl has a role in mediating copper 
uptake from the intestine. Iron and copper have been shown to inhibit one another’s 
transport (Arredondo et al., 2003; Tennant et al., 2002). Hence, at the apical membrane 
copper may compete with iron for transport through DMTl, this may cause the cell to be 
iron-deficient, resulting in an up regulation of iron transport machinery. This correlates 
with data from studies by Han and Wessling-Resnick, (2002), which showed an increase 
in DMTl, Iregl and hephaestin following 7 days low level (IpM) copper exposure. It 
seems likely that copper has more direct effects on DMTl expression as 24 h exposure to 
a high concentration (lOOpM) copper caused a reduction in iron uptake that corresponded 
to a decrease in DMTl expression (Tennant et al., 2002). This response may be mediated 
through a number of mechanisms including the activation of transcription factors or 
through modulating the activity of the IRE/IRP system.
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5.3 Regulation by Cadmium
Iron status also appears to influence the amount of cadmium in the body. Chronic 
exposure to cadmium can be toxic due to accumulation in the kidney (Reviewed in 
Patrick, 2003). It seems DMTl has some role in cadmium transport since changes in 
cadmium uptake correlate with alterations in DMTl expression when induced by iron 
deficiency or iron overload in animal and cell culture models (Olivi et al., 2001; Tallkvist 
et al., 2001; Park et al., 2002). As reported with copper, exposure to cadmium also 
regulates DMTl mRNA expression (Tallkvist et al., 2001), providing further evidence 
that DMTl may be involved in its transport.
5.4 Regulation by Zinc
While both cadmium and copper exposure may result in the down-regulation of 
DMTl levels (Tallkvist et al., 2001; Tennant et al., 2002), zinc has been shown to 
increase DMTl protein and mRNA correlating with an increase in iron uptake (Yamaji et 
al., 2001). Hence not all divalent metals appear to influence iron metabolism via the same 
mechanism and the data available so far suggests that the consequences of exposure to 
divalent metals is complex and may depend on the concentration and the duration of 
exposure. Possible mechanisms for regulation by divalent metals include indirect 
pathways, i.e. induction of iron deficiency by competition for uptake, or more direct 
mechanisms that may involve post-transcriptional mechanisms such as the IRE/IRP 
system, or transcriptional mechanisms. For example, DMTl gene has various regulatory 
elements in its promoter, including 5 metal response elements (MRE’s) (Lee et a l, 1998), 
which may be important in mediating transporter regulation by zinc.
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5.5 Hypoxia, Cobalt and Nickel
There is some evidence that intestinal iron uptake is up-regulated during hypoxia 
(O’Riordan et al., 1997). Expression of some proteins such as glyceraldehyde-3- 
phosphate dehydrogenase and vascular endothelial growth factor are increased via a 
transcriptional mechanism induced by hypoxia (Graven et a l, 1998; Namiki et a l, 1995). 
The genes for these proteins have a region called a hypoxia responsive element (HRE) 
that under hypoxic conditions may be bound by the transcription factor Hypoxia 
Inducible Factor-1 (HIFl). HIFl is a heterodimer of H IF la and aryl hydrocarbon 
receptor nuclear transporter (ARNT, also known as HIFlp) (Wang and Semenza, 1995). 
HIFl can bind to the HRE of genes under hypoxic conditions to promote the expression 
of the gene.
During normoxia, the von Hippel-Lindau tumor suppressor protein (VHL) binds to 
H IFla, at a region known as the oxygen-dependant degradation domain, to induce 
degradation of H IF la by proteasomal degradation (Huang et al., 1998; Tanimoto et al., 
2000). This binding of VHL to H IF la is controlled by the prolyl hydroxylation of H IF la 
(Epstein et al., 2001; Yu et al., 2001), and mediates the ubiquitination of H IFla, targeting 
the transcription factor for degradation (Kamura et al., 2000).
DMTl has a possible HRE in its promoter (Lee et al., 1998) but it is not known
whether this response element is functional. Although cobalt and iron can inhibit one
another’s uptake, there is little other data on the effects of cobalt on iron metabolism.
Cobalt has been shown to mimic the effects of hypoxia through binding to H IF la to
block binding of VHL and hence inhibit degradation of H IF la (Yuan et al., 2001, Yuan
et al., 2003). In addition the hydroxylation of H IF la  that is required for VHL binding is
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iron dependent, hence iron chelators such as DFO can inhibit degradation of H IFla 
(Epstein et al., 2001) also mimicking the effects of hypoxia. Increased stability of H IFla 
enhances expression of hypoxia responsive genes (Figure 5.1) and it is possible that 
cobalt may influence transcription of DMTl by this mechanism. In addition, nickel is a 
potential carcinogen (Oiler et al., 1997) that may be transported by DMTl (Gunshin et 
al., 1997; Tallkvist et al., 2003) and like cobalt, nickel is thought to induce transcription 
through a HIFl mediated mechanism.
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Figure 5.1: Summary of HIFI mediated gene regulation
Under normoxic conditions the transcription factor H IF la is ubiquitinatcd and subjected 
to proteasomal degradation. Hypoxia stabilises H IFla, promoting dimerization with the 
constitutively expressed nuclear factor ARNT (also known as HIFl(3). This forms HIFl, 
which activates gene transcription when bound to a hypoxia response element (HRE). 
Cobalt inhibits degradation of H IF la and therefore mimics the effects of hypoxia.
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5.6 Aims
The purpose of the experiments described in this chapter was to first investigate the 
response of Caco-2 cells to high and low iron levels over 72 h. The second aim was to 
investigate the effects of cobalt and nickel to further understand the mechanisms of 
regulation of iron transport by divalent metals and compare this with the response to 
changing iron availability to see if there is a common mechanism through which divalent 
metals influence iron metabolism.
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5 .7  Methods
5.7.1 Cell Culture
As described in section 2.2 Caco-2 TC7 cells were grown in 75 cm^ flasks, 
Trans well plates or 6-well plates for 21 days, and exposed to 100 pM ferric ammonium 
citrate (FAC), C0 CI2 , or NiCl2 for the final 24-72 h of the culture period. Desferrioxamine 
(DFO), an iron chelator, was used to study the effects of low iron availability on RNA 
and protein levels in Caco-2 cells. To study the effects of DFO, Caco-2 cells were treated 
with 100 pM DFO in serum free medium for up to 72 h with the medium changed each 
day.
5.7.2 Iron Transport Assays
Cells grown on Transwell inserts were exposed to 100 pM DFO, C0 CI2 or control 
cells were maintained in serum free medium for 24 h, then used for iron transport assays 
as described in section 2.8.
5.7.3 Protein Analysis
Cells exposed to 100 pM FAC, DFO, C0 CI2 or NiCl2 for either 24 or 72 h were 
collected from 75 cm^ flasks for isolation of membrane protein that was later subjected to 
Western blotting as described in 2.4. Blots were probed for DMTl (IRE), DMTl 
(nonIRE), Iregl or ferritin and the housekeeper protein villin was used as a control. 
Details of the antibodies used are shown in Table 2.1.
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5.7.4 RNA Analysis
Other cells treated with 100 pM FAC, DFO or C0 CI2 for 72 h were used for RNA 
isolation, and RT-PCR as described in sections 2.5 and 2.6. RT-PCR was performed using 
specific primers for DMTl (IRE), DMTl (nonIRE), Iregl and p-Actin was used as a 
control gene. Some experiments were performed using QRT-PCR as described in section 
2.7.
5.7.5 Electrophoretic Mobility Shift Assay
Cells were treated with 100 pM C0 CI2 or DFO and control cells were maintained in 
serum free medium for 72 h prior to nuclear protein isolation. To extract nuclear protein 
cells were scrapped into PBS, centrifuged (5 min, 750 g), and resuspended in Ripa lysis 
buffer (150 mM NaCl, 10 mM Tris (pH8), 1 mM EDTA, 1% NP40, 0.1% SDS, 0.5 mM 
PMSF, 0.2 mM benzamidine, 0.02% sodium azide). Following 7 min incubation on ice 
the samples were centrifuged (5 min, 750 g). The pellet was washed with HEPES buffer 
(20 mM HEPES pH 7.9) then resuspended in nuclear protein buffer (20 mM HEPES (pH 
7.9), 0.4 M NaCl, 1.5 mM MgCk, 1 mM DTT, 25% Glycerol, 0.5 mM PMSF) and 
incubated for 30 min at 4 °C. Samples were centrifuged (10 min, 15,000 g) and the 
supernatant, which contains the nuclear extract, was collected.
Electrophoretic Mobility Shift Assays (EMSA’s) were performed on nuclear 
extracts from 72 h control, DFO and C0 CI2 treated cells, using a LightShift™ 
Chemiluminescent EMSA Kit (Pierce, Illinois, USA). Composition of each binding 
reaction is described in Table 5.1. All components except the biotin labelled probe were 
added to each tube and incubated for 10 min. The reaction was incubated for a further 20
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min after the addition of the biotin labelled probe followed by addition of 5 pi of sample 
buffer (100 mM Dithiothreitol (DTT), 50 mM Tris, 2% sodium dodecyl sulphate (SDS), 
10% Glycerol, 0.1% Bromophenol Blue).
The samples were separated on a 6% polyacrylamide gel (0.5X TBE, 6% 
Acrylamide/Bis, 2.5% glycerol, 0.1% ammonium persulphate, 0.1% Temed) with 0.5% 
TBE buffer, then transferred (300 mA, 30 min) onto a nylon membrane soaked in 0.5% 
TBE. The DNA was cross-linked to the membrane using a UV Transilluminator for 15 
min. Detection of the biotin-labelled DNA was then performed according to the 
manufactures instructions.
Component Negative
Control
Sample Reaction Competitive
Control
lOX Binding Buffer IX IX IX
50% Glycerol 2.5% 2.5% 2.5%
1 mg/ml Poly dIxdC 50 ng/ml 50 ng/ml 50 ng/ml
Unlabeled DNA - - 4 pmol
Protein Extract 1 unit EBNA extract 
or 5 mg Caco-2 
nuclear extract
1 unit EBNA extract 
or 5 mg Caco-2 
nuclear extract
Biotin-DNA 20 fmole 20 finole 20 finole
Table 5.1: EMSA binding reactions
Each EMSA consisted of three reactions. 1) negative control - consisting of biotin 
labelled DNA but with no protein extract, 2) sample reaction -  with biotin labelled DNA 
and protein extract, 3) Competitive control -  biotin labelled DNA, protein extract and 
excess unlabelled DNA. The EBNA system was a positive control provided with the kit 
using EBNA DNA. Caco-2 nuclear extract was mixed with unlabelled or biotin labelled 
consensus HRE DNA.
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The specific DNA probes used to test potential HRE binding ability were obtained 
from MWG Biotech (Ebersberg, Germany) using the sequences as follows:
HRE Sense: 5 ’-TCTGTACGTGACCACACTCACCTC-3 ’BI0T3
HRE Antisense: 5 ’-GAGGTGAGTGTGGTCACGTACAGA-3 ’BI0T3
Identical oligonucleotides were obtained without the 3’biotin label for use as a 
competitive inhibitor to test the specificity of the binding. The DNA was provided as 
single strands, therefore complementary strands were incubated together at room 
temperature for 1 h prior to use in the EMSA.
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5.8 Results
In chapter 3.0, feeding rats an iron-loaded diet resulted in a decrease in DMTl 
(IRE) mRNA levels, but induced no significant changes in DMTl (nonIRE) mRNA levels 
in the duodenum. However when PCR was performed on RNA samples from Caco-2 
cells no significant differences were measured for either isoform in control and 72 h iron 
treated samples (Figure 5.2).
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Figure 5.2: 72 h iron exposure does not alter DM Tl mRNA expression in Caco-2 cells
Cells were treated with 100 pM iron for 72 h and mRNA isolated and analysed by RT- 
PCR. Band density was measured by densitometry using Scion image software. Data are 
expressed as means ± SEM of 6 experiments. No significant differences were found 
using Student’s unpaired t-test.
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The short-term studies described in section 4.0 showed that DMTl protein 
expression in Caco-2 cells is responsive to elevated iron levels. In agreement with this, 
exposure to iron for 72 h also caused a decrease in DMTl (IRE) protein levels, however, 
DMTl (nonIRE) expression was unaltered. The expression of villin, which is a structural 
protein used as a negative control was also unaltered by iron exposure (Figure 5.3).
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Figure 5.3: DMTl (IRE) expression is decreased by exposure to iron for 72 h
Caco-2 cells were exposed to 100 |iM iron for 72 h. Membrane protein was isolated and 
subjected to Western blotting. Band density was measured using Scion image software. 
Data are expressed as means ± SEM of 6 experiments. Statistical analysis was performed 
using Student’s unpaired t-test. ^Significant difference from control P <0.05.
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Expression of the basolateral transporter Iregl was also unchanged following 72 h 
iron exposure (Figure 5.4).
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Figure 5.4: Iron exposure for 72 h does not alter Iregl expression
Caco-2 cells were exposed to 100 pM iron for 72 h. Membrane protein was isolated and 
subjected to Western blotting. Band density was measured using Scion image software. 
Data are expressed as means ± SEM of 6 experiments. No significant differences were 
found using Student’s unpaired t-test.
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The iron chelator DFO was used to investigate the response of Caco-2 cells to 
limited iron availability. Cells grown on Transwell plates were treated with 100 pM DFO 
for 24 h or 72 h prior to measurement of iron uptake. Accumulation of ^^Fe was 
significantly higher in DFO treated cells compared with control (Figure 5.5).
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Figure 5.5: Iron uptake by Caco-2 cells after 24 h DFO treatment
Cells grown in Transwells were treated with 100 pM DFO for 24 h. Uptake of ^^FeClg 
from the apical chamber was measured after an hour by scintillation counting. Data are 
expressed as means ± SEM of 6 experiments. Statistical analysis was performed using 
Students unpaired t-test. * Significant difference from control P <0.05.
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To investigate the mechanisms involved in this response, RNA and membrane 
protein were harvested from Caco-2 cells treated with DFO. Western blotting showed a 
significant increase in the IRE isoform in DFO-treated cells, whereas nonIRE expression 
was unchanged (Figure 5.6).
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Figure 5.6: DMTl protein expression in Caco-2 cells exposed to DFO for 72 h
Caco-2 cells were exposed to 100 pM DFO for 72 h. Membrane protein was isolated and 
subjected to Western blotting, band density was measured using Scion image software. 
Data are expressed as means ± SEM of 6 experiments. Statistical analysis was performed 
using Student’s unpaired t-test. *Significant difference from control P <0.05.
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Parallel to the protein expression, when DMTl mRNA levels were analysed 
following exposure to DFO, expression of the DMTl (IRE) isoform was significantly 
increased, whereas the nonIRE isoform was unaffeeted compared with controls (Figure 
5.7).
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Figure 5.7: DMTl mRNA expression following 72 h exposure to DFO
Cells were treated with 100 pM DFO for 72 h and mRNA isolated and analysed by RT- 
PCR. Band density was analysed by densitometry using Scion Imaging. Data are 
expressed as means ± SEM of 6 experiments. Statistical analysis was performed using 
Student’s unpaired t-test. * Significant difference from control P  <0.05.
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In Caco-2 cells the response to iron-deficient conditions appears to be limited to the 
apical transport machinery, as no significant differences were found between Iregl 
protein expression in control and DFO treated cells (Figure 5.8).
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Figure 5.8: Iregl protein levels are unchanged by 72 h DFO treatment
Cells were treated with 100 pM DFO for 72 h. Membrane protein was isolated and 
subjected to Western blotting. Band density was measured using Scion image software. 
Data are expressed as means ± SEM of 6 experiments. No significant differences were 
found using Student’s unpaired t-test.
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Levels of Iregl mRNA were also measured following 72 h exposure to DFO 
however as shown in Figure 5.9 there was no significant change in expression.
Iregl (3-Actin
Control +DFO Control +DFO
0.3 -
Control +DFO
Figure 5.9: Iregl mRNA expression is unchanged by 72 h DFO exposure
Cells were treated with 100 pM DFO for 72 h and mRNA isolated and analysed by RT- 
PCR. Band density was measured by densitometry using Scion image software. Data are 
expressed as means ± SEM of 6 experiments. No significant differences were found 
using Student’s unpaired t-test.
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DMTl has been proposed to mediate the uptake of a range of metals in addition to 
iron (Gunshin et al., 1997), and various metals such as iron and copper have been shown 
to alter DMTl expression. Cobalt may also be a substrate for DMTl, therefore a series of 
experiments were performed to assess any effects of cobalt on expression of the iron 
transporters. Cells grown in Transwells were exposed to 100 pM cobalt (added to the 
apical chamber) for the final 24 h of the culture period prior to the measurement of iron 
uptake. In this study uptake of iron was significantly increased in the cobalt treated cells 
(Figure 5.10).
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Figure 5.10: Exposure to cobalt for 24 h increases iron uptake in Caco-2 cells
Cells were incubated with 100 pM CoCb for the last 24 h of the culture period. Cells 
were then exposed to ^^FeCb in the apical chamber and iron taken into the cell over 15 
min was measured by scintillation counting. Data are expressed as means ± SEM of 6 
experiments. Statistical analysis was performed using Student’s unpaired t-test. 
* Significant difference from control P <0.05.
138
A change in iron uptake would be expected to be associated with changes in DMT 1 
(IRE) as this is the major iron transporter at the apical membrane of the cell, however 
following 24 h cobalt exposure levels of DMTl (IRE) protein were not significantly 
changed (Figure 5.11).
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Figure 5.11: DMTl (IRE) protein expression is unchanged following cobalt exposure
Membrane protein was isolated from cells after 24 h treatment with 100 pM CoCE. 
Samples were subjected to Western blotting for DMTl (IRE) and band density quantified 
using Scion image software. Data are expressed as means ± SEM of 6 experiments. No 
significant differences were found using Student’s unpaired t-test.
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In contrast to DMTl (IRE), expression of the nonIRE isoform was found to be 
significantly higher in cobalt treated cells compared to control (Figure 5.12).
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Figure 5.12: DM Tl (nonIRE) expression is increased following cobalt exposure
Membrane protein was isolated from cells after 24 h treatment with 100 pM CoCh- 
Samples were subjected to Western blotting and band density quantified using Scion 
image software. Data are expressed as means ± SEM of 6 experiments. Statistical 
analysis was performed using Student’s unpaired t-test. ^Significant difference from 
control P <0.05.
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In contrast to the iron uptake data, efflux of iron from Caco-2 cells was unchanged 
following 24 h cobalt exposure (Figure 5.13).
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Figure 5.13: Iron efflux is unaffected by 24 h cobalt treatment
Cells were incubated with 100 pM CoCh for the last 24 h of the culture period. Cells 
were incubated for 1 h with ^^FeClg in the apical chamber to permit iron uptake across 
the apical membrane. Efflux into the basolateral chamber was determined over the next 2 
h by scintillation counting, and was calculated as a proportion of apical uptake. Data are 
expressed as means ± SEM of 6 experiments. No significant differences were found 
using Student’s unpaired t-test.
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Consistent with these data there were no differences in Iregl mRNA (cobalt and 
controls 1.09 ±0.07 and 1.11 ±0.05 (a.u. ± SEM) respectively) or protein expression in 
cobalt and control treated cells (Figure 5.14).
Iregl [3-Actin
mRNA
Control +Co Control +Co
Iregl Villin
P 30 -
Protein
Control +Co Control +Co
Control + Co
Figure 5.14: Iregl expression is unaltered by cobalt treatment
RNA and membrane protein were isolated from Caco-2 cells after 24 h treatment with 
100 pM CoCh- Samples were subjected to RT-PCR (upper inset) or Western blotting for 
Iregl. Band density was quantified using Scion image software. Data are expressed as 
means ± SEM of 6 experiments. No significant differences were found using Student’s 
unpaired t-test.
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The effect of cobalt on DMTl transporter mRNA isoforms was examined in more 
detail using quantitative real-time PCR (QRT-PCR). Interestingly exposure to cobalt did 
not alter the mRNA expression of either DMTl isoform (Figure 5.15).
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Figure 5.15: Cobalt exposure has no effect on DMTl mRNA expression
Caco-2 cells were exposed to 100 pM cobalt for the final 72 h of the culture period. 
QRT-PCR was performed on RNA samples using specific primers for DMTl (IRE) and 
DMTl (nonIRE). Data are expressed as means ± SEM of 6 experiments. No significant 
differences were found using Student’s unpaired t-test.
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Cobalt is known to stabilise the transcription factor H IF la (Yuan et a l, 2001; Yuan 
et a l, 2003) and so may enhance HRE-mediated transcription of some genes. In addition, 
DEO has also been shown to induce HIFl activity (Creighton-Gutteridge and Tyrrel,
2002). Since DMTl has a sequence in its promoter that may function as a HRE (Lee et 
al., 1998), electrophoretic mobility shift assays were performed to determine whether 
cobalt induces HIFl activity. Preliminary studies indicated that neither cobalt (Figure
5.16) nor DFO induced HIFl binding. However results were inconsistent, and while 
adding an excess of unlabelled control probe eliminated the specific band produced using 
control system provided with the EMSA kit (Pierce, Illinois, USA), unlabelled HRE 
probe was not able to eliminate the band produced using Caco-2 nuclear protein samples, 
this suggests that the binding observed during this experiment was non-specific. In 
addition, as there was no effect of cobalt on DMTl mRNA levels, it is unclear whether 
HIFl/HRE interaction is an important mechanism involved in control of DMTl 
expression.
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Figure 5.16: Representative EMSA for HRE binding
EMSA’s were performed using LightShift™ Chemiluminescent EMSA Kit (Pierce, 
Illinois, USA). Control reactions provided with the kit were run according to the 
manufacturers instructions. The left hand picture shows a typical result using this control 
to confirm a functioning assay. A) biotin-labelled control probe, B) biotin-labelled 
control probe and nuclear protein, C) biotin-labelled control probe, nuclear protein and 
excess unlabelled probe. Caco-2 cells were treated with 100 pM CoCb for the final 72 h 
of the culture period. Nuclear protein was isolated and subjected to an EMSA using a 
biotin labelled HRE sequence. Lanes were loaded as follows: 1) biotin-labelled probe, no 
protein, 2) biotin labelled probe and nuclear protein extract, 3) biotin labelled probe, 
nuclear protein extract and excess unlabelled probe.
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Nickel is another divalent metal thought to be transported by DMTl and is also 
believed to mimic hypoxia via stabilisation of HIFla. Caco-2 cells were exposed to 
nickel for 72 h in an attempt to clarify whether HIFla/HRE interactions are involved in 
the response of DMTl (nonIRE) to cobalt. When cells were exposed to 100 pM nickel for 
72 h no differences were observed in the expression of either isoform of DMTl (Figure
5.17).
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Figure 5.17: DMTl protein expression is not altered by nickel exposure
Membrane protein was isolated from cells after 72 h treatment with 100 pM NiCE. 
Samples were subjected to Western blotting and band density quantified using Scion 
image software. Data are expressed as means ± SEM of 6 experiments. No significant 
differences were found using Student’s unpaired t-test.
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Membrane protein samples were also analysed for Iregl expression, but no 
significant differences were found between control and nickel treated samples (Figure 
5.18).
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Figure 5.18; Nickel treatment for 72 h has no effect on Iregl protein expression
Membrane protein was isolated from cells after 72 h treatment with 100 pM NiCb- 
Samples were subjected to Western blotting and band density quantified using Scion 
image software. Data are expressed as means ± SEM of 6 experiments. No significant 
differences were found using Student’s unpaired t-test.
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5.9 Discussion
5.9.1 Regulation by Iron Availability
Expression of the iron transporters DMTl and Iregl is known to change with iron 
status in vivo. Previous studies from our laboratory using Caco-2 cells have shown using 
Northern blotting that DMTl mRNA expression is decreased by iron treatment (Tandy et 
a l, 2000). However, in the current work using the less quantitative RT-PCR method, no 
changes in mRNA levels of either DMTl isoform were observed. In contrast, using the 
more reliable Western blotting approach, DMTl (IRE) protein levels were significantly 
decreased in cells exposed to iron. In previous work we have shown that decreases in 
protein expression at the cell surface of Caco-2 cells results in a corresponding decrease 
in iron uptake (Tandy et al., 2000; Sharp et al., 2002). Iron exposure did not result in any 
changes in the expression of the basolateral transporter Iregl. These data are consistent 
with previous Caco-2 studies from our laboratory (Sharp et al., 2002), and from studies in 
iron-loaded animals (McKie et al., 2000).
When the iron chelator DFO was used to limit iron availability in Caco-2 cells there 
was a significant increase in iron uptake. Further investigation of this response showed 
that the increased uptake was associated with an increase in DMTl (IRE) protein 
expression in DFO-treated cells. Consistent with in vivo data from iron-deficient patients 
(Rolfs et al., 2002), the increased expression was limited to the IRE isoform (protein level 
of the nonIRE isoform was unaffected). Analysis of mRNA levels after DFO treatment 
correlated with the protein response, indicating possible regulation at the level of the IRE 
located in the 3’ untranslated region of DMTl mRNA.
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Expression of the basolateral transporter was not significantly changed by DFO 
exposure. This is in contrast to iron-deficient mice, which have increased Iregl 
expression compared to control mice (Abboud and Haile, 2000). One possible explanation 
for contrast between the two data sets may be the presence / absence of endogenous 
signals (for example hepcidin) that in addition to changes in dietary iron levels, are 
essential in establishing the full response to iron deficiency. These host factors may 
directly alter the absorptive capacity of mature enterocytes or participate in programming 
of immature cells in the crypts of Lieberkühn (reviewed in Frazer and Anderson, 2003).
5.9.2 Regulation by Divalent Metals and Hypoxia
In addition to mediating the uptake of iron, DMTl appears to be capable of 
transporting various other divalent metals, including some such as cadmium, that may be 
present as toxic impurities in food or drinking water in some areas (Reviewed in Patrick,
2003). The divalent metals copper, cadmium and zinc have been shown to influence iron 
metabolism through alterations in DMTl expression. Cobalt and nickel are both 
transported by DMTl, but there is little data available concerning their effects on iron 
metabolism, therefore a series of experiments were performed to assess the effects of 
cobalt and nickel on Caco-2 cells. When iron transport was measured in the cells 
following 24 h exposure to cobalt there was an increase in uptake across the apical 
membrane, but no change in efflux of iron. Consistent with these results there was no 
effect on protein or mRNA levels of the basolateral transporter Iregl when measured by 
Western blotting. Protein levels for DMTl were analysed next to see if there was a 
change in expression levels to account for the increased iron uptake. Interestingly, these 
studies revealed a dramatic increase in DMTl (nonIRE) protein levels after 24 h ( Figure
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5.12). Cadmium and copper have been found to specifically down-regulate DMTl (IRE), 
while zinc up-regulates this isoform (Tallkvist et ah, 2001; Tennant et al., 2002; Yamaji 
et al., 2001). However, there was no change in DMTl (IRE) expression following cobalt 
treatment, implying that cobalt affects DMTl via a different mechanism to the other 
divalent metals studied so far.
Possible targets of cobalt may include the 5 MRE’s in the DMTl promoter, or 
alternatively there is region that may act as a hypoxia response element (HRE) (Lee et al.,
1998). Both DFO and cobalt have been shown to increase HIFl levels and cobalt in 
particular is thought to mimic hypoxia through the stabilisation of H IF la (Wang et al., 
1995; Yuan et al., 2001; Creighton-Gutteridge and Tyrrel, 2002) It was thought that this 
might be a possible mechanism for the changes observed in DMTl (nonIRE) expression. 
Preliminary studies using EMSA's suggested that neither cobalt nor DFO induce HIFl 
binding in Caco-2 cells, however results were not consistent. Furthermore, if cobalt were 
working through H IF la then an increase in DMTl mRNA would be expected following 
cobalt exposure. However when mRNA levels were analysed using quantitative real time 
PCR no significant differences in mRNA for any of the transporters were found between 
control and cobalt treated cells.
Like cobalt, nickel is also capable of inducing some of the same genes that are 
induced during hypoxia, such as glyceraldehyde-3-phosphate dehydrogenase (Graven et 
al., 1998) by promoting accumulation of the transcription factor H IF la (Salnikow et al.,
1999). As described previously in section 5.5, hydroxylation of HIFl by prolyl 
hydroxylase promotes degradation of the transcription factor. There is some evidence that 
both cobalt and nickel may reduce intracellular ascorbate levels (Salnikow et al., 2004),
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and since ascorbate is a cofactor for prolyl hydroxylase this would result in accumulation 
of HIFl and mimic hypoxic conditions. However when protein levels were analysed from 
cells exposed to 100 p.M nickel for 24 h no changes were observed in any of the 
transporter levels adding further weight to the suggestion that cobalt is not operating 
through the HIFl/HRE pathway.
Further investigation will be necessary to determine the mechanism involved in the 
up regulation of DMTl (nonIRE) induced by cobalt. A plausible mechanism may involve 
redistribution of existing DMTl protein within the cell, similar to the rapid effects of iron 
seen in section 4.0. This possibility could be investigated using techniques such as 
subcellular fractionation, and immunoprécipitation with intracellular marker proteins, 
such as LAMPl or EEAl to determine whether cobalt induces changes in the cellular 
location of DMTl. These data further highlight the need for a more in depth investigation 
into the role of the DMTl promoter in mediating transcriptional regulation of DMTl 
expression. The use of EMSA together with reporter gene assays and DNA footprinting 
would be useful in pinpointing potential transcription factor binding sites and establishing 
how protein/DNA binding events might ultimately control intestinal iron absorption.
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6.0 Regulation of Intestinal Iron Transport by 
Cytokines
6.1 Anaemia o f  Chronic Disease and TNFa
The complex interaction of various cytokines and cells, which is responsible for 
mediating the immune response, also has some control over iron metabolism. This is 
demonstrated by the anaemia that may develop during chronic illness. Anaemia of 
chronic disease (ACD) is a disorder that develops in patients with chronic activation of 
cellular immunity such as during inflammation, infection or malignant diseases 
(Reviewed in Means and Krantz, 1992). Features of ACD include reduced iron 
absorption, but increased iron storage in the reticuloendothelial system. This anaemia may 
have a beneficial role in the immune response as iron is required for the proliferation of 
pathogens and tumour cells, hence anaemia may help limit the spread of the disease.
The pro-inflammatory cytokine TNFa may play a role in linking the immune
system and iron metabolism. TNFa is released from stimulated macrophages as part of an
inflammatory response (Benjamini et al., 1996). In THP-1 cells (a monocyte/macrophage
cell line), exposure to iron increased expression of TNFa, while treatment with DFO
caused a reduction in TNFa levels (Scaccabarozzi et al., 2000). TNFa has been shown to
induce selective transcription of ferritin H-chain (Torti et a l, 1988; Miller et al., 1991),
and further investigation has shown that this is dependent on a region of the promoter that
contains 2 sites capable of binding the transcription factor NF-kB (Kwak et al., 1995).
Iron status can influence ferritin expression at the translational level through binding of
IRP to an IRE under iron-deficient conditions. Although the transcriptional effect of
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TNFa was independent of iron levels, translation was still primarily regulated according 
to iron status (Miller et al., 1991). Hence, the increase in iron storage that is characteristic 
of ACD appears to be partly the result of TNFa induced up-regulation of ferritin 
transcription but other factors may also be interfering with normal post-transcriptional 
regulation of the protein by iron. A possible translational step in the induction of ferritin 
during ACD involves a nitric oxide (NO) mediated response. Macrophages stimulated by 
lipopolysaccaride/IFNy have increased ferritin H-chain expression that is dependent on 
NO. Unlike the response to TNFa that is brought about through increasing transcription, 
the up-regulation induced by NO is mostly achieved through post-transcriptional 
regulation via IRP-2 (Recalcati et al., 1998). A two-step process such as this would allow 
greater flexibility in modulating iron metabolism under various conditions.
Macrophages play an important part in iron homeostasis, as they are responsible for 
some iron storage and for recycling of iron from aged erythrocytes. When the immune 
system is activated, macrophages may have even greater influence over iron metabolism 
via increased production of cytokines. Antigen stimulates type 1 helper T cells (Thl) cells 
to release interleukin-2 and interferon gamma (IFNy), which in turn may stimulate 
macrophages to release more cytokines. There is some evidence that in addition to TNFa, 
IFNy, interleukin-6 (IL6) and NO may all have some influence over iron homeostasis.
6.2 Inflammation and Hepcidin
Recently an antimicrobial peptide named hepcidin has been isolated from human 
blood and urine (Krause et al., 2000; Park et al., 2001). Hepcidin is expressed in the liver 
as an 84 amino acid pro-peptide and excreted in the urine primarily as 20 and 25 amino
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acid metabolites (Krause et al., 2000). Hepcidin has been found to strongly influence iron 
metabolism and appears to be a major endogenous regulator of iron status.
As part of an investigation into glucose uptake a knockout mouse was developed 
lacking the promoter upstream regulatory factor 2 (USF2). One unexpected side effect of 
the USF2‘^‘ mice was severe iron overload in the liver and pancreas, accompanied by 
increased serum iron and transferrin saturation (Nicolas et al., 2001). The only apparent 
explanation for this overload was a lack of hepcidin expression. Using an alternative 
method to knockout the USF2 region in mice the overload was shown to be due to the 
lack of hepcidin, not the absence of USF2, as hepcidin expression was normal in this 
second strain (Nicolas et al., 2002a).
As described earlier, anaemia is sometimes induced in chronic illness. A recent 
study has shown that urinary levels of hepcidin are increased in patients with anaemia of 
inflammation (Nemeth et al., 2003). In addition, over-expression of hepcidin has been 
shown to induce severe microcytic anaemia in mice and this can be corrected with iron 
injections suggesting that hepcidin modulates dietary iron uptake (Nicolas et al., 2002a). 
Hence in addition to TNFa, hepcidin may provide a second link between the immune 
system and regulation of iron status.
The cytokine Interleukin-6 (IL6) is released from activated macrophages as part of 
an immune response, and has been shown to induce hepcidin expression in a primary 
culture of hepatocytes (Nemeth et al., 2003). Inflammation in wildtype mice caused by 
turpentine injections (which induces IL6) results in an increase in hepcidin expression 
that is associated with reduced serum iron. This decrease in serum iron is not reproduced 
following turpentine injections in hepcidin-deficient mice (Nicolas et al., 2002b) and
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there is no change in hepcidin expression, or serum iron levels in IL6 knockout mice 
injected with turpentine (Nemeth et al., 2004a). This pathway for induction of hepcidin 
by IL6 is also reproduced in humans. IL6 perfusion in healthy volunteers resulted in 
increased hepcidin excretion in the urine and decreased serum iron and transferrin 
saturation (Nemeth et al., 2004a). Hence one mechanism for the induction of anaemia 
during an immune response may involve the release of IL6 from stimulated macrophages, 
which causes an increase in hepcidin expression.
Initially it was concluded that interleukin-1 (ILl) could only induce hepcidin 
expression via an IL6 mediated pathway (Nemeth et al., 2003), however subsequent 
studies have shown that both ILl a  and ILl (3 can induce hepcidin transcription 
independently of IL6, and may contribute to the development of anaemia of chronic 
disease (Lee et al., 2004; 2005). Under the conditions of anaemia of chronic disease, as 
well as having a direct role on iron metabolism via control of ferritin expression, TNFa 
may also play a role in systemic regulation of iron levels via a down regulation of 
hepcidin expression (Nemeth et al., 2004a).
At present it is unclear what the molecular targets of hepcidin are but it seems likely 
that hepcidin exerts some effect on duodenal enterocytes to reduce iron absorption.
6.3 Aims
The aim of experiments described in this chapter was to study the effects of 
endogenous factors on iron metabolism, beginning by looking at the effects of the 
cytokines TNFa and IL6. As well as measuring iron transport, effects on transporter 
protein and mRNA expression were also measured.
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6,4 Methods
6.4.1 Cell Culture
Caco-2 cells were cultured as described in section 2.2. Cells grown in Transwells 
were exposed to 10 ng/ml TNFa or 10 ng/ml IL6 in the basolateral chamber for the last 
72 h of the culture period. Control cells also grown on Transwells were maintained in 
serum free medium for the final 72 h.
6.4.2 Hepatocyte Conditioned Medium
Stocks of HuH7 cells were maintained in 25 cm^ flasks with DMEM supplemented 
with 10% foetal bovine serum, 200 mM L-Glutamine, 1% non-essential amino acids and 
1% penicillin/streptomycin. When the flask was 90% confluent the cells were passaged as 
described in section 2.2 for Caco-2 cells. HuH7 cells were seeded at a density of 200,000 
cells per well in 6 well plates for preparation of hepatocyte-conditioned medium (HCM). 
Once the cells were 80% confluent they were placed in serum free medium with or 
without 10 ng/ml IL6. The conditioned medium (IL6-HCM and HCM) was collected 24 h 
later and added to the basolateral chamber of Transwells on which Caco-2 cells had been 
growing for 21 days. Serum free medium that had not been subjected to hepatocyte 
conditioning was placed in the apical chamber. After 24 h, the cells were collected and 
samples prepared for Western blotting.
157
6.4.3 Western Blotting
Following treatment, cells were scrapped into PBS and centrifuged (800 g, 5 min). 
The pellet was suspended in homogenisation buffer (50 mM mannitol, 10 mM HEPES pH 
7.2, 0.5 mM PMSF, 0.2 mM benzamidine, 0.02% sodium azide) and homogenised for 30 
seconds. The homogenate (15 pg) was subjected to Western blotting for DMTl (IRE), 
DMTl (nonIRE), Iregl, villin and ferritin as described in section 2.4. Antibody 
specifications are given in Table 2.1.
6.4.4 RT-PCR
Following treatment with pro-inflammatory cytokines or conditioned medium, 
mRNA was isolated using Trizol as described in section 2.5 and RT-PCR was performed 
as described in section 2.6 using specific primers for DMTl (IRE), DMTl (nonIRE), 
Iregl and P-actin.
6.4.5 Transport Studies
In parallel studies, cells were grown on Trans well inserts and exposed to 10 ng/ml 
TNFa or IL6 for use in iron transport assays as described in section 2.8.
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6.5 Results
TNFa is known to induce iron sequestration within a number of tissues by 
increasing ferritin H-chain transcription (Torti et al., 1988; Miller et al., 1991). This leads 
to decreased iron release from storage tissues into the serum resulting in the 
hypoferraemia associated with the anaemia of chronic disease. To determine the intestinal 
effects of this pro-inflammatory cytokine, Caco-2 cells were incubated with TNFa prior 
to protein isolation and Western blotting for ferritin.
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In cells exposed to TNFa for 72 h ferritin protein expression was significantly 
increased compared to control, suggesting that the cytokine may target the intestine to 
regulate iron metabolism (Figure 6.1).
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Figure 6.1: TNFa treatment Increases ferritin protein expression in Caco-2 cells
Following 72 h TNFa treatment cytosolic protein was isolated from Caco-2 cells and 
subjected to Western blotting. Band density was measured using Scion image software. 
Data are expressed as means ± SEM of 6 experiments. Statistical analysis was performed 
using Student’s unpaired t-test. ^Significant difference from control P <0.05.
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To determine the effects of TNFa on non-haem iron flux across the model intestinal 
epithelium, ^^Fe was added to the apical chamber of Trans well plates. Studies by Tandy et 
al (2000) demonstrate that in Caco-2 cells iron uptake reaches equilibrium after 1 h, 
therefore any changes observed in efflux after this time are independent of the initial rate 
of uptake. Accordingly, uptake was allowed to proceed for 1 h and efflux across the 
basolateral membrane measured over the next 2 h. Following exposure to TNFa iron 
accumulation in the basolateral medium was significantly decreased (Figure 6.2).
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Figure 6.2: TNFa exposure decreases iron efflux in Caco-2 cells
Cells grown in Transwells were treated with TNFa for 72 h. Cells were incubated for 1 h 
with ^^FeCb in the apical chamber to permit iron uptake across the apical membrane. 
Efflux into the basolateral chamber was determined over the next 2 h by scintillation 
counting, and was calculated as a proportion of apical uptake. Data are expressed as 
means ± SEM of 6 experiments. * Significant difference from control P <0.05.
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A decrease in iron efflux could be explained by two mechanisms; either increased 
iron sequestration within ferritin, or (and) by down regulation of the basolateral iron 
transport protein Iregl. Both Western blotting (Figure 6.3) and RT-PCR (Figure 6.4) 
revealed that TNFa had no effect on the expression of Iregl protein and mRNA 
suggesting that the decrease in iron efflux occurred as a consequence of increased 
intracellular retention.
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Figure 6.3: Iregl protein expression is not affected by72 h TNFa exposure
Following 72 h TNFa treatment membrane protein was isolated from Caco-2 cells and 
subjected to Western blotting. Band density was measured using Scion image software. 
Data are expressed as means ± SEM of 6 experiments. No significant differences were 
found using Student’s unpaired t-test.
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Figure 6.4: Iregl mRNA expression is not influenced by TNFa treatment
Cells were treated with TNFa for 72 h and mRNA isolated and analysed by RT-PCR. 
Band density was measured by densitometry using Scion image software. Data are 
expressed as means ± SEM of 6 experiments. No significant differences were found 
using Student’s unpaired t-test
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Next the effects of TNFa on apical iron uptake were investigated. In Caco-2 cells 
treated with this pro-inflammatory cytokine there was a significant decrease in iron entry 
across the apical membrane (Figure 6.5).
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Figure 6.5: TNFa exposure decreases iron uptake in Caco-2 cells
Cells grown in Trans wells were treated with TNFa for 72 h. Uptake of ^ ^FeClg from the 
apical chamber was measured after 15 min by scintillation counting. Data are expressed 
as means ± SEM of 6 experiments. Statistical analysis was performed using Student’s 
unpaired t-test. * Significant difference from control P <0.05.
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A reduction in uptake suggests that TNFa targets the transport machinery at the 
apical membrane, namely DMTl. When investigated using Western blotting, DMTl 
(IRE) protein expression was found to be significantly decreased following 72 h TNFa 
treatment (Figure 6.6).
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Figure 6.6: TNFa treatment decreased DM Tl (IRE) protein expression
Following 72 h TNFa exposure membrane protein was isolated from Caco-2 cells and 
subjected to Western blotting. Band density was measured using Scion image software. 
Data are expressed as mean ± SEM of 6 experiments. Statistical analysis was performed 
using Student’s unpaired t-test. ^Significant difference from control P <0.05.
165
In contrast to the IRE isoform, DMTl (nonIRE) protein levels were unchanged by 
stimulation of Caco-2 cells with TNFa (Figure 6.7).
3
é
3
£
w3O
3
100
DMTl (nonlRE) Villin
Control +TNEa Control +TNFa
Control TNF a
Figure 6.7: TNFa exposure has no effect on DMTl (nonIRE) protein expression
Following 72 h TNFa treatment membrane protein was isolated from Caco-2 cells and 
subjected to Western blotting. Band density was measured using Scion image software. 
Data are expressed as mean ± SEM of 6 experiments. No significant differences were 
found using Student’s unpaired t-test.
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The changes in DMTl protein expression were paralleled at the mRNA level, i.e. a 
decrease in the IRE-containing variant but no effect of TNFa on the nonIRE form (Figure 
6.8). There was no change in mRNA expression of the control gene p-Actin following 
cytokine exposure. This isoform-specific regulation suggests that TNFa may alter 
expression of the transporter by a mechanism involving the IRE.
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Figure 6.8: DMTl (IRE) mRNA is decreased following TNFa exposure
Cells were treated with TNFa for 72 h and mRNA isolated and analysed by RT-PCR 
using specific primers for DMTl (IRE) and (nonIRE). Band density was analysed by 
densitometry using Scion Imaging. Data are expressed as means ± SEM of 6 
experiments. Statistical analysis was performed using Student’s unpaired t-test. 
^Significant difference from control P <0.05.
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Taken together the data above suggest that the IRE in the 3’UTR of DMTl may be 
important in the regulation of apical iron uptake by TNFa. In order to confirm this the 
effects of TNFa on TFRl mRNA expression was also determined. TFRl mRNA contains 
5 IRE sequences within its 3’UTR and consistent with the hypothesis that TNFa induces 
changes via an IRE regulated mechanism, TfRl mRNA was also significantly decreased 
following 72 h TNFa exposure (Figure 6.9).
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Figure 6.9: TfRl mRNA is significantly reduced following TNFa exposure
Cells were treated with TNFa for 72 h and mRNA isolated and analysed by RT-PCR. 
Band density was analysed by densitometry using Scion Imaging. Data are expressed as 
means ± SEM of 6 experiments. Statistical analysis was performed using Student’s 
unpaired t-test. * Significant difference from control P <0.05.
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To determine whether the effects of TNFa on intestinal iron metabolism were a 
general mechanism induced by cytokines, the effects of IL6 on iron metabolism in Caco-2 
cells were also investigated. IL6 is a pro-inflammatory cytokine that also plays an 
important role in the aetiology of the anaemia of chronic disease. In contrast to the effects 
of TNFa, the cytokine IL6 had no effect on expression of ferritin in Caco-2 cells (Figure 
6.10).
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Figure 6.10: IL6 exposure does not alter ferritin protein expression
Cells were treated with 10 ng/ml IL6 for 72 h. Whole cell protein samples were subjected 
to Western blotting using specific antibodies against ferritin. Band density was measured 
by densitometry using Scion image software. Data are expressed as means ± SEM of 6 
experiments. No significant differences were found using Student’s unpaired t-test.
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Furthermore, there was no significant difference in iron uptake aeross the apical 
membrane (Figure 6.11) or in basolateral iron efflux (Figure 6.12) between eontrol cells 
and those exposed to IL6.
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Figure 6.11: Iron uptake is not altered by IL6 treatment of Caco-2 cells
Cells were incubated with 10 ng/ml IL6 for the last 24 h of the culture period. Cells were 
then exposed to ^^FeCb in the apical chamber and iron taken into the cell over 15 min 
was measured by scintillation counting. Data are expressed as means ± SEM of 6 
experiments. No significant differences were found using Student’s unpaired t-test.
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Figure 6.12: Iron efflux is unaltered by IL6 exposure in Caco-2 cells
Cells were incubated with 10 ng/ml IL6 for the last 24 h of the culture period. Cells were 
incubated for 1 h with ^^FeClg in the apical chamber to permit iron uptake across the 
apical membrane. Efflux into the basolateral chamber was determined over the next 2 h 
by scintillation counting, and was calculated as a proportion of apical uptake. Data are 
expressed as means ± SEM of 6 experiments. No significant differences were found 
using Student’s unpaired t-test.
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The lack of effect of IL6 on iron transport was corroborated by Western blotting 
studies that showed no difference in the protein expression of either DMTl variant, or 
Iregl in cells exposed to IL6 compared with control (Figure 6.13 and Figure 6.14).
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Figure 6.13: IL6 exposure does not alter DMTl protein expression
Cells were treated with 10 ng/ml 1L6 for 72 h. Whole cell protein samples were subjected 
to Western blotting using specific antibodies against each isoform of DMTl. Band 
density was measured by densitometry using Scion image software. Data are expressed 
as means ± SEM of 6 experiments. No significant differences were found using Student’s 
unpaired t-test.
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Figure 6.14: IL6 exposure does not alter Iregl protein expression
Cells were treated with 10 ng/ml 1L6 for 72 h. Whole cell protein samples were subjected 
to Western blotting using specific antibodies against Iregl. Band density was measured 
by densitometry using Scion image software. Data are expressed as means ± SEM of 6 
experiments. No significant differences were found using Student’s unpaired t-test.
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The data above suggest that IL6, unlike TNFa, does not have a direct action on 
intestinal epithelial cells. However it is possible that 1L6 exerts some influence on 
intestinal iron metabolism via an indirect route. IL6 is known to cause the release of 
hepcidin from hepatocytes (Nemeth et ah, 2003). To test the hypothesis that IL6 requires 
the release of hepcidin to mediate any action on intestinal absorption, hepatocyte 
conditioned medium was produced using HuH7 cells incubated for 24 h in serum free 
medium alone (HCM), or in medium containing 10 ng/ml IL6 (IL6-HCM). The 
conditioned medium was placed in the basolateral chamber of Transwell plates for the 
final 24 h of Caco-2 cell growth. Whole cell protein homogenate samples were collected 
and analysed using Western blotting for DMTl (IRE), DMTl (nonIRE), Iregl and the 
control protein villin.
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In contrast to direct application of 1L6 to Caco-2 cells, addition of the 1L6-HCM 
caused a significant decrease in DMTl (IRE) levels (Figure 6.15).
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Figure 6.15: DMTl (IRE) is decreased in Caco-2 cells exposed to 1L6-HCM
1L6 stimulated hepatocyte conditioned medium (1L6-HCM) was prepared by stimulating 
HuH7 cells with 10 ng/ml 1L6 for 24 h. Caco-2 cells grown in Transwells were 
stimulated with the HCM or 1L6-HCM in the basolateral chamber for 24 h. Whole cell 
protein samples were subjected to Western blotting and band density was measured by 
densitometry using Scion image software. Data are expressed as means ± SEM of 6 
experiments. Statistical analysis was performed using Student’s unpaired t-test. 
^Significant difference from control P <0.05.
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Further analysis using Western blotting showed that there was no decrease in 
DMTl (nonIRE) suggesting that the effects of the HCM were speeific to the IRE- 
containing DMTl isoform (Figure 6.16).
VillinDMTl (nonIRE)
HCM +1L6-HCM HCM +1L6-HCM
« 100
HCM IL6-HCM
Figure 6.16: DMTl (nonIRE) expression is not altered by exposure to 1L6-HCM
Hepatocytes were treated with 10 ng/ml 1L6 for 24 h, 1L6-HCM collected and added to 
the basolateral chamber of Transwells on which Caco-2 cells were grown. Whole cell 
protein samples were subjected to Western blotting. Band density was measured by 
densitometry using Scion image software. Data are expressed as means ± SEM of 6 
experiments. No significant differences were found using Student’s unpaired t-test.
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Western analysis revealed that protein expression of the basolateral transporter 
Iregl was not affected by the IL6-HCM and hence its effects appeared to be limited to the 
apical membrane (Figure 6.17).
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Figure 6.17: Iregl expression is not altered by exposure to IL6-HCM
Hepatocytes were treated with 10 ng/ml 1L6 for 24 h, conditioned medium collected and 
added to the basolateral chamber of Trans wells on the inserts of which Caco-2 cells were 
grown. Whole cell protein samples were subjected to Western blotting. Band density was 
measured by densitometry using Scion image software. Data are expressed as means ± 
SEM of 6 experiments. No significant differences were found using Student’s unpaired t- 
test.
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6.6 Discussion
Apical iron uptake and enterocyte ferritin content may be linked to the status of the 
immune system via several cytokines including TNFa and IL6 (Han et al., 1997). The 
links between iron metabolism and the immune system are most pronounced during long­
term illness such as chronic inflammatory disease or cancer when anaemia of chronic 
disease (ACD) may develop. This occurs despite adequate dietary iron and is 
characterised by increased iron storage (especially within the hepatic Kupffer cells and 
splenic macrophages that form the reticuloendothelial system) and impaired utilisation for 
erythropoiesis.
Increased production of TNFa has been associated with ACD (Tracey et al., 1988; 
Means and Krantz, 1992; Feelders et al., 1998) and the impact of this cytokine on ferritin 
expression has been extensively studied. TNFa up-regulates ferritin H-chain transcription 
via an NF-kB mediated mechanism (Kwak et al., 1995). The intestine may be a target 
tissue for this action. TNFa is released from intraepithélial lymphocytes residing within 
the intestinal mucosa following increased dietary iron intake (Ten Elshof et al., 1999) 
through a mechanism that is thought to involve HFE on the basolateral surface of the 
crypt epithelium (Chomey et al., 2003). Release of TNFa results in iron deposition within 
intestinal enterocytes via a TNF receptor 2-dependent mechanism (Meyer et al., 2002). In 
addition, in Caco-2 cells exposed to a cocktail of cytokines consisting of IL-ip, IL6 and 
TNFa, ferritin expression was increased, as were cellular iron levels (Han et al., 1997). 
Consistent with these findings, the work presented here showed that in Caco-2 cells 
exposed to 10 ng/ml TNFa for 72 h ferritin protein expression was up-regulated (Figure 
6.1). TNFa reduced iron efflux from the cell into the basolateral medium independently
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of changes in iron uptake, suggesting that iron accumulated across the apical membrane 
was not readily transported due to either sequestration within ferritin or down regulation 
of the Iregl transport system. Further investigation showed that expression of the 
basolateral iron transporter Iregl was unaltered by treatment with TNFa, suggesting that 
the decrease in efflux probably occurred as a result of increased iron retention within the 
cell due to the increase in expression of the iron storage protein ferritin. These data are 
supported by previous studies demonstrating that while inflammatory stimuli such as 
lipopolysaccaride and turpentine down-regulate Iregl mRNA in the spleen, TNFa has no 
effect on transporter expression (Yang et a l, 2002).
Short-term iron transport studies displayed a reduction in apical iron uptake in cells 
that had been exposed to TNFa. To gain an insight into the molecular events underlying 
the decrease in iron uptake, parallel sets of cells were treated with TNFa and used to 
isolate cellular protein, or total RNA that were analysed using Western blotting and RT- 
PCR. The effects of TNFa were found to be restricted to the IRE-containing variants. In 
total, four DMTl splice variants have been described that exhibit sequence differences at 
either the 3’ (Lee et al., 1998) or 5’ end (Hubert and Hentze, 2002) of the gene. Published 
work from our laboratory (Johnson et al., 2004) has ruled out the 5’ flanking region 
upstream of exon IB as a target site for the actions of TNFa. Thus TNFa may exert its 
influence on DMTl expression at either the promoter upstream of exon lA, or within the 
3’UTR possibly via regulation of IRE/IRP interaction. To investigate the latter possibility 
we investigated the effects of TNFa on TfRl mRNA expression. Like DMTl (IRE), 
TfRl has IRE sequences within its 3’UTR (Casey et al., 1989). TfRl mRNA was also 
down-regulated in TNFa treated cells. However, while other inflammatory mediators
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such as lipopolysaccharide and IFNy have been shown to decrease TfRl expression by 
reducing IRP RNA binding activity, there is no similar evidence for a regulatory role of 
TNFa on lRP-1 or lRP-2 activity (Kim and Ponka, 2000). Thus the relative roles of the 
extreme 5’ and 3’ regions of the DMTl gene in mediating the response to TNFa remain 
to be clarified.
In addition to TNFa, macrophages release IL6 and IFNy when stimulated during an 
immune response. In order to determine whether the effects of TNFa on intestinal iron 
metabolism were mediated by a general cytokine mechanism, the effects of IL6 were also 
studied. Measurements of iron transport, together with Western blotting for DMTl and 
Iregl showed no effect of IL6 suggesting that it had no direct effect on iron metabolism in 
intestinal epithelial cells (effects on other intestinal cell types cannot be ruled out).
IL6 is capable of inducing expression of the regulatory protein hepcidin in 
hepatocytes (Nemeth et al., 2003). Several studies have shown a correlation between the 
IL6 induced expression of hepcidin, and reduced serum iron levels (Nicolas et al., 2002b; 
Nemeth et al., 2004a). As IL6 has no direct effect on iron metabolism in Caco-2 cells, the 
next step was to determine whether IL6 could indirectly influence intestinal iron uptake 
via an increase in hepcidin. To achieve this, HuH7 cells were challenged with IL6 at 
concentrations that stimulate hepcidin production. The resulting conditioned medium 
(IL6-HCM) was collected after 24 h and then applied to the basolateral side of Caco-2 
cells. Control cells were treated with conditioned medium from HuH7 cells not exposed 
to IL6. Whole cell protein samples were collected from the Caco-2 cells, and subjected to 
Western blotting. While no significant differences were found in expression of DMTl 
(nonIRE), Iregl, or villin, the IL6-HCM caused a specific down regulation of DMTl
180
(IRE) expression. These results correlate with the theory that hepcidin released following 
a pro-inflammatory stimulus can target the duodenum to reduce dietary iron uptake. 
Previous studies using Caco-2 cells support the idea that hepcidin is the active component 
of the IL6-HCM. When synthetic hepcidin was applied to Caco-2 cells for 24 h a 
reduction in iron uptake was found with a corresponding decrease in DMTl (IRE) 
(Yamaji et ah, 2004).
Regulation of iron availability can play an important part in the body’s defence 
against pathogens. The results described in this chapter highlight some of the factors 
involved in this response. The present studies suggest that the intestinal response to ACD 
is not uniform. The onset of inflammation or infection leads to the release of a cocktail of 
pro-inflammatory cytokines. One of these cytokines, TNFa, interacts directly with the 
intestinal epithelium to decrease iron transport by reducing the expression of DMTl, 
whereas IL6 may influence iron metabolism indirectly through increased hepatic 
production of hepcidin.
More investigations are necessary to completely understand the role of hepcidin and 
factors governing its expression. It is unclear whether TNFa has a role in the hepcidin 
pathway. Not only is TNFa induced during inflammation, its expression can also be 
controlled by iron availability (Scaccabarozzi et al., 2000). Therefore it is possible that 
TNFa is a local regulator responding to varying dietary iron levels and working via 
release from tissue macrophages residing within the duodenum, while hepcidin has a 
wider systemic role (Figure 6.18).
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Figure 6.18: Model for regulation of iron absorption by hepcidin and TNFa
A; Hepcidin expression is stimulated in response to various factors including 1L6 during 
an immune response. Hepcidin then acts on mature enterocytes to reduce the expression 
of DMTl (IRE) and therefore decrease iron absorption. B: High iron concentration 
stimulates release of TNFa from intraepithélial macrophages in the duodenum. TNFa 
causes a reduction in DMTl (IRE) and increases ferritin expression.
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7.0 Discussion
Levels of iron in the body have to be carefully regulated to prevent either iron- 
deficiency, which may result in anaemia, or iron-overload, which can cause significant 
tissue damage. As there are no controlled mechanisms for the removal of excess iron from 
the body, homeostasis is maintained through careful regulation of intestinal iron 
absorption with subsequent recycling and storage. The body can adapt rapidly to the level 
of iron ingested, and can also make long term changes to compensate for prolonged 
disturbances in iron homeostasis. In humans perturbations in iron metabolism may be 
present in vulnerable groups such as infants, adolescents, or pregnant women. Each of 
these groups is susceptible to anaemia since there is a dramatic increase in body 
requirements while dietary iron supply is often insufficient to meet these needs.
In contrast there are several disorders that may cause severe iron overload. The term 
haemochromatosis is used to describe a range of conditions that have similar clinical 
consequences in which the amount of iron absorbed by the duodenum is excessive 
relative to the level of body iron stores. Mutations in HFE, Iregl, hemojuvelin and 
hepcidin (Roetto ei al., 2004), have been described in patients with variations of 
haemochromatosis (Feder et al., 1998; Montosi et al., 2001; Fleming et al., 2002).
Fully understanding the mechanism for regulating iron homeostasis is essential to 
finding the best methods to control iron balance during either iron deficiency or iron 
overload.
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7.1 Hepcidin: The Central Regulator o f  Iron Metabolism
7.1.1 Hepcidin and the Immune System
Considering the diverse range of iron-dependent functions in the body, and the 
potential toxicity of iron when in excess amounts, it seems necessary for there to be a 
central regulator for iron homeostasis, which can respond to a variety of signals and 
initiate pathways to alter iron metabolism as appropriate. The recently identified 
antimicrobial peptide hepcidin (Krause et aL, 2000; Park et al., 2001) may fulfil this role. 
Hepcidin is a negative regulator of iron status (Nicolas et ah, 2002a). In humans the role 
of hepcidin has been highlighted by a group of patients suffering with hepatic adenomas 
that expressed high levels of hepcidin. These patients presented with chronic anaemia, 
which is thought to be caused by the excess hepcidin down-regulating intestinal iron 
absorption and impairing the release of recycled iron from the reticuloendothelial system. 
The anaemia in these patients resolved upon removal of the adenoma (Weinstein et al.,
2002) demonstrating that hepcidin may have a role as regulator of iron status in humans. 
Consistent with these findings, transgenic mice over-expressing hepcidin develop 
anaemia, while in contrast targeted deletion of the hepcidin gene results in an iron 
overload that resembles haemochromatosis (Nicolas et al., 2002a). Many cases of 
haemochromatosis are caused by a mutation in the gene HFE, and interestingly several 
studies have demonstrated that hepcidin expression is reduced in HFE^ mice as well as 
haemochromatosis patients (Ahmad et al., 2002; Bridle et al., 2003; Muckenthaler et al.,
2003). Normally, iron loading would be expected to increase hepcidin expression (Pigeon 
et al., 2001). The data from haemochromatosis patients and knockout mice suggests that 
HFE may have some role in the regulation of hepcidin (Bridle et al., 2003), and that the
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disruption of this may add to the miss-regulation of iron homeostasis present in 
haemochromatosis.
Hepcidin regulation may be closely linked to the immune system through cytokines. 
In particular interleukin-6 (IL6), which has been associated with decreased serum iron 
levels (Nicolas et al., 2002b; Nemeth et al., 2004a), is capable of stimulating hepatocytes 
to release hepcidin (Nemeth et al., 2003). Interestingly, in chapter 6 it was demonstrated 
that IL6 had no direct effect on iron metabolism in Caco-2 cells when these cells are used 
as a model of intestinal enterocytes. However, further investigation demonstrated that IL6 
might be involved in regulating dietary iron absorption indirectly through the release of a 
bioactive substance (presumably hepcidin) from hepatocytes. In the studies described in 
chapter 6, HuH7 hepatoma cells were stimulated with IL6. When this conditioned 
medium was applied to Caco-2 cells DMTl (IRE) expression was significantly decreased. 
In support of a functional role for the IL6-hepcidin axis in regulating intestinal iron 
absorption, a recent study by Yamaji et al. (2004) has shown that direct application of 
hepcidin to Caco-2 cells reduces iron uptake across the apical membrane of these cells by 
reducing DMTl (IRE) expression. Therefore in vivo it seems likely that in the absence of 
any overriding signals, conditions that increase IL6 expression, such as chronic 
inflammation, will result in a hepcidin-mediated decrease in DMTl (IRE) expression and 
hence reduce iron intake from the diet. In humans this pattern of regulation has been 
demonstrated in volunteers given IL6 perfusion. In these volunteers IL6 caused a decrease 
in serum iron and transferrin levels that was associated with an increase in hepcidin 
excretion in the urine (Nemeth et al., 2004a). An IL6-hepcidin pathway that reduces iron 
absorption may partially explain the mechanism that induces the anaemia of chronic 
disease. One condition that may override this IL6-hepcidin pathway is hypoxia. Under
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hypoxic conditions iron absorption is increased (O’Riordan et a l, 1997). IL6 is induced 
under hypoxic conditions (Jeong et al, 2003), but hepcidin expression is decreased 
(Nicolas et a l, 2002b) to allow for increased iron absorption.
Interestingly, recent work has suggested that, in addition to the previously 
described effects on DMTl (IRE) expression, hepcidin can interact directly with Iregl to 
reduce its membrane levels and thereby inhibit iron release (Nemeth et a l, 2004b). 
Further studies will be required to fully establish the molecular basis for these actions on 
iron metabolism.
A second inflammatory cytokine, TNFa, can also inhibit iron absorption by 
targeting DMTl (IRE) to reduce uptake and also increase ferritin expression to sequester 
iron (results in chapter 6; Torti et a l, 1998; Miller et a l, 1991). TNFa may have an 
additional role in local regulation of intestinal iron metabolism. Iron stimulates the release 
of TNFa from intraepithélial lymphocytes residing within the intestinal mucosa following 
increased dietary iron intake (Ten Elshof et a l, 1999) and this may form the basis of a 
local feedback circuit as shown in Figure 7.1. TNFa may then signal intestinal epithelial 
cells via a TNF receptor 2 mediated mechanism to decrease DMTl (IRE) expression, and 
increase ferritin expression to sequester iron within these cells (Meyer et a l, 2002; 
Johnson et a l, 2004). Whether this proposed mechanism has a physiological role is yet to 
be determined.
7.1.2 Hepcidin and Iron Availability
In addition to responding to signals from the immune system, hepcidin expression is 
also induced by high iron load (Pigeon et a l, 2001). Studies by Frazer et a l (2002) show
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that hepcidin expression can alter in response to a change in dietary iron levels even 
before any changes develop in the level of iron stores of rats. Iron may be directly 
targeting hepcidin, possibly via a CCAAT/enhancer-binding protein a  (C/EBPa) 
mediated mechanism (Courseland et al., 2002). In the present study iron-deficient rats had 
significantly increased DMTl (IRE) expression, while in iron-loaded animals protein 
expression was unchanged although mRNA expression was significantly decreased. 
Consistent with a role for hepcidin in the regulation of DMTl (IRE) in the duodenum, 
unpublished data from this work showed that hepcidin mRNA was decreased in iron- 
deficient rats but unchanged in iron-loaded rats compared to the control group (Dr Kelly 
Johnston, personal communication). It has previously been demonstrated that hepcidin 
expression increases in iron overload (Pigeon et al., 2001). Table 3.5 shows that in the 
present study, transferrin saturation was elevated in control animals indicating a high 
degree of iron loading, which may account for the difference in these data. Together with 
the observations of Yamaji et al. (2004) that hepcidin can alter DMTl (IRE) expression in 
vitro it seems likely that hepcidin is capable of targeting mature enterocytes in the 
duodenum to modify body iron status.
7.2 Role o f  the IRE in Regulation o f  Dietary Iron 
Absorption
A range of mechanisms may control iron metabolism, including transcriptional and 
post-transcriptional events. Some regulatory factors may interact with iron regulatory 
proteins (IRP) to modulate binding to iron response elements (IRE). IRE’s are regulatory 
structures in the untranslated region (UTR) of some mRNA. When bound by IRP either 
the translation rate or the stability of mRNA is altered depending on the region containing
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the IRE, and hence levels of the product are modified (described in section 1.10.1). The 
negative influence of iron on IRP binding activity has been well characterised (Constable 
et al., 1992; Guo et al., 1995; Kim et al., 1995), however evidence suggests that this 
signalling pathway may also be used to regulate iron metabolism under hypoxic 
conditions, as well as during the immune response when cytokines such as interferon-y 
may influence IRP binding activity (Bouton et al., 1998; Hanson et al., 1999).
Alternative splicing leads to the expression of two distinct isoforms of DMTl, only 
one of which contains an IRE in its 3’UTR (Lee et al., 1998). To investigate the role of 
the IRE it is useful to compare the expression of the IRE and nonIRE forms of DMTl. In 
this report studies in the duodenum of iron-deficient rats found that the mRNA levels of 
both isoforms were increased, DMTl (IRE) protein was also significantly increased 
whereas the nonIRE protein showed a non-significant trend to higher levels. In vitro 
studies in Caco-2 cells showed that 72 h treatment with DFO to chelate iron (mimicking 
iron-deficiency) did not induce the changes seen in DMTl (nonIRE) mRNA of iron- 
deficient animals. Therefore it may be that transcription of DMTl isoforms is induced by 
endogenous signals in iron deficiency, possibly through a hepcidin mediated pathway, 
and final protein levels may be fine tuned by the activity of the IRE present in DMTl 
(IRE).
In contrast to DMTl (IRE), Iregl has an IRE in its 5’UTR (Abboud and Haile, 
2000; McKie et a l, 2000). The in vitro studies described in this report were unable to 
measure any significant effects on Iregl expression following treatment of Caco-2 cells 
with iron from 0 -  72 h. In the rat duodenum although mRNA was increased in rats fed an 
iron-deficient diet for 2 weeks there was no change in protein levels. An increase in Iregl
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mRNA has also been reported in iron-deficient mice (McKie et aL, 2000). This pattern of 
regulation does not suggest regulation via a 5TRE. An IRE in the 5’UTR would be 
responsible for a decrease in protein levels since translation would be blocked by binding 
of the IRP, but there would be no change in mRNA levels. A study in Caco-2 cells has 
found that both DFO and iron induce changes in DMTl (IRE) and Iregl expression by 
transcriptional, rather than post-transcriptional mechanisms (Zoller et aL, 2002). This 
suggests that iron-deficiency may induce changes in Iregl transcription while the IRE 
may be responsible for control of the final protein expression level depending on local 
iron status. The combination of these two regulatory mechanisms may explain why 
investigations into the regulation of Iregl expression by iron are not always consistent 
and may depend on the degree of iron deficiency or iron overload in the experimental 
system.
7.3 Rapid Changes Induced by Dietary Iron
Studies in this report (chapter 4) and by others (Yeh et aL, 2000; Ma et aL, 2000; 
Frazer et aL, 2003) show that DMTl expression is rapidly altered within the time-scale 
for digestion and absorption of a meal. These studies have observed decreasing membrane 
expression of DMTl (IRE) at 1-4 h after iron exposure. Much of this rapid regulation 
involves internalisation and recycling of existing protein, hence the IRE does not appear 
to play a role over this time-scale. Furthermore, the work performed by Frazer et aL
(2002) demonstrated that changes in hepcidin expression occur 2-6 days after a change in 
dietary iron levels, hence the rapid changes occurring 1-4 h after iron exposure are not 
likely to be induced by hepcidin. However a recent study has demonstrated that in healthy 
human volunteers given a single iron supplement there is a dramatic increase in urinary
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hepcidin excretion within 24 h (Nemeth et aL, 2004a). The possibility that rapid and 
transient changes in hepatic hepcidin production play a role in regulating intestinal iron 
absorption therefore warrants further investigation.
The signalling mechanism controlling the rapid internalisation of DMTl (IRE) on 
iron exposure is not yet known, but the ability to detect iron-induced changes in cell 
culture models implies that the signals initiating these changes are mediated locally. 
Substrate-induced trafficking of transporter protein is a recognised phenomenon in the 
gastro-intestinal tract. For example, the membrane targeting of the facilitated glucose 
transporter GLUT2 is dramatically altered in response to the prevailing level of glucose in 
the small intestinal lumen. GLUT2 can be readily detected at the basolateral membrane of 
intestinal epithelial cells. When luminal glucose is high GLUT2 can also be found at the 
brush border membrane. This is a highly dynamic and fully reversible system since when 
the luminal glucose coneentration drops between meals the transporter is rapidly 
trafficked away from the brush border membrane (Affleck et aL, 2003). This trafficking 
of GLUT2 is mediated by protein kinase C (PKC) pil, which may be activated through 
pathways initiated by glucose (Kellet and Helliwell, 2000). Regulation of GLUT2 (and 
GLUT5 which is a brush border membrane fructose transporter), is complex due to cross­
talk between several intracellular signalling pathways, such as P38 mitogen activated 
kinase and phosphatidylinositol 3 kinase pathways (Helliwell et aL, 2000). In this way the 
glucose transporter can be rapidly regulated by the presence of its substrate. There is 
some evidence that activation of PKC has a role in increasing iron uptake by increasing 
the stability of DMTl mRNA (Olivi et aL, 2001), but the effects of pathways involving 
PKC on trafficking of DMTl are still unknown.
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7.4 Changes in Iron Metabolism in Iron Deficiency
Glyceraldehyde-3-phosphate dehydrogenase (Graven et aL, 1998) and vascular 
endothelial growth factor (Namiki et aL, 1995) are both regulated at the transcriptional 
level by hypoxia. Each of the genes contains a hypoxia response element (HRE) that 
promotes transcription of the gene when bound by the transcription factor HIE la . Iron 
absorption in the duodenum is up-regulated by hypoxia (O’Riordan et aL, 1997). While 
investigating the effects of cobalt, as an example of a divalent metal also transported by 
DMTl, an increase in DMTl (nonIRE) protein was detected following cobalt exposure. 
Cobalt can mimic the effects of hypoxia by binding to hypoxia-inducible factor 1 a  
(HIFla) promoting transcription of the gene. The DMTl gene contains a region that may 
act as a HRE (Lee et al., 1998) and this may provide a mechanism for the increase in iron 
absorption during hypoxia. Hypoxia is likely to be present during iron deficiency so may 
provide a method of sensing iron status.
Expression of some proteins may be sensitive to hypoxia via post-translational 
regulation involving iron regulatory proteins 1 and 2 (IRPl and 2). Both IRPl and 2 may 
be regulated by hypoxia, but interestingly while IRPl activity is reduced, IRP2 activity is 
increased (Hanson and Leibold, 1998; Hanson et aL, 1999). This difference in regulation 
may have significant consequences for targets more sensitive to one or other IRP and 
highlights the complexity of regulation of iron metabolism.
The main use for iron in the body is as part of the oxygen binding component in 
haemoglobin, hence close interaction between oxygen and iron metabolism is essential 
and the hormone erythropoietin may provide a common link. Erythropoietin, a growth 
factor for red blood cells, is synthesised in response to hypoxia (reviewed in Jelkmann,
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1992). Erythropoietin has been shown to induce the IRE binding activity of IRPl, which 
leads to increased TfRl mRNA expression (Weiss et aL, 1997). Regulation of iron 
absorption by hypoxia may be via a pathway involving hepcidin. Nicolas et aL (2002b) 
demonstrated that hepcidin expression is decreased during hypoxia. This is likely to result 
in higher DMTl (IRE) expression and hence increased iron absorption. Another 
interesting link between oxygen and iron metabolism may result from the interaction of 
erythropoietin with hepcidin. Injection of erythropoietin into mice has been shown to 
inhibit hepcidin gene expression (Nicolas et aL, 2002c), which under hypoxic conditions 
may promote iron uptake and hence increase oxygen-binding capacity of the blood. 
Together this adds further weight to the body of evidence showing hepcidin as the key to 
regulating iron metabolism in response to diverse stimuli from sites of uptake, storage and 
utilization of iron.
7.5 Iron Metabolism and Divalent Metals
The popularity of consuming multivitamin and mineral supplements is increasing, 
however the absorption and interactions of these supplements and components of the diet 
is not always fully understood. This study (chapter 5) and others (Tandy et aL, 2000; 
Tallkvist et aL, 2001; Yamaji et aL, 2001; Tennant et aL, 2002) have shown how a range 
of divalent metals may affect iron transport and transporter expression. Some of these 
metals are presented together with enhancers and inhibitors of iron absorption in 
supplement tablets, presenting a risk of interactions and competition for uptake. For 
example vitamin C is known to be an enhancer of iron absorption (Han et aL, 1995), 
while calcium inhibits iron absorption (Minihane and Fairweather-Trait, 1998). Therefore 
a single supplement containing iron and calcium would probably limit the bioavailability
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of iron, whereas taking an iron supplement at the same time as vitamin C may increase 
the bioavailability of iron. As several other divalent metals are transported to some extent 
by DMTl, their presence in the diet or supplements in high amounts may compromise 
iron absorption due to competition for uptake. In addition metals may inhibit/enhance iron 
absorption by modulating transporter expression. For example cadmium and copper 
decrease DMTl (IRE) expression (Tallkvist et aL, 2001; Tennant et aL, 2002) while zinc 
can increase the expression of this transporter (Yamaji et aL, 2001). In addition, studies in 
chapter 5 describe how cobalt can alter iron metabolism via a specific increase in DMTl 
(nonIRE) expression. There are various mechanisms through which these metals may 
influence transporter gene expression. The 5’ region of the DMTl gene contains 
sequences that may act as metal response elements (MRE’s) (Lee et aL, 1998), or 
alternatively non-iron metals may be capable of influencing the binding activity of IRP’s 
and hence induce post-translational changes in expression of the transporters (Oshiro et 
aL, 2002).
7.6 Summary o f  Findings and Future Work
Figure 7.1 shows a summary of the findings from this report and their significance 
together with current knowledge of iron metabolism. Some aspects concerning the 
regulation of iron metabolism remain unclear and further investigation into the following 
points may provide useful information:
• Hepcidin: Whether hepcidin is a useful tool to treat disorders of iron 
metabolism has not yet been tested. Other substances that may elicit a 
response from hepcidin need to be identified and the downstream targets of
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this peptide studied. It will also be necessary to investigate exactly how 
hepcidin interacts with the intestinal epithelium to reduce iron transport.
• Cytokines: In this report it was shown that TNFa could interact in vitro with 
Caco-2 cells to decrease iron transport when the eells were used as a model of 
intestinal epithelial cells. This leads to the possibility that cytokines may act as 
local regulators of iron transport in the intestine. Further work may determine 
whether a local role for cytokines in the intestine is only relevant in disease or 
whether this is a physiological role for regulating iron metabolism.
• Divalent Metals: Further studies would be useful to determine the extent of 
metal-metal interactions in terms of competition for uptake and diet-gene 
regulation of iron transporters.
• Cellular regulation: This report demonstrated the rapid internalisation of 
DMTl (IRE) in Caco-2 cells exposed to iron. Future work may explain how 
trafficking of transporter protein is controlled and the role of cell signalling in 
rapid changes in transporter localization and function.
• Priority of Regulatory Signals: It would be useful to investigate the priority 
of signals regulating iron metabolism and how each of the regulatory 
mechanisms interact with one another. It is unclear whether transcriptional 
regulation or post-transcriptional regulation through IRE/IRP binding has the 
most significant effect on control of iron absorption from the diet.
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Figure 7.1 : Overview of Findings
Mature enterocytes are targeted by components of the diet to modulate iron absorption. 
Often these changes are via altered expression or localisation of DMTl (IRE). 
Endogenous signals may also be sensed at the basolateral membrane to alter iron uptake. 
Many of these pathways may alter hepcidin expression from the liver, which may then 
directly target mature enterocytes. In addition, signals from sites of storage or utilisation 
may target immature enterocytes in the crypts of Lieberkiihn to pre-program the capacity 
of the mature cell to absorb iron.
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